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 Cardiovascular diseases (CVD) result from a complex interplay of genetic, 
developmental, environmental and behavioural factors. CVD mortality rates increase 
with the number of risk factors to which an individual is exposed, supporting that the 
risk for CVD depends on the interaction among those factors to complete a sufficient 
causal mechanism. In young women, pregnancy puts a physiological stress on the 
body that can unmask an underlying propensity for chronic disease. Additionally, 
pregnancy is often regarded as a good opportunity for health promotion and disease 
prevention, due to the strong motivation of mothers to protect the health of the unborn 
baby. 
This thesis aims to study the cardiovascular risk profile of mothers of a 
Portuguese birth cohort (Geração XXI), before and during pregnancy, and 4 years after 
delivery. To answer this main question, the following 5 specific objectives were defined 
and pursued, resulting in 5 papers: 
1. To estimate the prepregnancy prevalence of five major cardiovascular risk factors 
(overweight/obesity, smoking, hypertension, dyslipidemia and diabetes mellitus), and to 
describe their distribution by age, gravidity and indicators of socioeconomic position 
(SEP). 
2. To assess the impact of age, education, family history of cardiovascular disease, 
prepregnancy BMI and pregnancy weight gain on hypertensive disorders in pregnancy, 
in primiparous and multiparous mothers. 
3. To assess the extent to which gestational hypertensive disorders lead to higher 
blood pressure in women and their offspring as early as 4 years after birth, and to 
assess the effect of fetal sex on these consequences. 
4. To assess the frequency and determinants of maternal smoking cessation during 
pregnancy and of the sustainability of smoking cessation 4 years after delivery. 
5. To estimate the prevalence of established cardiovascular risk factors (smoking, low 
fruit and vegetables intake, sedentariness, general overweight/obesity, abdominal 
obesity, hypertension, dyslipidemia and diabetes mellitus), 4 years after delivery, and 
to describe their distribution by age, gravidity and indicators of socioeconomic position 
(SEP). 
 The birth cohort Geração XXI was assembled between 2005 and 2006 at all 5 
public maternity units covering the metropolitan area of Porto, Portugal. Trained 
interviewers invited the mothers to participate, after delivery. Of the invited mothers, 
91.4% accepted to participate. A total of 8647 infants, corresponding to 8495 mothers, 
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were enrolled in the cohort. Data on demographic and socioeconomic characteristics, 
personal and family medical history, gynaecologic and obstetric history, prenatal care, 
and lifestyles were collected in a face-to-face interview. Anthropometrics were 
measured. Clinical records were also reviewed at birth by the same interviewers to 
retrieve data on prenatal care, pregnancy complications, delivery and neonatal 
characteristics. Missing data on the questionnaires were recovered through the review 
of obstetrical records (PAPER I), by 2 trained abstractors. Data on personal history of 
diabetes was highly concordant, while for hypertension it was moderately concordant. 
In general, the discrepancies found for weight and height indicated higher values in the 
clinical record than in the questionnaire and lead to discrepancies in prepregnancy 
body mass index classes of 10.3% of women. Data were very consistent between 
reviewers, with highest agreement for gestational diabetes and birth weight.  
At 4 years of the child’s age, between 2009 and 2011, all the mothers with their 
children were invited to attend the re-evaluation of the cohort, comprising an interview 
and physical examination. If they refused, they were invited to answer a telephone 
interview. Overall, 86.2% of the children and 84.2% of the mothers were re-evaluated. 
In the face-to-face interview, information was collected by trained interviewers, using 
two structured questionnaires. Mothers’ questionnaire comprised data on demographic 
characteristics, personal and family medical history, gynaecologic and obstetric history, 
and lifestyles. Children’s questionnaire included data on socioeconomic characteristics 
of the parents, and on child’s development, health and habits. A physical examination 
was also performed on all mothers and children, including anthropometric evaluation 
and blood pressure measurement, and a fasting venous blood sample was withdrawn.  
The telephone interview also contained data regarding the health of the mother and the 
child, although with a restricted number of questions. 
 In this sample of Portuguese women, before pregnancy, 21.3% were 
overweight and 8.8% were obese, 26.6% smoked and 11.2% were former smokers 
(PAPER II). The prevalence of hypertension, dyslipidemia and diabetes mellitus was 
1.7%, 1.7% and 0.6%, respectively, with an evident tendency to cluster. The 
prevalence of all cardiovascular risk factors, except smoking, increased with age and 
body mass index. Education and income were inversely associated with excessive 
weight. Current smokers were younger, thinner and in a lower socioeconomic position. 
 Overall, hypertensive disorders affected 4.6% of single pregnancies, and were 
associated with older age, lower education, family history of cardiovascular disease 
and excessive weight before and during pregnancy, similarly in primiparae and 
multiparae (PAPER III). Approximately 50% of hypertensive disorders among 
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primiparae and 70% among multiparae were attributable to the joint effect of 
pregnancies after 34 years of age, education below 12 years, family history of 
cardiovascular disease, overweight/obesity before pregnancy and excessive weight 
gain during pregnancy. 
 Four years after delivery, gestational hypertensive disorders were associated 
with significant increases of systolic and diastolic blood pressure of the mother 
(PAPER IV). The risk of hypertension in women affected by gestational hypertensive 
disorders was almost 6 times higher among mothers who delivered a girl, and 3 times 
higher among those who delivered a boy. Additionally, systolic and diastolic blood 
pressure at 4 years were significantly higher in boys born of mothers with hypertensive 
disorders of pregnancy, while no effect was detected among girls. 
 Although almost half of smokers ceased tobacco consumption during 
pregnancy, approximately two thirds resumed smoking 4 years after delivery (PAPER 
V). Cigarette smoking cessation during pregnancy was more likely among primigestae, 
those living with a partner, with higher educational levels, overweight or obese, with 
adequate prenatal care, who began smoking later and who smoked a lower amount of 
cigarettes. Those who sustained the smoking cessation were more likely to be older, 
primigestae, living with a husband/partner at 4 years, with lower tobacco consumption 
before pregnancy, and to have breastfed for 52 weeks or more, to have gotten 
pregnant again after the index pregnancy and to have  a medical diagnosis of asthma 
and/or rhinitis in their child. 
 At follow-up, 25.3% of the participants were smokers, 50.7% consumed less 
than 3 portions of fruit and vegetables per day, and 81.3% did not practice any leisure-
time physical exercise (PAPER VI). Moreover, 31.4% were overweight, 21.3% obese 
and 31.8% had abdominal obesity. Regarding the cardiometabolic comorbidities, 8.7% 
of the women had hypertension and the prevalence of dyslipidemia and diabetes 
mellitus was 18.5% and 0.9%, respectively. The presence of at least one risk factor 
from each of the 3 groups (adverse lifestyles, adiposity and cardiometabolic 
comorbidities) was observed in 17.0% of women. All risk factors were associated with 
unemployment, lower education and lower income. 
In conclusion, Portuguese young women are at a high level of risk for 
cardiovascular disease, before and after pregnancy. The clustering of cardiovascular 
risk factors, as well as the high prevalence of adverse lifestyles and adiposity, show an 
adverse cardiovascular risk profile of Portuguese mothers since the preconceptional 
period. 
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Pregnancy induces profound alterations in maternal health, by revealing 
previous background risk and/or increasing the propensity to develop cardiovascular 
diseases. Prepregnancy risk factors explained a high proportion of hypertensive 
disorders during pregnancy, with excessive weight before and during pregnancy, 
having a very large contribution, particularly among primiparae. Additionally, 4 years 
after a single pregnancy complicated by gestational hypertensive disorders in 
primiparae, the impact on mothers’ blood pressure and incident hypertension was 
large, and this effect was stronger when the foetus was female. Regarding the children, 
a differential effect by child’s sex was observed, supporting the hypothesis of 
heterogeneous causes of hypertension in pregnancy and that boys live dangerously in 
the womb.  
During pregnancy almost half of the women stopped smoking. However, 4 
years after delivery two thirds of these resumed smoking, showing that this behavioural 
change showed little long-term impact on women’s smoking trajectory. 
The high risk of cardiovascular disease described in young and apparently 
healthy women, who achieved at least one successful pregnancy, emphasizes the 
need to implement coherent and effective strategies of health promotion and disease 
prevention at early stages of life in order to optimize women’s current and future health. 
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As doenças cardiovasculares resultam de uma complexa interação entre 
fatores genéticos, de desenvolvimento, ambientais e comportamentais. A taxa de 
mortalidade por doenças cardiovasculares aumenta com o número de fatores de risco 
a que um indivíduo está exposto, ilustrando que estes fatores têm efeitos 
interdependentes para completarem um mecanismo causal suficiente. Em mulheres 
jovens, a gravidez condiciona uma situação de stress fisiológico no organismo, que 
pode desmascarar uma propensão mais elevada, previamente inaparente, para a 
ocorrência de doenças crónicas. Adicionalmente, a gravidez é uma boa oportunidade 
para a promoção de saúde e para a prevenção da doença, devido à forte motivação 
das mães para proteger a saúde do feto. 
Esta tese tem como objetivo estudar o perfil de risco cardiovascular em mães 
de uma coorte de nascimento Portuguesa (Geração XXI), antes e durante a gravidez, 
e 4 anos após o parto. Para responder a esta questão geral, foram definidos os 
seguintes 5 objetivos específicos, os quais resultaram em 5 manuscritos científicos: 
1. Estimar a prevalência de cinco fatores de risco cardiovascular major (excesso de 
peso/obesidade, tabagismo, hipertensão arterial, dislipidemia e diabetes mellitus) 
antes da gravidez, e descrever a sua distribuição de acordo com a idade, o número de 
gravidezes prévio e indicadores da posição socioeconómica. 
2. Avaliar o impacto da idade, da escolaridade, da história familiar de doença 
cardiovascular, do índice de massa corporal prévio à gravidez e do ganho de peso 
durante a gravidez na ocorrência de complicações hipertensivas da gravidez, em 
mulheres primíparas e multíparas. 
3. Avaliar em que medida o desenvolvimento de complicações hipertensivas durante a 
gravidez conduz ao aumento da pressão arterial das mães e das crianças 4 anos após 
o parto, e avaliar o efeito do sexo da criança nestas consequências. 
4. Avaliar a frequência e os determinantes da cessação tabágica durante a gravidez e 
da manutenção da cessação tabágica 4 anos após o parto. 
5. Estimar a prevalência de fatores de risco cardiovascular previamente estabelecidos 
(tabagismo, baixo consumo de frutas e vegetais, sedentarismo, excesso de 
peso/obesidade, obesidade abdominal, hipertensão arterial, dislipidemia e diabetes 
mellitus), 4 anos após o parto, e descrever a sua distribuição de acordo com a idade, o 
número de gravidezes prévio e indicadores da posição socioeconómica. 
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 A coorte de nascimento Geração XXI foi recrutada entre 2005 e 2006, nos 5 
hospitais públicos com maternidade da área metropolitana do Porto, Portugal. Após o 
parto, inquiridores treinados convidaram as mães a participar. De entre as mães 
convidadas, 91,4% aceitaram participar. Um total de 8647 crianças e as respetivas 
8495 mães foram incluídas na coorte. Através de uma entrevista presencial às mães, 
foram recolhidas informações sobre as características demográficas e 
socioeconómicas, história pessoal e familiar de doença, história ginecológica e 
obstétrica, cuidados pré-natais e estilos de vida. As mães e as crianças realizaram 
uma avaliação antropométrica. Os mesmos inquiridores treinados reviram também os 
processos clínicos na altura do parto, para recolher informações relativas aos cuidados 
pré-natais, à ocorrência de complicações durante a gravidez, e às características do 
parto e neonatais. Para recuperar informações em falta nos questionários, revimos os 
processos clínicos obstétricos das mães (ARTIGO I), por 2 revisores treinados. A 
concordância entre os dados do questionário e dos registos obstétricos para a história 
pessoal de diabetes foi altamente concordante, enquanto para a de hipertensão foi 
moderadamente concordante. Em geral, as discrepâncias encontradas para o peso e a 
altura indicavam valores mais elevados nos registos clínicos do que nos questionários, 
o que resultou em divergências na classe de índice de massa corporal em 10,3% das 
mulheres. A informação recolhida foi extremamente consistente entre os dois 
revisores, com máxima concordância para a diabetes gestacional e o peso ao 
nascimento.  
 Aos 4 anos de idade das crianças, entre 2009 e 2011, todas as mães e os 
respetivos filhos foram convidados a participar na reavaliação da coorte, composta por 
uma entrevista e avaliação física. Caso recusassem, eram convidadas a responder a 
uma entrevista telefónica. Do total, 86,2% das crianças e 84,2% das mães foram 
reavaliadas. Durante a entrevista presencial, a informação foi recolhida por 
inquiridores treinados, utilizando dois questionários estruturados. O questionário da 
mãe continha informação sobre as suas características demográficas, história pessoal 
e familiar de doença, história ginecológica e obstétrica, e estilos de vida. O 
questionário da criança incluía informações relativas às características 
socioeconómicas parentais, e sobre o desenvolvimento, saúde e hábitos da criança. 
Foi realizado um exame físico às mães e crianças, incluindo avaliação antropométrica 
e medição da pressão arterial, e colheita de uma amostra de sangue em jejum. Na 
entrevista por telefone também se recolheu informações relativas à saúde da mãe e da 
criança, ainda que com um número mais restrito de questões. 
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 Nesta amostra de mulheres Portuguesas, 21,3% tinham excesso de peso e 
8,8% eram obesas, 26,6% fumavam e 11,2% eram ex-fumadoras, antes de engravidar 
(ARTIGO II). A prevalência de hipertensão arterial, dislipidemia e diabetes mellitus era 
de 1,7%, 1,7% e 0,6%, respectivamente, com uma clara tendência de agregação. A 
prevalência de todos os fatores de risco cardiovascular, com a exceção do tabagismo, 
aumentou com a idade e com o índice de massa corporal. A escolaridade e o 
rendimento associaram-se inversamente com a prevalência de excesso de peso. As 
fumadoras eram mais novas, com um índice de massa corporal mais adequado e 
tinham uma posição socioeconómica mais baixa. 
Globalmente, as complicações hipertensivas afetaram 4,6% das gravidezes de 
feto único, e estavam associadas a idade mais avançada, menor escolaridade, história 
familiar de doença cardiovascular e excesso de peso antes e durante a gravidez, de 
forma similar em mulheres primíparas e multíparas (ARTIGO III). Aproximadamente 
50% dos casos de complicações hipertensivas na gravidez em mulheres primíparas e 
70% em multíparas foram atribuíveis ao efeito conjunto de idade superior a 34 anos, 
escolaridade inferior a 12 anos, história familiar de doença cardiovascular, excesso de 
peso/obesidade e ganho de peso excessivo durante a gravidez. 
 Quatro anos após o parto, as complicações hipertensivas gestacionais 
associaram-se a aumentos significativos na pressão arterial sistólica e diastólica da 
mãe (ARTIGO IV). O risco de hipertensão arterial nas mães que desenvolveram uma 
complicação hipertensiva durante a gravidez, comparativamente com as que tiveram 
uma gravidez sem hipertensão, foi cerca de 6 vezes superior nas que deram à luz uma 
criança do sexo feminino e 3 vezes maior nas que deram à luz uma criança do sexo 
masculino. Adicionalmente, a pressão arterial sistólica e diastólica aos 4 anos de idade 
foi significativamente superior nos rapazes cujas mães tiveram uma complicação 
hipertensiva durante a gravidez, enquanto não foi detetado nenhum efeito nas 
raparigas. 
 Apesar de quase metade das fumadoras terem parado de fumar durante a 
gravidez, aproximadamente dois terços destas retomaram o consumo 4 anos após o 
parto (ARTIGO V). A cessação tabágica durante a gravidez foi mais frequente em 
mulheres primigestas, que viviam com o marido/companheiro, com escolaridade mais 
elevada, com excesso de peso ou obesas, com cuidados pré-natais adequados, que 
começaram a fumar mais tardiamente e que fumavam uma menor quantidade de 
cigarros diária. Aquelas que mantiveram a cessação tabágica eram mais velhas, e 
mais frequentemente primigestas, viviam com o marido/companheiro 4 anos após o 
parto, tinham um menor consumo de tabaco antes de engravidar, amamentaram 52 
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semanas ou mais, voltaram a engravidar após a gravidez índice e os seus filhos 
tinham mais frequentemente um diagnóstico médico de asma ou rinite. 
 Na reavaliação da coorte, 25,3% das participantes eram fumadoras, 50,7% 
consumiam menos de três porções de frutas e vegetais por dia, e 81,3% não 
praticavam qualquer tipo de exercício físico de lazer (ARTIGO VI). Adicionalmente, 
31,4% apresentavam excesso de peso, 21,3% eram obesas e 31,8% possuíam 
obesidade abdominal. Relativamente às comorbilidades cardiometabólicas, 8,7% das 
mulheres eram hipertensas e, a prevalência de dislipidemia e diabetes mellitus era de 
18,5% e 0,9%, respectivamente. A presença de pelo menos um fator de risco de cada 
um dos três grupos (estilos de vida adversos, adiposidade e comorbilidades 
cardiometabólicas) foi observada em 17,0% das mulheres. Todos os fatores de risco 
estavam associados com o desemprego e com níveis de escolaridade e rendimento 
mais baixos. 
 Em conclusão, as mulheres jovens Portuguesas apresentam um risco elevado 
de doença cardiovascular, antes e após a gravidez. A agregação de fatores de risco 
cardiovascular, assim como as elevadas prevalências de estilos de vida adversos e de 
adiposidade, mostram um perfil de risco cardiovascular desfavorável em jovens mães, 
desde o período pré-concepcional.  
A gravidez induz profundas alterações na saúde da mãe, desmascarando 
riscos prévios e/ou uma propensão acrescida para o desenvolvimento de doenças 
cardiovasculares. As características prévias à gravidez explicam uma elevada 
proporção de complicações hipertensivas durante a gravidez, com o excesso de peso 
antes e durante a gravidez a terem uma grande contribuição, particularmente nas 
mulheres primíparas. Adicionalmente, 4 anos após uma gravidez de feto único, 
agravada por uma complicação hipertensiva da gravidez, em mulheres primíparas, as 
mães já possuem valores elevados de pressão arterial e mais frequentemente 
apresentam hipertensão arterial crónica, sendo este efeito mais acentuado quando o 
feto é do sexo feminino. Relativamente às crianças, foi observado um efeito diferencial 
de acordo com o sexo da criança, o que suporta a hipótese da existência de causas 
heterogéneas para a hipertensão na gravidez e que o desenvolvimento uterino coloca 
os rapazes em maior risco no futuro.  
Durante a gravidez cerca de metade das mulheres parou de fumar. Contudo, 4 
anos após o parto dois terços retomaram os hábitos tabágicos, revelando que esta 
mudança comportamental tem pouco impacto a longo prazo na trajetória tabágica das 
mulheres. 
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O elevado risco de doença cardiovascular descrito em mulheres jovens e 
aparentemente saudáveis, que tiveram pelo menos uma gravidez que resultou num 
nado-vivo, reforça a necessidade de implementar estratégias coerentes e eficazes de 
promoção de saúde e de prevenção de doença nas fases precoces da vida adulta, de 
forma a otimizar a saúde atual e futura das mulheres. 
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CARDIOVASCULAR DISEASE 
 
 
Cardiovascular diseases (CVD), defined as diseases of the heart and 
circulatory system, are the leading cause of death and morbidity worldwide (1), 
accounting for nearly 30% of deaths (2).  
In Europe, CVD are responsible for almost half of deaths (54% in women and 
43% in men) (3). Since 1970, a continuous decrease in total cardiovascular mortality 
rates has been observed in men and women in Western Europe. In fact, between 1970 
and 2000, total cardiovascular mortality decreased on average 50% and 60%, 
corresponding to an average annual decline of 1.8% and 2.0%, in men and women, 
respectively (4). Two main factors have contributed to this decline: decrease in 
incidence due to substantial reductions in the prevalence of some major cardiovascular 
risk factors and decrease in case-fatality due to improvements in treatments, which 
become more effective and widely used (5). However, despite the decline of age-
adjusted cardiovascular death rates during the last decades (4, 6), coronary heart 
diseases and stroke remain the two most common causes of death in Europe (3). 
In Portugal, diseases of the circulatory system accounted for 32.2% of all 
deaths in 2006; 37.3% in women and 27.6% in men (7). The total CVD mortality rates 
in Portugal are higher than the European average, with cerebrovascular diseases being 
the single most important cause of death in Portugal (8). 
Beyond their contribution to mortality, CVD also has a large contribution to 
morbidity outcomes. Morbidity from CVD is more difficult to quantify than mortality, 
since at present there is no routinely updated source of CVD morbidity data covering 
the European population (3). Additionally, there are many different measures of 
morbidity which difficult the comparison of data. The disability adjusted life years 
(DALYs) lost, which is an aggregate measure of years of life lost due to premature 
death and years of healthy life lost to disability, is used as an indicator of the burden of 
the disease. The estimates provided by the World Health Organization (WHO) Global 
Burden of Disease project indicates that over 34 million DALYs (23% of all DALYs) are 
lost each year due to CVD, in Europe (9). Regarding more developed European 
countries, it is estimated that 17% of all DALYs lost are due to CVD, which represent 
the largest cause of disability after neuropsychiatric disorders. In less developed 
European countries, CVD were the leading cause of DALYs lost. 
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Moreover, CVD has major economic costs for Europe (3, 10). In 2006, CVD 
cost the health care systems of the European Union just under €110 billion, which 
represents around 10% of the total health care expenditure. However, looking only at 
the direct costs to the health care systems grossly underestimates the true cost of 
CVD, since production losses from death and illness in those of working age and from 
the informal care of people with the disease contribute greatly to the overall financial 
burden. Production losses due to mortality and morbidity associated with CVD cost 
almost €41 billion in the European Union, with around two-thirds of this cost due to 
death and one-third due to illness in those of working age. Overall, CVD is estimated to 
cost the European Union economy €192 billion a year, of which 57% is due to direct 
health care costs, 21% to productivity losses and 22% to the informal care of people 
with CVD (3). Similarly, in Portugal, 10% of the total health care expenditure is spent 
on CVD, with 69%, 15% and 16% of the overall cost of CVD due to direct health care 
costs, productivity losses and the informal care of people with CVD, respectively (3). 
Due to the extremely high human and economic impact of CVD (3, 6, 10), it is 
important to descriptively quantify the distribution of cardiovascular risk factors in order 
to monitor trends over time and guide preventive strategies to reduce the future burden 
of disease, by identifying groups at higher risk and understanding factors that 
contribute to the exposure. 
 
 
 
CARDIOVASCULAR RISK  
 
CVD reflect a combination of genetic, developmental, environmental and 
behavioural factors (6, 11). The modifiable nature as well as the considerable impact of 
lifestyles on the development of CVD (12) emphasize the importance of investing in 
primary prevention. CVD result of a complex causal chain, with different roots in a 
multifaceted sequence of events over time, consisting of socioeconomic factors, 
environmental and community conditions, and individual behaviour. Figure 1 outlines 
the causal chain of ischaemic heart disease (2). Some elements in the chain, such as 
high blood pressure or cholesterol, act as a relatively direct cause of the disease, while 
others risks, located further back in the causal chain, act indirectly through intermediary 
factors. These risks include physical inactivity, alcohol, smoking or fat intake. Less 
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certainty can be attributed to the causal role of other risk factors, such as education 
and income. However, modifying these background causes is more likely to have 
amplifying effects, since such modifications have the potential to yield fundamental and 
sustained improvements to health. 
 
 
Figure 1. The causal chain. Major causes of ischaemic heart disease are shown. Arrows 
indicate some (but no all) of the pathways by which these causes interact (2). 
 
 
Worldwide, hypertension, dyslipidemia, diabetes, obesity, physical inactivity, 
poor diet with insufficient fruit and vegetables intake, excessive alcohol consumption, 
smoking and stress are responsible for approximately 90% of all cases of acute 
myocardial infarction in both sexes (12). According to the up-to-date WHO Report on 
health risks (2) these risks factors together, except stress, account for 61% of healthy 
years of life lost due to CVD and 61% of cardiovascular deaths. Among European 
populations, CVD is mainly attributable to cigarette smoking, high blood pressure, high 
serum cholesterol, diabetes, overweight/obesity and unhealthy diet (13). They are 
designated major risk factors for three reasons: their high prevalence in populations, 
their strong impact on coronary risk; and their preventability and reversibility, primarily 
by safe improvements in population lifestyles (13). The relation between these risk 
factors and CVD seem to be independent, strong, continuous and graded, and the 
modification of these risk factors can result in substantial reduction in mortality (5).  
In the Portuguese population, central obesity, defined through the waist-to-hip 
ratio, was the risk factor with the highest impact in acute myocardial infarction, being 
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responsible for 81.2% of cases in younger men and 88.7% of cases in men aged over 
45 years (14) , although the relative contribution of different factors depends largely on 
the operationalization of their definition. Additionally, fruit and vegetables intake, 
vitamin and mineral supplement use and leisure-time physical exercise were found to 
decrease acute myocardial infarction risk, with similar effects between sexes (15). 
In the last decades, several studies have shown that CVD mortality rates 
increase with the number of risk factors to which an individual is exposed (16-18), 
supporting that the risk for CVD depends on the interaction among those factors to 
complete a sufficient causal mechanism (19). In fact, these studies reveal that the 
lower the risk factor profile, the lower the risk for CVD and all-cause mortality. In a 
prospective population-based cohort of men and women aged 18 to 74 years at 
baseline, clustering of 3 or more risk factors occurred in about 17% of both sexes and 
were associated with a 2-fold and an almost 6-fold increased risk of coronary heart 
disease in men and women, respectively, after 16 years of follow-up (20).  
Currently, CVD risk assessment constitutes an important tool in the primary 
prevention of these diseases. Guidelines advocate the use of cardiovascular risk 
scores to calculate global risk instead of focusing on single risk factors modification, in 
order to prevent the occurrence of disease (21). The Framingham Heart Study 
provided data for the first and most widely used risk prediction tool (22, 23). However, 
this score overestimated CVD risk in European populations, particularly in those 
considered at low risk (24-26). In 2003, the Third Joint Task Force of the European 
Societies on Coronary Prevention recommended the use of the SCORE function in the 
management of cardiovascular disease prevention in clinical practice (27). Actually, 
SCORE remains the tool of choice for the prediction of the 10-year risk of fatal CVD 
(21). 
 For the most effective prevention of CVD, it is also very important to take into 
account factors of different nature that could both have direct physiological effects and 
influence the biological risk factors, referred to, in this context, as “the causes of 
causes”. Psycho-social factors play an increasingly recognized role in this regard. In 
particular, socioeconomic position (SEP) has been consistently described as a risk 
factor for CVD, with those in poorer socioeconomic circumstances presenting poorer 
health (28). It is argued that SEP influences the capacity to access and interpret health 
information including the adoption of healthy lifestyles (29, 30). Therefore, health 
education should be literacy sensitive in order to enhance health knowledge, self-
efficacy and motivation to change one’s risk profile.  
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CARDIOVASCULAR DISEASE IN WOMEN 
 
Gender differences in the cardiovascular system and sex diversity in genetic 
susceptibility to CVD are highly recognized. At present, there is growing awareness of 
many fundamental gender dissimilarities in cardiovascular anatomy and 
pathophysiology (31). These differences become apparent soon after puberty and are 
more pronounced with age (31, 32). 
Women have traditionally been thought of as a low-risk population for CVD. 
However, as illustrated in Figure 2, CVD are the main cause of death for women in 
Europe, and are responsible for more than 50% of deaths in women, ranging from 31% 
of deaths in France to 71% in Bulgaria (3). 
 
 
Figure 2. Deaths among women by cause, in Europe (3) 
 
 
The onset of clinically significant coronary heart disease occurs on average a 
decade later in women compared with men (33). The more favourable risk profile of 
CVD among young women may theoretically be explained by the effects of sex 
hormones. Premenopausal women have lower blood pressure compared with men of 
similar age, a pattern that is no longer seen after menopause (34). Additionally, the 
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higher risk factor levels at younger ages in men compared to women may also play a 
role in the course of disease (33). 
Nevertheless, young women are also affected and may be at particularly high 
risk of complications when CVD is present. Recently, an American study focused on 
coronary heart disease mortality among young adults from 1980 through 2002, 
postulated that among women aged 35 to 44 years, the mortality rate from coronary 
heart disease changed little since the late 1980s (35). Particularly noteworthy is that 
the mortality rate among women, in this age range, has been increasing on average 
1.3% (95%CI 0.2-2.5) per year since 1997 (35). Similarly, coronary heart disease 
mortality rates in Scotland have tended to level off among young adults over the last 
few years (36). However, according to data derived from the WHO database, different 
trends have been described for Europe as a whole (37). Since the 1980s, CVD 
mortality rates at ages 35 to 44 years in both sexes steadily declined in Europe, except 
in Russia, whose rates were 10 to 15-fold higher than those of most western European 
countries. Patterns were similar in men and women, though with appreciably lower 
rates in women. The average annual percent of change in the European Union for 
coronary heart disease was -3.3% in men and -2.1% in women, while for 
cerebrovascular disease was -2.5% in both sexes, with steeper declines from the mid-
late 1990s onwards. 
Despite less common, CVD that occurs at younger ages is associated with a 
substantial risk of morbidity and mortality in women. It was reported that after 
myocardial infarction, younger women, but not older women, had higher rates of death 
during hospitalization than men of similar age (38-40). This may be due to a delay in 
diagnosis or a lower index of suspicion by health care providers in young women. 
Several studies reported that women are more likely to present with atypical symptoms 
including fatigue, weakness, dyspnea, nausea, palpitations, or midback pain (41, 42). 
In fact, the absence of chest pain or discomfort with acute coronary syndrome is more 
common in women than in men, particularly among those below 60 years of age (43). 
Similarly, women with less than 55 years of age are more likely to be discharged from 
the emergency department with a missed diagnosis of acute coronary syndrome than 
any other age or gender group (44). A delay in diagnosis or a lower index of suspicion 
by health care providers may cause treatment delay and less aggressive interventions 
(45). Additionally, the lack of awareness of risk may be a barrier to prevention of CVD 
in women. In a survey conducted in the United States, only 16% of women recognized 
heart disease as the greatest health problem facing women today, and only half 
identified it as the leading cause of death (46).  
25 
 
Data from the INTERHEART study indicate that nine potentially modifiable risk 
factors account for 94% of the population attributable risk of myocardial infarction in 
women (33). Regarding young adulthood, results from a prospective cohort study of 
women aged 18 to 39 years (17) show that favourable levels of all five major risk 
factors (smoking, hypertension, diabetes, serum cholesterol and body mass index) 
were associated with lower long-term CVD and all-cause mortality, after an average 
follow-up of 31 years. Moreover, the age-adjusted CVD death rate increased with the 
number of risk factors. In fact, CVD mortality rate per 10000 person-years for women 
with 2 or more risk factors was approximately 6 times higher than low-risk women. 
Unfortunately, only about 20% of women younger than 40 years meet these low-risk 
criteria, presenting favourable levels of for all the risk factors considered (17). Another 
study reported that in women aged between 18 and 75 years, 19% presented a 
clustering of three or more metabolic risk factors for coronary heart disease (20). 
As illustrated in Figure 3, men and women share most classic cardiovascular 
risk factors, across various regions of the world (12). Nevertheless, the significance 
and the relative weighting of these factors are different according to sex (47). As was 
demonstrated across Europe in the EUROASPIRE III survey, women have a higher 
prevalence of diabetes and hypertension than men and, especially young women, have 
taken up smoking habits with its consequences for CVD incidence and prevalence (48). 
Overall, hypertension and diabetes mellitus imposed a higher risk for myocardial 
infarction in women compared with men, while exercise and moderate alcohol intake 
were more protective among women (12, 49). In the INTERHEART study, the 
population attributable risk for hypertension was 36% in women, while the 
corresponding figure in men was 19% (33). Regarding diabetes, in a meta-analysis of 
37 prospective cohort studies, the risk of fatal coronary heart disease was 50% higher 
in women with diabetes compared with men (49). The constellation of symptoms 
termed metabolic syndrome was also found to be most predictive of future myocardial 
infarction in young women (50).  
Across Europe, exposure to modifiable unfavourable lifestyle factors have 
aggravated, with its consequences for CVD incidence and prevalence (48). With the 
increase in smoking rates in younger women, reinforcement of healthy lifestyle 
becomes more important. Smoking has a particularly harmful effect in young women, 
with a 60% increased risk for myocardial infarction when compared with men (51). A 
recent prospective cohort study suggests that women with high central obesity are 
about 20% more likely to develop coronary heart disease compared to their male 
counterparts (52). Similarly, prospective data from the Women’s Health Initiative 
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Observational Study indicate that both walking and vigorous exercise are associated 
with substantial reductions in the incidence of cardiovascular events among women, 
irrespective of race or ethnic group, age, and body-mass index (53). Additionally, 
coping with stress and emotions as well as depression and anxiety disorders are more 
associated with elevated CVD risk among women (54, 55).  
 
 
Figure 3. Association of risk factors with acute myocardial infarction in men and women after 
adjustment for age, sex, and geographic region (12) 
 
 
As mentioned above, in Europe, the SCORE system is recommended to 
evaluate CVD risk (27). These guidelines have comparable limitations to the 
Framingham guidelines for primary prevention in women and tend to underestimate 
CVD risk in especially the younger age-groups (21). The Reynolds Risk Score was 
developed specifically for women (56) and the main difference from the Framingham 
score is the incorporation of parental history of ischemic heart disease and C-reactive 
protein. This score reclassified 15% of intermediate risk women to high risk in the 
Women’s Health Study, a nationwide cohort of American women aged 45 years and 
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older. However, it needs validation in other populations and is not applicable to young 
women. 
In summary, there is strong international evidence on gender-related 
specificities of CVD (57). However, few epidemiological studies have assessed the 
prevalence and clustering of cardiovascular risk factors in women, in a fertile age. 
Understanding the differences diversities may lead to a better management of CVD 
and guarantee an improved overall prognosis. Priorities to improve cardiovascular care 
among women should be discussed within multidisciplinary teams, with a focus on the 
major threats to cardiovascular health in women. 
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WOMEN’S REPRODUCTIVE HEALTH 
 
Reproductive health is a state of complete physical, mental and social well-
being, and not merely the absence of disease or infirmity, addressing the reproductive 
processes, functions and system at all stages of life (8, 58).  Therefore, it implies that 
people are able to have a responsible, satisfying and safe sex life and that they have 
the capability to reproduce and the freedom to decide if, when and how often to do so. 
Implicit in this concept are the right of men and women to be informed and to have 
access to safe, effective, affordable and acceptable methods of fertility regulation of 
their choice, and the right of access appropriate health care services that will enable 
women to go safely through pregnancy and childbirth and provide couples with the best 
chance of having a healthy infant (8, 58). In this context, preconceptional, prenatal and 
postnatal care are critical components in the continuum of care of women and 
newborns (59). 
Women’s health in Portugal has experienced a huge overall improvement since 
the late 70s and the implementation of the National Health System, which ensures all 
citizens nearly free access to primary care centers and public hospitals (60). The 
dramatic improvements in perinatal health are worth noticing. In 2004, the maternal 
mortality rate was 7.7 per 100,000 live births, very similar to the Europe mean of 6.6 
per 100,000 live births (61). Also, between 1996 and 2008, the infant mortality declined 
from 6.9 to 3.3 per 1000 live births, the neonatal mortality from 4.2 to 2.1 per 1000 live 
births and the perinatal mortality from 8.4 to 4.0 per 1000 live births (7). These declines 
during the last decades are major successes of Portuguese perinatal health (62).  
Pregnancy and childbirth are physiological events, but they carry risks that can 
be reduced by health-care interventions such as the provision of family planning and 
maternity care and access to safe abortion care (63). In women, preconceptional and 
prenatal care can provide the opportunities for regular risk assessment and prevention 
of pregnancy-related co-morbidities. Postpartum care is important for detecting and 
treating infections and other conditions, including postpartum depression, and for 
providing advice on family planning. This continued care throughout pregnancy, 
childbirth and the postpartum period is essential for health promotion at young ages.  
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PREGNANCY AND CARDIOVASCULAR RISK 
 
 Pregnancy is a natural life event, in a woman’s life, but implies some 
psychological and physiological adaptations. It constitutes a stress test for maternal 
cardiovascular function (64), due to the occurrence of several adaptive changes in the 
woman’s body that facilitate foetal growth. At the same time, it is a good opportunity for 
health promotion and disease prevention (65), since mothers tend to be strongly 
motivated to adopt healthier lifestyles in order to protect the health of the unborn baby 
(65, 66).  
 
 
Pregnancy: a stress test for maternal cardiovascular function 
 
In healthy pregnancies, hemodynamic changes, hyperlipidaemia, insulin 
resistance, up-regulation of inflammatory markers and plasma volume expansion take 
place in women’s physiology to meet demands of the rapidly developing foetus (67, 
68).  
During pregnancy, there is a fall of approximately 10 mmHg in blood pressure 
until 22 to 24 weeks (69). This reflects the marked reduction in total peripheral vascular 
resistance, which decreases by 25%, while cardiac output is increased by as much as 
50% (68, 70, 71). The fall in blood pressure may obscure the diagnosis of pre-existing 
mild hypertension, particularly in young women who do not have blood pressure 
measured regularly before pregnancy. In the third trimester, the blood pressure 
gradually increases and may normalize to pre-pregnant values by term (69). 
Immediately after delivery, blood pressure usually falls, but increases again over the 
first five postnatal days (71). Even women whose blood pressure was normal 
throughout pregnancy may experience transient hypertension in the early postpartum 
period, probably reflecting a degree of vasomotor instability (69). Plasma and red cell 
volumes also expand in normal pregnancy by approximately 40% and 25%, 
respectively. These changes begin as early as the fourth week of gestation and peak 
around the 28th week (72, 73). The progressive rise in plasma and blood volume are 
likely adaptations, via renal sodium retention, to the vasodilatation and fall in blood 
pressure (74, 75).  
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Normal pregnancy is a state of insulin resistance, with a doubling in fasting 
insulin concentrations. This is due to changes in maternal hormonal and metabolic 
factors related to the placenta, adipose tissue, and the growth hormone axis (76, 77). 
The increased insulin resistance reaches a maximum in the third trimester, and 
improves following delivery (78, 79). During pregnancy, there are also changes in lipid 
profile, with a particular increase of around 300% in triglyceride levels and a 25–50% 
increase in total cholesterol (80). This gestational hyperlipidaemia fulfils the 
physiological role of supplying both cholesterol and triglyceride to the rapidly 
developing foetus (81, 82). Additionally, pregnancy is associated with a generalised 
maternal inflammatory response (83, 84) and with an overall state of hypercoaguability, 
due to increases in the levels of several coagulation factors (85). It is likely that this 
state of hypercoagulability may serve to limit life-threatening bleeding at delivery but 
there is an increased risk of thromboembolism associated with pregnancy (86). 
Altogether, these changes in maternal physiology allow the cardiovascular 
system to adjust to the physiological demands of the foetus while maintaining maternal 
cardiovascular integrity (67). However, in some women, this normal adaptive response 
is greatly exaggerated and can lead to prenatal complications, such as recurrent 
miscarriage, congenital malformations, gestational hypertensive disorders, gestational 
diabetes mellitus and venous thromboembolism. Additionally, data linking the maternal 
vascular, metabolic, and inflammatory complications of pregnancy with an increased 
risk of vascular disease in later life, have been increasing (64). Moreover, the marked 
pregnancy-induced hemodynamic alterations put a physiological stress on the body 
that have a profound effect on future health. Hypertensive disorders in pregnancy have 
been shown to be predictors for hypertension and CVD events (87, 88), with women 
with placental complications (89), poor foetal growth or intrauterine death considered to 
be at the greatest risk (90). Further, an impaired glucose tolerance during pregnancy 
and gestational diabetes constitute female specific risk factors for the development of 
diabetes and the metabolic syndrome in relatively young women (91, 92). 
Hypertensive disorders in pregnancy are major complications of pregnancy, 
increasing the risk of adverse obstetric and perinatal outcomes (93-95). They include 
chronic and gestational hypertension, preeclampsia and eclampsia, with the latter three 
entities representing generally transient hypertensive conditions with onset during 
pregnancy (96). 
According to the National High Blood Pressure Education Program Working 
Group on High Blood Pressure in Pregnancy (96), chronic hypertension is defined as 
systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg, 
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diagnosed before pregnancy or before the 20th week of gestation. Gestational 
hypertension refers to the new onset of hypertension in the absence of proteinuria, in a 
previously normotensive pregnant woman at or after 20 weeks of gestation. However, if 
blood pressure elevation persists by 12 weeks postpartum, the woman is considered to 
have chronic hypertension. Preeclampsia is defined as gestational blood pressure 
elevation with proteinuria and usually occurs after 20 weeks of gestation. Proteinuria is 
defined as the urinary excretion of ≥ 300 mg of protein in a 24-hour period. 
Preeclampsia superimposed on chronic hypertension is diagnosed when a woman with 
pre-existing hypertension develops new onset proteinuria after 20 weeks of gestation 
or after a sudden increase in proteinuria or blood pressure in women with hypertension 
and proteinuria before 20 weeks’ gestation. Eclampsia refers to the development of 
grand mal seizures, not attributable to another cause, in a woman with gestational 
hypertension or preeclampsia. Because blood pressure usually falls during the first half 
of pregnancy, pre-existing hypertension may not be recognized if the woman is first 
seen during that time (96).  
Due to the difficulty in establishing a unique cause for preeclampsia, in spite of 
many attempts to understand its biologic characteristics and characterize its predictors, 
heterogeneous causes of gestational hypertensive disorders have been proposed (97). 
These can be categorized into two major causes: one whose genesis is the result of 
primarily reduced placental perfusion, and another primarily due to pre-existing 
maternal disorders, frequently not yet spontaneously evident but unmasked by 
pregnancy. The placental disorder has a currently unidentified pathobiologic origin. The 
maternal disorder includes cases with obvious underlying morbidity before pregnancy 
such as hypertension, renal disease, overweight, diabetes and women with 
predisposing factors for cardiovascular disease that may not be clinically evident (97).  
It is not clear whether gestational hypertension and preeclampsia are different 
diseases with a similar phenotype (hypertension) or if gestational hypertension is an 
early or mild stage of preeclampsia. However, studies that analysed gestational 
hypertension and preeclampsia described similar associations with chronic 
hypertension later in life (98). Studies that analysed preeclampsia and gestational 
hypertension separately described similar effects, though with stronger associations for 
preeclampsia (99, 100) which could be interpreted in light of spectrum effects related 
with the higher severity of this clinical entity. 
The etiology and pathogenesis of hypertensive disorders in pregnancy is not 
completely understood. Abnormal trophoblast invasion of uterine blood vessels, 
immunological intolerance between fetoplacental and maternal tissues, maladaptation 
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to the cardiovascular changes or inflammatory changes of pregnancy, dietary 
deficiencies, and genetic abnormalities have been proposed as potential etiologies 
(101, 102). Moreover, the pathophysiologic abnormalities of preeclampsia are 
numerous, including placental ischemia, generalized vasospasm, abnormal 
homeostasis with activation of the coagulation system, vascular endothelial 
dysfunction, abnormal nitric oxide and lipid metabolism, leukocyte activation, and 
changes in various cytokines as well as in insulin resistance (101, 103).  
Risk factors for hypertensive disorders in pregnancy represent a selection of 
antecedents that reflect the disease’s complexity (104). Among the strongest 
established risk factors for preeclampsia are nulliparity, multifetal gestation and family 
or personal history of preeclampsia (105, 106). Advanced maternal age is also an 
established risk factor for adverse outcomes in pregnancy, with all types of 
hypertensive disorders in pregnancy more frequent in mothers above 35 years old 
(107). Additionally, family history of hypertension is associated with a doubling risk of 
preeclampsia (108). The association between excessive weight before and during 
pregnancy and the risk of hypertensive disorders in pregnancy (100, 109-112) is also 
already recognized. Despite some contradictory results, other potential risk factors, 
such as socioeconomic status (113, 114), seasonality (115) and psychosocial stress 
(116) have been suggested.  
Worldwide, hypertensive disorders in pregnancy affect approximately 10% of all 
pregnant women (117, 118). An Australian study (95) reported an overall prevalence of 
9.8% pregnancies complicated by hypertension, including 0.6% with chronic 
hypertension, 4.3% with gestational hypertension, 4.2% with preeclampsia and 0.3% 
with superimposed preeclampsia on chronic hypertension. Also, a prospective cohort 
study from the United States of America (109), described a prevalence of gestational 
hypertension and preeclampsia of 7.5% and 3.6%, respectively. Recently, a study 
performed in Netherlands (100), restricted to low-risk pregnancies, reported 
prevalences of 2.1% and 4.1% for preeclampsia and gestational hypertension, 
respectively. 
In Portugal, a national survey conducted in 2005 estimated an overall 
prevalence of hypertensive disorders in pregnancy of approximately 6%, with 1.5% due 
to chronic hypertension, 2.5% to gestational hypertension, 1.4% to preeclampsia, 0.2% 
to superimposed preeclampsia and 0.1% to eclampsia (119). Despite the lower rate 
than described in other countries (95, 100, 109), preterm birth, small for gestational age 
newborns and foetal death were also more frequent in women with hypertension during 
pregnancy (119).  
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These major complications of pregnancy increase the risk of adverse obstetric 
and perinatal outcomes (93-95). In Africa and Asia, nearly one tenth of all maternal 
deaths are associated with hypertensive disorders of pregnancy, whereas one quarter 
of maternal deaths in Latin America have been associated with those complications. In 
European countries, North America, Australia, New Zealand, and Japan hypertensive 
disorders during pregnancy are the leading cause of maternal death, being responsible 
for 16.1% of all deaths (120). Considering only Europe, complications of hypertension 
accounted for 9.2% of maternal deaths, ranging from 2.3% in Germany to 25% in Spain 
(61). Although there is less information about morbidity, recent data from large national 
surveillance studies have confirmed that severe obstetric morbidity occurs at a higher 
rate than maternal mortality (121-124). In fact, all types of hypertensive disorders 
during pregnancy are associated with severe obstetric morbidity during delivery 
hospitalizations such as renal failure, pulmonary edema, adult respiratory distress 
syndrome, puerperal cerebrovascular disorder, disseminated intravascular coagulation 
syndrome, cardiac arrest or failure, obstetric embolism, sepsis and antepartum or 
postpartum haemorrhage (94, 95, 125). 
Likewise, infants exposed to hypertension during pregnancy are more likely to 
suffer death or major morbidity than those without exposure to hypertension (93, 95). 
Despite the overall decrease in neonatal mortality during the last decades (93), 
preeclampsia still carries a 2-fold increased risk of neonatal death and this increased 
risk has remained relatively constant over time (126). Additionally, offspring of women 
with hypertension during pregnancy are also at increased risk of preterm birth, being 
small for gestational age, low Apgar scores, intubation, seizures, respiratory distress 
syndrome, transient tachypnea, sepsis and neonatal intensive care unit admission (95, 
125, 127).  
A consistent association has been found between preeclampsia and high blood 
pressure and cardiovascular disease later in women’s life (88, 98). Recently, a 
systematic review and meta-analysis described that, after preeclampsia, women have 
an almost fourfold increased risk of hypertension and an approximately twofold 
increased risk of fatal and nonfatal ischaemic heart disease, stroke, and venous 
thromboembolism in later life. Furthermore, the overall increase mortality risk after 
preeclampsia was largely driven by an increased risk of death due to cardiovascular 
disease (87). 
Despite some conflicting results, a meta-analysis (128) reported higher systolic 
and diastolic blood pressure among offspring of women with preeclampsia during 
pregnancy. Offspring of pregnancies complicated by preeclampsia, between 6 and 19 
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years old, had an increase of 2.3 and 1.7 mmHg in systolic and diastolic blood 
pressure, respectively, when compared with offspring from normotensive pregnancies. 
Also, increased risks of hospitalization have been noted in children born to mothers 
who had preeclampsia (129). A long-term follow-up study showed that people born 
after pregnancies complicated by gestational hypertension or preeclampsia are at 
increased risk of stroke, 60 to 70 years after their birth (130).  
The pathophysiological mechanisms underlying the association between 
gestational hypertensive disorders and later high blood pressure in women and their 
children remain not completely understood (64, 131). In women, hypertensive disorders 
of pregnancy and chronic hypertension share pathways initiated by similar risk factors, 
such as older age and higher body mass index (106, 132, 133). Additionally, abnormal 
placentation resulting in reduced perfusion may induce de novo hypertension in the 
pregnant women, possibly related with an immunologically mediated mechanism for 
which enhanced exposure to paternal antigens is protective (97). Any of these 
complications may in turn induce long-term metabolic and vascular abnormalities that 
increase the overall risk for cardiovascular disease later in life (134). Intrauterine 
growth restriction, due to mother’s cardiometabolic abnormalities during pregnancy and 
placental dysfunction, may also increase the risk of vascular dysfunction in the 
offspring (135-137). In the womb, boys have a different placental growth which puts 
them at a higher risk of becoming undernourished particularly because their larger size 
increases nutritional needs. This milieu could increase the vulnerability of boys to 
consequences of metabolic and vascular derangements of the mother during 
pregnancy (138). 
 
 
Pregnancy: opportunity for health promotion and disease prevention  
 
Pregnancy has been widely referred as a good opportunity for prevention and 
intervention because of mothers’ strong motivation to protect the wellbeing of the 
foetus (65, 139).  
It is well established that adverse lifestyles such as smoking, alcohol intake, 
poor diet and lack of moderate physical activity are associated with increased risks of 
adverse maternal and foetal outcomes such as ectopic pregnancy, placental abruption, 
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placenta previa, small for gestational age babies, low birth weight and preterm birth 
(140-146). 
The label “teachable moment” has been used to describe naturally occurring life 
transitions or health events thought to motivate individuals to spontaneously adopt risk-
reducing health behaviours. McBride et al (65) proposed a model to describe 
characteristics of effective teachable moments. These are characterized as times that 
increase perceptions of personal risk and outcome expectancies, prompt strong 
affective or emotional responses, and redefine self-concept or social roles. In other 
words, the cognitive response precedes motivation, skills acquisition and self-efficacy 
that in turn, increase the likelihood of cease the adverse lifestyle. Additional key factors 
to consider are predisposing factors such as age, dispositional and cultural 
characteristics that may influence an individual’s cognitive and emotional response 
(65). Within this model, pregnancy is conceptualized as a powerful “teachable 
moment”.  
Pregnancy provides an immediate and personal experience of risk that is 
related with the health of the mother and baby, which enhances the perceived need of 
adopting healthy lifestyles (147). According to a study performed in the United Kingdom 
between 1998 and 2003 (148), there was a significant reduction in smoking, alcohol 
consumption and intake of caffeinated drinks when women became pregnant, although 
little change occurred in fruit and vegetable intake. In fact, before pregnancy, 27% of 
women smoked, 54% of women drank more than 4 units of alcohol per week and 39% 
had estimated intakes of caffeine in drinks of more than 300mg per day, whereas 
comparable figures for early pregnancy were 15%, 10% and 16% respectively.  
The emotional responses that surround pregnancy may also make it an 
opportune time to initiate change. Emotional responses are thought to influence an 
individual’s judgment about the significance and meaning of an event (149).Therefore, 
pregnancy may prompt feelings of concern about the well-being of the foetus, which 
may motivate women to change their lifestyles. Finally, pregnancy is a time when 
personal and social roles change as women become mothers in addition to their other 
roles. Women are adopting the maternal role, which carries expectations for major 
changes in lifestyle and self-image (147). 
Worldwide, smoking is the single most frequent preventable cause of death 
(150) and smoking cessation reduces the long-term risk of cancer and cardiovascular 
diseases (151, 152). Cigarette smoking during pregnancy is associated with increased 
risks for both the mother and the newborn (140-142). Therefore, mothers tend to be 
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strongly motivated to protect the health of the unborn baby and there is important social 
pressure to quit smoking during pregnancy (66, 139, 153). The EURO-PERISTAT 
study, that monitored and evaluated perinatal health in Europe, reported prepregnancy 
smoking prevalence levels in 2004 ranging from 7.9% in Lithuania to 35.9% in France 
(61). In Portugal, according to a study performed in 25 public maternity units, 30% of 
women smoked before pregnancy in Portugal (154). In many countries in Europe, more 
than 10% of women smoke during pregnancy (61). In Portugal, 14.7% of women 
smoked during the third trimester of pregnancy in 2004 (61). 
Previous literature reported smoking cessation rates ranging from 30% to 50% 
in different countries (155-158). Predictors of smoking cessation among pregnant 
women have been well investigated, internationally. Women who quit smoking during 
pregnancy are more likely to report being married or in a stable relationship and having 
higher educational qualifications (156, 157, 159). However, a study that assessed the 
reporting of prenatal smoking in birth certificates and in confidential questionnaires 
found that more educated women are less willing to admit smoking to prenatal care 
providers, which may lead to overestimation of the association between education and 
smoking cessation during pregnancy (160). Quitting in pregnancy appears to be more 
successful in first pregnancies regardless of social background, with the probability 
decreasing with the number of pregnancies (161). It has been suggested that past 
pregnancies resulting in the birth of a healthy child despite tobacco consumption might 
weaken the women’s motivation to change their smoking habits in subsequent 
pregnancies (162). Also, women receiving adequate prenatal care show a higher rate 
of smoking cessation (163, 164). Despite the impact of adequate prenatal care on 
smoking cessation, this may also be due to personal characteristics of women since 
those more prone to quit smoking are also probably more likely to attend prenatal care 
(165). Those who initiate smoking earlier or were heavier smokers were more likely to 
smoke during pregnancy, which may emphasize the physiological and psychological 
role of nicotine dependence in smoking cessation (166). Additionally, concern about 
weight gain during and after pregnancy may be a factor that interferes with smokers’ 
efforts to quit during pregnancy (167), with pregnant smokers reporting the use of 
smoking as a weight management strategy (168). 
Smoking cessation during pregnancy could be a unique opportunity in women 
life to achieve long-term sustainability of smoking cessation, with clear benefits for their 
future health. However, despite a high proportion of women quitting their tobacco 
consumption during pregnancy the rate of relapse or return to previous rates following 
childbirth is high. In fact, approximately 25% of women who quit smoking during 
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pregnancy will relapse within one month of delivery (157). By three months postpartum, 
40% to 50% of women will have returned to smoke and, 70% will have experienced a 
relapse within one year postpartum (156, 157, 169). 
It has been previously described that younger women, divorced or without a 
partner and with a lower education were more likely to resume smoking (156, 157). 
Furthermore, breastfeeding may help to prevent or delay postpartum smoking relapse 
(158), by educating women about the benefits of breastfeeding and by facilitating and 
encouraging continued breastfeeding throughout the first postpartum year (170). The 
health of the offspring can also constitute a motivation to stop smoking. A substantial 
body of evidence supports that involuntary tobacco smoke exposure adversely affects 
children’s respiratory health by increasing the risk of respiratory infections (171, 172). 
In uterus exposure to maternal smoking was associated with an almost two-fold 
increased prevalence of physician-diagnosed asthma (171), while children exposed 
after birth had more often rhinitis than children of non-smoking parents (172). 
In Portugal, smoking remains more frequent among men but its prevalence is 
increasing in women (173). The prevalence is higher among younger and more 
educated women placing Portugal at a relatively early stage of the epidemic compared 
to other Western European countries (174, 175). Therefore, it is expected that, in the 
near future, the burden of tobacco-related illness will increase substantially (176). In 
order to guide the development of preventive strategies to reduce the future burden of 
smoking and promote the health of children and families, it is important not only to 
describe exposure to smoking in pregnancy and postpartum but also to identify 
modifiable determinants of such behaviours.  
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This research aims to study the cardiovascular risk profile in mothers of a 
Portuguese birth cohort (Geração XXI), before and during pregnancy, and 4 years after 
delivery, including both descriptive and analytic approaches. To answer this main 
question, the following 5 specific objectives were defined and pursued, resulting in 5 
papers: 
 
 
1. To estimate the prepregnancy prevalence of five major cardiovascular risk factors 
(overweight/obesity, smoking, hypertension, dyslipidemia and diabetes mellitus), and to 
describe their distribution by age, gravidity and indicators of socioeconomic position 
(SEP). 
 
2. To assess the impact of age, education, family history of cardiovascular disease, 
prepregnancy BMI and pregnancy weight gain on hypertensive disorders in pregnancy, 
in primiparous and multiparous mothers. 
 
3. To assess the extent to which gestational hypertensive disorders lead to higher 
blood pressure in women and their offspring as early as 4 years after birth, and to 
assess the effect of fetal sex on these consequences. 
 
4. To assess the frequency and determinants of maternal smoking cessation during 
pregnancy and of the sustainability of smoking cessation 4 years after delivery. 
 
5. To estimate the prevalence of established cardiovascular risk factors (hypertension, 
dyslipidemia, diabetes mellitus, general overweight/obesity, abdominal obesity, 
smoking, low fruit and vegetables intake and sedentariness), 4 years after delivery, and 
to describe their distribution by age, gravidity and indicators of socioeconomic position 
(SEP). 
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RESEARCH METHODS 
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 This PhD thesis is based on the cohort Geração XXI, the first prospective 
Portuguese population-based birth cohort. A general description of the participants and 
methods in this cohort study is provided below. The selection of participants eligible for 
each analysis depended on the specific objectives of the investigations and is 
described in detail in the methods sections of the individual papers. 
 
 
 
ASSEMBLING OF THE BIRTH COHORT 
 
The birth cohort Geração XXI was assembled between 2005 and 2006 at all 5 
public maternity units covering the metropolitan area of Porto, Portugal: Centro 
Hospitalar de Vila Nova de Gaia (CHVNG), Centro Hospitalar do Porto - Maternidade 
de Júlio Dinis (MJD), Hospital de São João (HSJ), Centro Hospitalar do Porto - 
Hospital de Santo António (HSA), and Unidade Local de Saúde de Matosinhos – 
Hospital Pedro Hispano (HPH). The maternities corresponded to level III units, with 
differentiated perinatal support, and all except MJD, were included in a general 
hospital, with a variety of medical and surgical specialties.  
Trained interviewers at the five hospitals were responsible for the study 
presentation and subsequent invitation of the mothers after delivery. Fathers were also 
invited to participate. Of the invited mothers 91.4% accepted to participate. A total of 
8647 infants, corresponding to 8495 mothers, were enrolled in the cohort.  
 
 
DATA COLLECTION 
 
Mothers were invited to participate after delivery, during the hospital stay. Data 
on demographic and socioeconomic characteristics (age, marital status, years of formal 
education, occupation), personal and family medical history, gynaecologic and obstetric 
history (age at menarche, number of previous pregnancies and births), prenatal care 
(number and place of the prenatal care, medication, and symptoms and pregnancy-
related co-morbidities), and lifestyles (including smoking, alcohol intake and illicit drug 
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use) were collected within 72 hours after delivery, in a face-to-face interview, 
conducted by trained interviewers using structured questionnaires. Clinical records 
were also reviewed at birth by the same interviewers to retrieve data on prenatal care, 
pregnancy complications (gestational hypertensive disorders, gestational diabetes and 
placental abnormalities), delivery (type of delivery and medication) and neonatal 
characteristics (birth weight and gestational age). Fathers were also invited to answer a 
self-administered questionnaire focused on demographic and social conditions, 
lifestyles and medical history. Anthropometrics were performed, by the same 
interviewers, to the mother, the father and their newborn. 
After delivery, blood samples were collected from the mother and the umbilical 
cord. Fathers were also requested to provide a venous blood sample. Plasma and 
serum samples were distributed in aliquots and a whole blood sample was maintained 
for each member of the family. All blood samples were put into transitory storage at -
20ºC and later stored at -80ºC. 
 
 
MISSING DATA RECOVERY 
 
Between October 2008 and June 2009, missing data on the questionnaires 
were recovered through the review of obstetrical records (PAPER I). We reviewed the 
medical records of 3657 women with at least one missing value on personal history of 
disease, anthropometrics, pregnancy complications, blood glucose or oral glucose 
tolerance test results during pregnancy, or newborn characteristics at birth, and 
assessed the agreement of information reported by participants with data from medical 
records. All the clinical records were reviewed by one trained abstractor, who had been 
an interviewer at the baseline evaluation of Geração XXI, using standardized criteria. 
Inter-observer variability was assessed using 400 clinical records randomly selected 
among the 3657 reviewed. Data were collected independently by 2 trained abstractors, 
both interviewers at birth. 
Data on pregnancy pathological complications and mothers’ anthropometrics 
were successfully recovered. Agreement between questionnaire and records in family 
history data was fair, particularly for cardiovascular disease [k=0.27; 95%confidence 
interval (95%CI) 0.23-0.32]. Personal history of diabetes was highly concordant 
(k=0.82; 95%CI 0.70-0.93), while hypertension was moderately concordant (k=0.60; 
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95%CI 0.50-0.69). In general, the discrepancies found for weight and height indicated 
higher values in the clinical record than in the questionnaire and led to discrepancies in 
prepregnancy body mass index classes of 10.3% of women (weighted k=0.82; 95%CI 
0.80-0.83).  
Data were very consistent between reviewers, with highest agreement for 
gestational diabetes (k=1.00) and birth weight (99.5% concordant). The differences 
observed for women’s weight and height were negligible, not affecting the global 
classification by body mass index categories before pregnancy (weighted k=0.99; 
95%CI 0.98-1.00).  
 
 
 
RE-EVALUATION OF THE BIRTH COHORT AT 4 YEARS 
 
Between April 2009 and April 2011, an average of 4 years after birth, all the 
children with their mothers were invited to attend the re-evaluation of the cohort. During 
this evaluation period, participants were invited to an interview and physical 
examination. If they were unable to participate, they were invited to answer a telephone 
interview, covering part of the self-reported data collected in the default interview.   
During the follow-up period, 5986 (69.2%) of the children attended a face face-
to-face interview, 1472 (17.0%) provided self-reported data by telephone interview, and 
1189 (13.7%) were lost to follow-up. Regarding the mothers, 5729 (67.4%) participated 
in the face face-to-face interview, 1428 (16.8%) provided self-reported data by 
telephone interview and 1338 (15.8%) were lost to follow-up. Figure 4 presents the 
maternal participation at follow-up, according to the different strategies implemented. 
Overall, 86.2% of the children and 84.2% of the mothers were re-evaluated. 
The comparison of socio-demographic characteristics between participant and 
non-participant mothers at follow-up and among mothers who attended a face-to-face 
interview and who answered a telephone interview are presented in Table 1. Mothers 
who attended the follow-up re-evaluation were older, more likely to be pregnant for the 
first time at baseline and married, with a higher educational level, and more frequently 
employed, than those who did not participate in the re-evaluation. When comparing 
mothers evaluated by the two strategies of data collection, those who answered a face-
to-face interview were older, more educated and more frequently employed. 
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Figure 4. Maternal participation at follow-up, according to the different strategies implemented. 
 
 
Table 1. Comparison of socio-demographic characteristics between participant and non-
participant mothers at follow-up and, among the former, between mothers who attended a face-
to-face interview and who answered a telephone interview.   
 Non 
participants  
Face-to-face 
interview  
Telephone 
interview 
  
 n(%) n(%) n(%) p*   p** 
Age (years), n (%)    <0.001 <0.001 
   < 25 487 (36.7) 1010 (17.7) 356 (25.0)   
   25-29 368 (27.7) 1723 (30.2) 441 (31.0)   
   30-34 322 (24.3) 1961 (34.3) 406 (28.5)   
   ≥ 35 150 (11.3) 1019 (17.8) 220 (15.5)   
Gravidity, n (%)    <0.001 0.205 
   1 607 (45.7) 2778 (48.7) 679 (47.8)   
   2 423 (31.9) 1969 (34.5) 475 (33.4)   
   ≥ 3 298 (22.4) 963 (16.9) 268 (18.9)   
Marital status, n (%)    <0.001 0.058 
   Married/living with a partner 1196 (90.4) 5389 (94.5) 1320 (93.2)   
   Single/ divorced/widow   127 (9.6) 312 (5.5) 96 (6.8)   
Education (years), n (%)    <0.001 <0.001 
   ≤ 4 159 (12.0) 371 (6.5) 133 (9.4)   
   5-9 672 (50.9) 2181 (38.4) 634 (44.8)   
   10-12 312 (23.6) 1571 (27.7) 370 (26.1)   
   > 12 178 (13.5) 1551 (27.3) 279 (19.7)   
Working condition, n (%)    <0.001 <0.001 
   Employed 760 (57.4) 4238 (74.9) 989 (70.0)   
   Unemployed 382 (28.9) 1017 (18.0) 276 (19.5)   
   Housewife 122 (9.2) 268 (4.7) 103 (7.3)   
   Others  60 (4.5) 132 (2.3) 45 (3.2)   
* Participation vs. non participation 
** Face-to-face interview vs. telephone interview 
Note: In each variable, the total may not add to 8495 due to missing data 
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DATA COLLECTION 
 
In the face-to-face interview, information was collected by trained interviewers, 
using two structured questionnaires: one concerning the child’s health and another 
regarding the health of the mother. The mothers’ questionnaire comprised data on 
demographic characteristics (marital status and owning one’s house), personal and 
family medical history, gynaecologic and obstetric history (number of pregnancies and 
births before and after the index pregnancy), and lifestyles (including smoking, alcohol 
intake, physical activity and diet). The children’s questionnaire included data on 
socioeconomic characteristics of the parents (years of formal education, occupation) 
and on child’s development, health and habits (including sleeping hours, physical 
activity and diet). Mothers and children also underwent a physical examination, 
including anthropometric evaluation, blood pressure measurement and a venous blood 
sample withdrawal. Children were submitted, additionally, to tetrapolar bioimpedance 
analysis. The venous blood sample was drawn after 12-hour overnight fast and all the 
samples were analyzed at the central laboratory of Hospital de São João.  
The telephone interview also contained data regarding the health of the mother 
and the children, although with a restricted number of questions. Information was 
collected by trained interviewers, who also performed face-to-face interviews, using a 
structured questionnaire. Data on medical and obstetric history (pregnancies and births 
after the index pregnancy) as well as smoking status and self-reported weight and 
height were collected for the mothers. Regarding the child, data on socioeconomic 
characteristics of the parents (years of formal education, occupation), and on child’s 
development, health and habits (including sleeping hours, physical activity and diet) 
were collected. 
 
 
 
QUALITY CONTROL 
 
In both evaluation periods, all interviewers were rigorously trained using a 
structured protocol addressing all the questionnaires’ queries and periodic supervision 
of their work was undertaken. At baseline, interviewers were responsible for the 
application of the questionnaires to the mothers, the distribution of self-administered 
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questionnaires to the fathers and the anthropometric evaluations of the parents and 
newborns, having received specific and intensive training for these tasks. Interviewers 
were also responsible for managing the blood samples, namely their coded 
identification and storage. During follow-up reevaluation, interviewers were responsible 
for the application of the questionnaires to the mothers and for the physical 
examination both of the mothers and their children.  
A multidisciplinary team, including physicians, psychologists, nutritionists and 
pharmacists, with experience in other national and international projects, were 
responsible for the staff training and the development of the questionnaires applied at 
baseline and at follow-up.  
 
 
 
STATISTICAL ANALYSES 
 
All statistical analyses were performed using Stata 9.0 (College Station, TX, 
2005). Overall, we used classical inferential statistics to answer the objectives of this 
PhD thesis. 
Data were described as counts and proportions for categorical variables, mean 
and standard deviation (SD) for normally distributed continuous variables, and median 
and interquartile range (IQR) for non-normally distributed continuous variables. The 
prevalence of the outcomes is presented with 95% confidence intervals (95% CI), as 
well as the incidence rates of hypertension, which were reported per 1000 person-
years. 
According to the specific objectives established, different analytic approaches 
were used and are described in detail in the methods sections of the papers. The 
prevalence ratio (PR) is more conservative, consistent, and interpretable than the odds 
ratio (OR) when prevalences are to be compared between groups (177, 178). For this 
reason, we privileged the estimate of PR in our models. Therefore, in Papers III and V 
crude and adjusted prevalence ratios (PR) were computed, using robust Poisson 
regression. However, PR applies only to dichotomous outcomes, whereas categorical 
dependent variables with more than two classes request multinomial logistic regression 
models. Thus, in Papers II and VI, to privilege homogeneity in the analysis among all 
the outcomes, we used logistic regression to estimate OR for all the risk factors 
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considered, binary for dichotomous outcomes and multinomial for 3-class outcomes. In 
order to assess the potential for prevention, population attributable fractions were 
calculated using the command punaf (179) in Stata, based on the adjusted PR and 
putative alternative distributions of exposure (Paper III). In Paper IV, to estimate 
adjusted mean differences in systolic and diastolic blood pressure, for mothers and 
offspring, according to gestational hypertensive disorders, multiple linear regression 
was used. The association between gestational hypertensive disorders and the 
mother’s incidence of hypertension was estimated by crude and adjusted incidence 
rate ratios (IRR) and respective 95% CI, using Poisson regression. 
 
 
 
ETHICAL CONSIDERATIONS 
 
The study protocols for both evaluation periods were approved by the Ethics 
Committee of Hospital de São João and by the Portuguese Authority of Data 
Protection. 
Procedures were developed in order to guarantee data confidentiality and 
protection. All participants received an explanation on the purposes and design of the 
study, and gave written informed consent at baseline and at follow-up evaluation. The 
children gave it through their legal representative. Verbal consent was explicitly 
solicited at the beginning of telephone interviews. 
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ABSTRACT 
 
 
Purpose: To assess the impact of age, education, family history of cardiovascular 
disease, prepregnancy overweight/obesity and weight gain during pregnancy on 
hypertensive disorders, among primiparae and multiparae.  
Methods: In a birth cohort study, puerperae were consecutively recruited at all public 
maternities of Porto, Portugal (2005-2006). We included 6952 women with singletons 
and complete data on key variables. Hypertensive disorders included chronic 
hypertension, gestational hypertension or preeclampsia/eclampsia. Prevalence ratios 
were computed using Poisson regression and population attributable fractions were 
calculated. 
Results: Overall, hypertensive disorders affected 4.6% of single pregnancies, and 
were associated with older age, lower education, family history of cardiovascular 
disease and excessive weight before and during pregnancy, similarly in primiparae and 
multiparae. Approximately 50% of cases among primiparae and 70% among 
multiparae were attributable to the joint effect of pregnancies after 34 years of age, 
education below 12 years, family history of cardiovascular disease and excessive 
weight before and during pregnancy. 
Conclusions: The risk factors explained a high proportion of hypertensive disorders 
during pregnancy. Excessive weight before and during pregnancy had a very large 
contribution. The substantial joint effect of the risk factors suggests that interventions 
focusing on these risk factors should be part of pre-conceptional and prenatal care. 
 
 
Keywords: Cohort studies; Hypertension, Pregnancy-Induced; Risk factors 
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INTRODUCTION 
 
 Hypertensive disorders complicating pregnancy include chronic and gestational 
hypertension, preeclampsia and eclampsia, with the latter three entities representing 
generally transient hypertensive conditions with onset during pregnancy (1). These 
major complications of pregnancy increase the risk of adverse obstetric and perinatal 
outcomes (2, 3, 4) and are associated with high blood pressure and cardiovascular 
disease later in women’s life (5, 6), with approximately half of those with preeclampsia 
developing chronic hypertension (7).  
 In Portugal, a national survey conducted in 2005 estimated an overall 
prevalence of hypertensive disorders in pregnancy of approximately 6% (8). Although 
this rate was lower than in other countries (4, 9, 10), preterm birth, small for gestational 
age newborns and fetal death were more frequent in women with hypertensive 
pregnancies (8). 
 Maternal socio-demographic and metabolic factors, as well as family history of 
hypertension, have been reported as determinants of hypertension in pregnancy, but 
the etiology of hypertensive disorders of pregnancy is not completely understood (11, 
12, 13). Primiparity is consistently associated with preeclampsia (12) while other risk 
factors, usually related with chronic hypertension in the general population, could be 
expected to have a stronger effect in multiparae. Also, the interdependence of these 
risk factors, resulting in their clustering (14), raises the question of the added predictive 
value of considering several factors simultaneously. We are unaware of studies 
considering the joint impact of several risk factors on the risk of hypertension during 
pregnancy. 
 Thus, we assessed the impact of age, education, family history of 
cardiovascular disease, prepregnancy BMI and pregnancy weight gain on hypertensive 
disorders in pregnancy, in primiparous and multiparous mothers of a Portuguese birth 
cohort. In order to assess the potential for prevention, we estimated the population 
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attributable fractions for each risk factor, individually and in aggregation with each 
other. 
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METHODS 
 
 This study is based on the baseline information obtained at the assembling of 
the birth cohort Geração XXI. A total of 8495 mothers, who gave birth to 8647 live born 
infants, were enrolled. We excluded a subgroup of 313 who were recruited and 
evaluated during pregnancy to address specific objectives (15), since self-report of 
prepregnancy clinical characteristics is expected to change over time during 
pregnancy. In the present study, from the 8182 mothers consecutively invited at 
delivery we only included 8045 who delivered singleton babies. The recruitment took 
place between April 2005 and September 2006 at all 5 public maternity units covering 
the metropolitan area of Porto, Portugal. All the maternities corresponded to level III 
units, with differentiated perinatal support, and were included in a general hospital, with 
a variety of medical and surgical specialties, except one. Of the invited mothers 91.4% 
accepted to participate. 
 Data on demographic and socioeconomic characteristics, lifestyles, obstetric 
history and anthropometrics were collected within 72 hours after delivery, during the 
hospital stay, in a face-to-face interview conducted by trained interviewers using 
structured questionnaires. Clinical records were also reviewed at birth to retrieve data 
on complications of pregnancy. Parity was recorded as the number of deliveries, 
including the index one. Family history of cardiovascular disease was considered when 
participants reported to have at least one parent or sibling affected by stroke and/or 
myocardial infarction. Current smokers included both daily and occasional smokers. 
Women were considered former smokers if they had previously smoked but not in the 3 
months before pregnancy. Prepregnancy weight was recalled and recorded to the 
nearest 0.1 Kg. At baseline, height was measured (without shoes) to the nearest 0.1 
cm. When measurement was not possible, height was reported by the mother as 
registered in the identity card (30.8% of women with data on height). BMI was 
categorized according to the standard WHO definition as underweight, normal weight, 
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overweight and obese (16). Weight gain during pregnancy was calculated as the 
difference between the mother’s reported weight immediately before delivery and 
prepregnancy weight, and categorized as bellow, above or as recommended, taking 
into account the prepregnancy BMI, according to the IOM guidelines (17). 
 Hypertensive disorders in pregnancy included the presence of chronic 
hypertension, gestational hypertension or preeclampsia/eclampsia. Personal history of 
hypertension was considered present when participants recalled a medical diagnosis of 
this condition before the current pregnancy, while gestational hypertension or 
preeclampsia/eclampsia were considered only when explicitly recorded on obstetrical 
records as a diagnosis during the current pregnancy. When gestational hypertension 
and preeclampsia/eclampsia were simultaneously recorded in the medical record, the 
diagnosis of preeclampsia/eclampsia was considered.  
 Missing data on the questionnaires were recovered through the review of 
obstetrical records. The agreement between data collected by questionnaire and 
abstracted from obstetrical records was good for personal history of hypertension, 
weight and height, and there was very low inter-rater variability between two 
independent abstractors (18).  
 After excluding participants who presented at least one missing value on key 
variables, 6952 women were considered in the current analysis. There were no 
significant differences between participants with complete and missing data regarding 
age [mean (standard deviation (SD)): 29.0(5.6) vs. 29.1(5.8) years, p=0.570], BMI 
(overweight or obese: 30.0% vs. 33.1%, p=0.208) and parity (primiparous: 56.5% vs. 
57.4%, p=0.588), while women with no missing data on key variables had a higher 
educational level [median (interquartile range (IQR)): 10(7-12) vs. 9(6-12) years, 
p<0.001]. 
 Statistical analysis was performed using the statistical software Stata 11.0 
(College Station, TX, 2005). The associations between explanatory variables and 
gestational hypertensive disorders were estimated by crude and adjusted prevalence 
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ratios (PR) and respective 95%CI, using robust Poisson regression. Separate models 
were built for primiparae and multiparae, considering the hypothesis of different effects 
of risk factors in the two groups. The final model was fitted adjusting for age at delivery 
and social, clinical, obstetric and behavioral characteristics which were a priori 
considered potential confounders of the association. The population attributable 
fractions were calculated using the command punaf (19) in Stata, based on the 
adjusted PR and putative alternative distributions of exposure. We considered several 
scenarios of prevention defined according to the potential of change at the individual 
level: (1)prevention of pregnancies in women after 34 years of age (shift to 30-34 years 
old); (2)prevention of pregnancies in women with education below 12 years (shift to 
≥12 years); (3)prevention of pregnancies in women with family history of cardiovascular 
disease; (4)prevention of pregnancies in overweight/obese women (shift to normal 
weight); (5)prevention of pregnancies in women with weight gain during pregnancy 
above recommended (shift to weight gain as recommended); (6)prevention of 
pregnancies in women after 34 years old (shift to 30-34 years old), with 
overweight/obesity (shift to normal weight) and weight gain during pregnancy above 
recommended (shift to weight gain as recommended); (7)prevention of pregnancies in 
women after 34 years old (shift to 30-34 years old), with education below 12 years 
(shift to ≥12 years), family history of cardiovascular disease, overweight/obesity (shift to 
normal weight) and weight gain during pregnancy above recommended (shift to weight 
gain as recommended). We emphasize that not all risk factors are regarded as 
modifiable in the individual, but rather the occurrence of pregnancies in women with 
those characteristics. 
 The study protocol was approved by the Ethics Committee of Hospital de São 
João. Written informed consent was obtained from all participants. 
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RESULTS 
 
 The characteristics of the study participants are summarized in Table 1. Overall, 
the mothers’ mean age at the child’s birth was 29 years (range: 14 to 47 years). Most 
women were married or living with a partner (93.9%) and the median (IQR) educational 
level was 10 (7-12) years. Almost 72% were employed and 6.4% of the participants 
had a household monthly income below 500€. Family history of cardiovascular disease 
was reported by 16.3% of the mothers and, three months before pregnancy, 26.7% of 
the women smoked and 11.4% were ex-smokers. Before pregnancy, 21.2% were 
overweight and 8.8% were obese. During the index pregnancy, 37.7% of the women 
gained more weight than recommended for their prepregnancy BMI, while 25.8% 
gained less than recommended. This was the first delivery for 56.5% of women and 
51.0% delivered a male newborn. In this sample, multiparae were older, more 
frequently married, with a lower socioeconomic position and with a higher prevalence 
of family history of cardiovascular disease. They were also more frequently overweight 
and obese but gained less weight during pregnancy than recommended. 
 In this sample of Portuguese women who delivered a singleton live born, 342 
(4.6%; 95%CI: 4.1–5.1) presented a hypertensive disorder during pregnancy. The 
prevalence was slightly higher in primiparae than multiparae (5.0%; 95%CI: 4.3–5.7 vs. 
4.1%; 95%CI: 3.5–4.9). This increased prevalence among primiparous was mainly due 
to preeclampsia/eclampsia (1.6% vs. 0.8% in multiparous). Primiparae and multiparae 
had a similar prevalence of chronic (1.6% vs. 1.9%) and gestational hypertension 
(1.9% vs. 1.7%). Among all 86 cases of preeclampsia/eclampsia, 6 (7.0%) were 
superimposed on chronic hypertension, 3 in primiparous and 3 in multiparous. 
 Overall, the occurrence of hypertensive disorders during pregnancy differed 
according to socio-demographic, familial and metabolic factors, both in primiparae and 
multiparae (Table 2). Women older than 34 years were more likely to have a 
hypertensive disorder than those younger than 25 years, with non-significantly stronger 
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effects in multiparae than primiparae (PR=2.98 vs. PR=1.82; p for interaction=0.268). 
Hypertension was more frequent among participants with less than 5 years of 
education, with a slightly stronger association for primiparae than multiparae (PR=2.04 
vs. PR=1.53; p for interaction=0.820). In both primiparae and multiparae, family history 
of cardiovascular disease was associated with a 1.5-fold increased prevalence of 
hypertensive disorders during pregnancy, overweight and obesity with an almost 2-fold 
and 4-fold increased prevalence, respectively, and weight gain during pregnancy above 
recommended with a 1.4-fold increase in prevalence. A significant 32% decrease in 
prevalence was observed for delivery of a female newborn among primiparae (Table 
2).  
 Among primiparae, previous BMI and weight gain during pregnancy were the 
most relevant independent contributors of hypertension complicating pregnancy. 
Overweight and obesity explained almost a third of hypertensive disorders in 
pregnancy, while gaining more weight than recommended throughout pregnancy 
independently contributed 17.0%. The joint effect of age above 34 years old, 
overweight, obesity, and excessive weight gain during pregnancy explained, altogether, 
44.2% of cases. An additional 7.7% (PAF=51.9%) were explained by the contribution of 
education and family history of cardiovascular disease.  
 In general, the assessed risk factors had a higher impact on the hypertensive 
disorders in pregnancy in multiparae, particularly for age, education and family history 
of cardiovascular disease. Independently, age and overweight/obesity before 
pregnancy had the largest contribution to hypertensive cases (29.2% and 36.5%, 
respectively). Overall, the combination of all risk factors considered was responsible for 
over two thirds of the hypertensive disorders in pregnancy among multiparae (PAF= 
69.9%). 
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DISCUSSION 
 
 In this study of Portuguese puerperae, 5% of primiparae and 4% of multiparae 
had a hypertensive disorder in pregnancy. Approximately 50% of cases among 
primiparae and 70% among multiparae were attributable to the joint effect of 
pregnancies after 34 years of age, low education, family history of cardiovascular 
disease, prepregnancy overweight/obesity and excessive weight gain during 
pregnancy. The associations between the risk factors and hypertensive disorders 
during pregnancy were not different between primiparae and multiparae, but overall the 
impact was higher among multiparous reflecting the higher prevalence of risk factors 
among those women.  
 This is the first study that approaches the impact of several risk factors on 
hypertensive disorders in pregnancy in a large population-based cohort study. 
However, some limitations should be pointed. In our study, the prevalence of 
hypertensive disorders during pregnancy was lower than reported in other 
industrialized nations (4, 9, 10), and also slightly lower than the 5.6% previously 
described in a national survey for the Portuguese population (8) Since the authors 
reported no significant differences in prevalence across the country (8) we expected to 
find a similar prevalence. Despite the high proportion of participation in our cohort, it is 
possible that the refusals occurred mainly in cases with higher maternal and/or 
perinatal complications in the post-partum. Since hypertensive disorders are 
associated with increased risks of adverse outcomes (2, 3, 4) their prevalence may 
have been underestimated. The absence of objective measurements of blood pressure 
could also lead to this underestimation. However, 99.3% of the women had more than 
three prenatal visits and 85% attended the first appointment before 12 weeks of 
gestation (results not shown); thus, it is unlikely that a diagnosis of hypertension was 
missed. Additionally, considering a combined endpoint of hypertensive disorders during 
pregnancy is an advantage, because even if some cases of chronic hypertension were 
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misclassified as gestational, due to the low awareness of hypertension in young ages 
(20) they were still identified as a hypertensive disorder in our sample. 
 The higher proportion of missing data among those with lower education, which 
is also associated with the outcome, raises the possibility of a selection bias. In this 
case, we may be underestimating the prevalence and, consequently, the association of 
hypertensive disorders in pregnancy among less educated women. Also, since pre-
pregnancy weight was self-reported after delivery and weight tends to be 
underreported by women (21), the prevalence of overweight and obesity may be 
underestimated; if this information bias affected hypertensive women less than non-
hypertensives, the differential effect could have contributed to an overestimation of the 
association. However, it is unlikely that such effect would explain an almost 4-fold 
increase in prevalence. 
 We observed a positive association between delivering a male newborn and 
hypertensive disorders during pregnancy among primiparae. Heterogeneous causes of 
gestational hypertensive disorders have been proposed, comprising both a background 
increased vascular risk possibly with a yet unidentified higher blood pressure 
beforehand and hypertension induced by disturbed perfusion of the placenta (22). In 
light of this causal model, the role of an immune response to paternal antigens in a de 
novo and transient hypertensive state could be expected to occur more often with male 
babies. The lack of association in multiparae may be explained by the sex of previous 
children, which was not assessed.  
 In contrast, the associations between all other risk factors and hypertensive 
disorders during pregnancy were not different between primiparae and multiparae. 
Although most previous research has focused on preeclampsia (23), the similarities in 
risk factors according to parity support that gestational hypertension and 
preeclampsia/eclampsia represent different stages of one pathological process, as 
previously proposed (24). Studies that analyzed these two entities separately described 
similar effects, though with stronger associations for preeclampsia (10, 25) which could 
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be interpreted in light of spectrum effects related with the higher severity of this clinical 
entity. When analyzing chronic hypertension as the sole outcome, we found no 
significant differences regarding the associations with the risk factors considered in 
comparison with their association with gestational hypertension and 
preeclampsia/eclampsia (data not shown). It could be hypothesized that, even if a 
specific pregnancy-induced hypertension due to disturbed circulation in the placenta 
exists, as discussed above, the risk would be higher in women with more classical risk 
factors for high blood pressure. 
 Overall, 30.6% and 36.5% of hypertensive cases were attributable to 
overweight or obesity, among primiparae and multiparae, respectively. Our study 
confirms the association between excessive weight before and during pregnancy and 
the risk of hypertensive disorders in pregnancy (9, 10, 23, 26, 27). In a Danish study, 
overweight independently contributed 9.2% and obesity 11.0% for the occurrence of 
preeclampsia in primiparae (26). Similarly, among multiparae, overweight and obesity 
were responsible for 8.3% and 10.9% cases of preeclampsia, respectively. In a 
population of Latin women, those who gained more weight than recommended had a 3-
fold increased risk of gestational hypertension and a 4-fold increased risk of 
preeclampsia (27). In our obstetric population, overweight, obesity and weight gain 
during pregnancy above recommended were common and had a considerable 
independent impact on hypertension in pregnancy. These metabolic conditions 
constitute main modifiable risk factors at the individual level, with a vast potential for 
prevention before and during pregnancy. Information regarding lifestyles, such as 
physical exercise and diet were not available in our cohort. However, BMI is a good 
surrogate for these lifestyles and is much more objective and easy to quantify reliably. 
Socio-demographic and metabolic factors, as well as family history of cardiovascular 
disease were positively associated with hypertensive disorders during pregnancy in 
both primiparae and multiparae. Maternal age is an established risk factor for adverse 
outcomes in pregnancy, with all types of hypertensive disorders more frequent in 
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mothers above 35 years old (28). Family history of hypertension is associated with a 
doubling risk of preeclampsia (29). Similarly, a first-degree family history of vascular 
risk increases the likelihood of developing preeclampsia and gestational hypertension 
(30). Despite some contradictory results, probably due to differences in exposure or 
outcome definition, prospective data from a large Dutch population-based cohort 
showed that women with low educational level were more likely to develop gestational 
hypertension (31) and preeclampsia (32) than women with higher educational level. 
The association between education and pregnancy hypertension may represent an 
early manifestation of the socioeconomic differences in cardiovascular morbidity and 
mortality in women (33). Despite similar associations, the impact of low education and 
family history of cardiovascular disease was approximately double in multiparous, while 
the effect of age increased from 5 to 29%, due to the higher proportion of pregnancies 
after 35 years of age in multiparae. We recognize that, regarding these risk factors, the 
potential for change is mainly theoretical or only effective at the global community level. 
However, a stricter control of overall risk could be attained if health education was 
sensitive to literacy (34). 
 In conclusion, the five risk factors explained a high proportion of hypertensive 
disorders during pregnancy. Despite the relatively low prevalence of these conditions, 
the severity of short- and long-term consequences for both mother and child 
emphasizes the importance of control of this outcome. Excessive weight before and 
during pregnancy, the most modifiable of all factors considered, had a very large 
contribution, particularly among primiparae. The substantial joint effect of the risk 
factors emphasizes the need to improve patient education and suggests that 
interventions focusing on these risk factors should be part of pre-conceptional and 
prenatal care in order to prevent maternal and perinatal complications. 
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 Table 1. Characteristics of the participants, according to parity. 
    Parity 
  Overall  Primiparae Multiparae  
  n (%)  n (%) n (%) p 
Age (years)       
   <25  1504 (21.6)  1164 (29.6) 340 (11.3)  
   25-29  2119 (30.5)  1423 (36.2) 696 (23.0)  
   30-34  2210 (31.8)  1059 (27.0) 1151 (38.1)  
   ≥35  1119 (16.1)  283 (7.2) 836 (27.6) <0.001 
Marital status       
   Married/cohabiting  6512 (94.0)  3575 (91.3) 2937 (97.5)  
   Single/divorced/widow  416 (6.0)  339 (8.7) 77 (2.6) <0.001 
Education (years)       
   <5  493 (7.1)  110 (2.8) 383 (12.7)  
   5-9  2883 (41.5)  1491 (38.0) 1392 (46.0)  
   10-11  528 (7.6)  337 (8.6) 191 (6.3)  
   ≥12  3048 (43.8)  1991 (50.7) 1057 (35.0) <0.001 
Employment status       
   Employed  4973 (71.7)  2904 (74.1) 2069 (68.6)  
   Unemployed  1374 (19.8)  737 (18.8) 3637 (21.1)  
   Housewife  385 (5.6)  104 (2.6) 281 (9.3)  
   Other (student/retired)  205 (3.0)  175 (4.5) 30 (1.0) <0.001 
Income (€/month)       
   <500  435 (6.4)  210 (5.5) 225 (7.6)  
   500-1000  2002 (29.4)  1086 (28.2) 916 (30.8)  
   1001-1500  1767 (25.9)  1052 (27.4) 715 (24.1)  
   ≥1501  1943 (28.5)  1101 (28.6) 842 (28.3)  
   Does not know/ Prefers not to answer  669 (9.8)  395 (10.3) 274 (9.2) <0.001 
Family history of cardiovascular 
disease
§
 
      
   No  5820 (83.7)  3408 (86.7) 2412 (79.8)  
   Yes  1132 (16.3)  7521 (13.3) 611 (20.2) 0.001 
Newborn’s sex       
   Male  3548 (51.0)  2030 (51.7) 1518 (50.2)  
   Female  3404 (49.0)  1899 (48.3) 1505 (49.8) 0.230 
Smoking status       
   Never smoker  4303 (61.9)  2433 (61.9) 1870 (61.9)  
   Current smoker  1855 (26.7)  1066 (27.1) 789 (26.1)  
   Ex-smoker  794 (11.4)  430 (10.9) 364 (12.0) 0.289 
Prepregnancy BMI (Kg/m
2
)       
   <25.0  4867 (70.0)  2943 (74.9) 1924 (63.6)  
   25.0-29.9  1475 (21.2)  717 (18.2) 758 (25.1)  
   ≥30  610 (8.8)  269 (6.9) 341 (11.3) <0.001 
Weight gain during pregnancy
¥
       
   As recommended  2536 (36.5)  1425 (36.3) 1111 (36.8)  
   Bellow recommended  1796 (25.8)  916 (23.3) 880 (29.1)  
   Above recommended  2620 (37.7)  1588 (40.4) 1032 (34.1) <0.001 
BMI, body mass index  
§ 
Reporting at least one parent or sibling affected by stroke and/or myocardial infarction 
¥ 
According to the Institute of Medicine recommendations (2009) 
Note: In each variable, the total may not add to 6952 due to missing data 
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Table 2. Crude and adjusted prevalence ratios for the association between baseline characteristics of women, pregnancy and newborn, and 
pregnancy complicated by hypertension, among primiparous and multiparous women. 
95%CI, 95% confidence interval; BMI, body mass index; PR, prevalence ratio 
* Adjusted for all the variables in the table 
¥According to the Institute of Medicine recommendations (2009) 
  Primiparae  Multiparae  
 
 
n (%) 
Crude PR 
(95%CI) 
Adjusted PR* 
(95%CI) 
 
n (%) 
Crude PR 
(95%CI) 
Adjusted PR* 
(95%CI) 
p for 
interaction 
Age (years)          
<      <25  45 (3.9) 1 1  6 (1.8) 1 1  
   25-29  73 (5.1) 1.33 (0.92-1.91) 1.23 (0.83-1.82)  21 (3.0) 1.71 (0.70-4.20) 1.51 (0.61-3.78)  
   30-34  55 (5.2) 1.34 (0.91-1.97) 1.25 (0.82-1.91)  43 (3.7) 2.12 (0.91-4.93) 1.92 (0.81-4.59)  
   ≥ 35  22 (7.8) 2.01 (1.23-3.29) 1.82 (1.07-3.10)  55 (6.6) 3.73 (1.62-8.58) 2.98 (1.26-7.08) 0.268 
Education (years)          
   ≥12  87 (4.4) 1 1  33 (3.1) 1 1  
   10-11  15 (4.6) 1.02 (0.60-1.74) 1.05 (0.60-1.83)  7 (3.7) 1.17 (0.53-2.62) 1.15 (0.50-2.62)  
   5-9     80 (5.4) 1.23 (0.91-1.65) 1.22 (0.88-1.70)  59 (4.2) 1.36 (0.89-2.06) 1.31 (0.85-2.04)  
   <5  13 (11.8) 2.70 (1.56-4.69) 2.04 (1.12-3.70)  26 (6.8) 2.17 (1.32-3.59) 1.53 (0.90-2.61) 0.820 
Family history of cardiovascular disease          
   No  159 (4.7) 1 1  86 (3.6) 1 1  
   Yes  36 (6.9) 1.48 (1.04-2.10) 1.33 (0.92-1.91)  39 (6.4) 1.79 (1.24-2.59) 1.48 (1.00-2.17) 0.589 
Newborn’s sex          
   Male  118 (5.8) 1 1  65 (4.3) 1 1  
   Female  77 (4.1) 0.70 (0.53-0.92) 0.68 (0.51-0.91)  60 (4.0) 0.93 (0.66-1.31) 0.92 (0.55-1.49) 0.185 
Smoking status          
   Never smoker  127 (5.2) 1 1  88 (4.7) 1 1  
   Current smoker  41 (3.9) 0.74 (0.52-1.04) 0.77 (0.53-1.10)  26 (3.3) 0.70 (0.46-1.08) 0.82 (0.53-1.29)  
   Ex-smoker  27 (6.3) 1.20 (0.80-1.80) 1.21 (0.80-1.84)  11 (8.8) 0.64 (0.35-1.19) 0.71 (0.37-1.33) 0.327 
Prepregnancy BMI (Kg/m
2
)          
   <25.0  97 (3.3) 1 1  46 (2.4) 1 1  
   25.0-29.9  54 (7.5) 2.29 (1.65-3.16) 1.94 (1.37-2.76)  40 (5.3) 2.21 (1.46-3.34) 1.78 (1.14-2.77)  
   ≥30  44 (16.4) 4.96 (3.55-6.93) 4.16 (2.87-6.03)  39 (11.4) 4.78 (3.17-7.21) 3.61 (2.29-5.69) 0.704 
Weight gain during pregnancy
¥
          
   As recommended   53 (3.7) 1 1  38 (3.4) 1 1  
   Bellow recommended  36 (3.9) 1.06 (0.70-1.60) 1.07 (0.70-1.63)  27 (3.1) 0.90 (0.55-1.46) 0.91 (0.55-1.49)  
   Above recommended  106 (6.7) 1.79 (1.30-2.48) 1.46 (1.04-2.05)  60 (5.8) 1.70 (1.14-2.53) 1.41 (0.93-2.14) 0.841 
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Figure 1. Population attributable fractions (PAF) for pregnancy complicated by hypertension, 
according to several scenarios of exposure change for prevention, among primiparous and 
multiparous women. All estimates are based on adjusted prevalence ratios from the models 
presented in Table 2. 
Primiparae Multiparae
5.1
(-0.1 to 10.0)
 
(1) prevention of pregnancies in women after 34 years of age (shift to 30-34 years old); 
(2) prevention of pregnancies in women with education below 12 years (shift to ≥12 years); 
(3) prevention of pregnancies in women with family history of cardiovascular disease; 
(4) prevention of pregnancies in overweight or obese women (shift to normal weight); 
(5) prevention of pregnancies in women with weight gain during pregnancy above recommended (shift to weight 
gain as recommended);  
(6) prevention of pregnancies in women after 34 years old (shift to 30-34 years old), with overweight or obesity 
(shift to normal weight) and weight gain during pregnancy above recommended (shift to weight gain as 
recommended). 
(7) prevention of pregnancies in women after 34 years old (shift to 30-34 years old), with education below 12 
years (shift to ≥12 years), family history of cardiovascular disease, overweight or obesity (shift to normal weight) 
and weight gain during pregnancy above recommended (shift to weight gain as recommended). 
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ABSTRACT 
 
A putative association between gestational hypertensive disorders and higher blood pressure 
in mothers and offspring later in life is of concern. The aim of this study was to assess to 
which extent gestational hypertensive disorders lead to higher blood pressure in women and 
their offspring 4 years after birth, and to assess the effect of fetal sex on these 
consequences. A birth cohort was assembled at public maternities of Porto, Portugal in 
2005-2006 and reevaluated an average of 4 years after delivery. In the current analysis, 
2877 primiparous women with singletons and no previous chronic hypertension and 2460 
children were included. Gestational hypertensive disorders included gestational hypertension 
and preeclampsia/eclampsia. At follow-up, systolic and diastolic blood pressure were 
measured. Overall, the 4-year risk of hypertension in women affected by gestational 
hypertensive disorders was almost 6 times higher among mothers who delivered a girl, and 3 
times higher among those who delivered a boy. Systolic and diastolic blood pressure at 4 
years were 2.3 and 3.1 mmHg significantly higher in boys born of mothers with hypertensive 
disorders of pregnancy, while no effect was detected among girls. The differential effects 
observed by child’s sex support the hypothesis of heterogeneous causes of hypertension in 
pregnancy and that boys live dangerously in the womb. The high incidence of chronic 
hypertension in women and the higher blood pressure in their offspring as early as 4 years 
after birth emphasizes the short period after delivery as critical to develop and promote 
preventive strategies.  
 
 
Key words: Blood Pressure; Child; Cohort Studies; Hypertension, Pregnancy-Induced; 
Incidence. 
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INTRODUCTION 
 
 Gestational hypertension, preeclampsia and eclampsia are major complications of 
pregnancy, associated with increased risks of adverse maternal and perinatal outcomes.1-3 
Although these complications are considered transient, an association between gestational 
hypertensive disorders and hypertension, fatal and non-fatal ischaemic heart disease, stroke, 
and venous thromboembolism in mothers4, 5 and higher blood pressure in offspring later in 
life6 has been documented. 
 The pathophysiological mechanisms underlying the association between gestational 
hypertensive disorders and high blood pressure in women and their children remain 
incompletely understood.7, 8 In women, hypertensive disorders of pregnancy and chronic 
hypertension share pathways initiated by similar risk factors, such as older age and higher 
body mass index.9-11 Additionally, abnormal placentation resulting in reduced perfusion may 
induce de novo hypertension in the pregnant women, possibly related with an 
immunologically mediated mechanism for which enhanced exposure to paternal antigens is 
protective.12 Any of these complications may in turn induce long-term metabolic and vascular 
abnormalities that increase the overall risk for cardiovascular disease later in life.13 
Intrauterine growth restriction, due to mother’s cardiometabolic abnormalities during 
pregnancy and placental dysfunction, may also increase the risk of vascular dysfunction in 
the offspring.14-16 A meta-analysis reported higher systolic and diastolic blood pressure in the 
offspring after preeclampsia, but most studies involved small samples and focused on school 
aged children and adolescents.6  
 In the womb, boys have a different placental growth which puts them at a higher risk 
of becoming undernourished particularly because their larger size increases nutritional 
needs. This milieu could increase the vulnerability of boys to consequences of metabolic and 
vascular derangements of the mother during pregnancy.17  
108 
 
 Most studies that reported an increased risk of later hypertension and cardiovascular 
outcomes after preeclampsia were retrospective and focus on the occurrence of the 
outcomes a long time after pregnancy,4 limiting the ability to study the time frame for 
development of such outcomes. An association with chronic hypertension shortly after 
delivery would argue in favour of the continuous nature of the pathological process, once 
long term effects are know.  
 The aim of this study was to assess the extent to which gestational hypertensive 
disorders lead to higher blood pressure in women and their offspring as early as 4 years after 
birth, and to assess the effect of fetal sex on these consequences in a prospectively followed 
birth cohort. 
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METHODS 
 
Study design 
 This study is based on the birth cohort Geração XXI, assembled between 2005 and 
2006 at 5 public maternity units covering the metropolitan area of Porto, Portugal. All the 
maternities corresponded to units with differentiated perinatal support, and were included in a 
general hospital, except one. Of the invited mothers 91.4% accepted to participate. A total of 
8495 mothers, who gave birth to 8647 infants, were enrolled in the cohort. At 4 years of the 
child’s age, the cohort was re-evaluated. Mothers were invited to participate in a parallel 
study on women’s cardiovascular health, and 67.3% attended a face-to-face interview and 
physical examination at the study site. An additional 16.7% provided data by telephone 
interview, but were not included in the current analysis due to the lack of blood pressure 
measurement. 
 We excluded 313 participants who had been recruited and evaluated during the first 
trimester of pregnancy to address specific objectives18 because the diagnosis and 
management could be expected to be different in these cases who had prenatal care at the 
hospital and 3461 multiparous women. Among the primiparae, we excluded 91 with multiple 
gestations, 85 with chronic hypertension before pregnancy and 39 with missing data on 
gestational hypertensive disorders. From the remaining, 3070 participated in the follow-up 
evaluation at the study site. After exclusion of 139 women who were pregnant at the follow-
up visit and 54 with missing data on key variables, 2877 women were available for the 
current analysis. From those, 99 had a diagnosis of gestational hypertensive disorders during 
the index pregnancy.  
 Blood pressure measurement in children only started in September 2009. Thus, data 
on blood pressure among children was available for 2460 consecutively recruited cohort 
members. Among these, 86 were born from mothers who developed gestational 
hypertensive disorders (Figure 1). 
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 Among the 4506 eligible mothers, those who attended the follow-up re-evaluation 
were older [mean (standard deviation (SD)): 28.4 (5.4) vs. 26.4 (5.0) years, p<0.001], had a 
higher socioeconomic position (schooling >12 years: 31.6% vs. 20.3%, p<0.001 and income 
>1500€/month: 31.6% vs. 20.3%, p<0.001), and were more likely to live with a partner 
(92.5% vs. 88.6%, p<0.001) than those who did not participate in the re-evaluation, but there 
were no significant differences between the two groups regarding the prevalence of 
gestational hypertensive disorders (3.4% vs. 3.3%, p=0.811). The proportion of low birth 
weight (8.4% vs. 7.2%, p=0.450) and preterm newborns (11.0% vs. 10.2%, p=0.457) was not 
significantly different among children who participated and those who missed the follow-up 
reevaluation, and there were no differences regarding the sex of the child (male sex: 51.3% 
vs. 52.2%, p=0.566). 
 
Baseline evaluation 
 At baseline, data on demographic and socioeconomic characteristics, lifestyles, 
reproductive history and anthropometrics were collected within 72 hours after delivery, during 
the hospital stay, in a face-to-face interview conducted by trained interviewers using 
structured questionnaires. Clinical records were also reviewed at birth to retrieve data on 
complications of pregnancy, birth weight and gestational age of the newborn. Personal 
history of hypertension was considered present when participants recalled a medical 
diagnosis of this condition and/or reported antihypertensive drug therapy prescribed 
specifically for hypertension, before the current pregnancy.  
 Prepregnancy weight was recalled and recorded to the nearest 0.1 Kg and height was 
measured by the interviewers to the nearest 0.1 cm. When measurement was not possible, 
height was self-reported as registered in the identity card. The participants’ body mass index 
(BMI) was categorized according to the standard World Health Organization definition.19 
Weight gain during pregnancy was calculated as the difference between the mother’s 
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reported weight before delivery and prepregnancy weight, and was categorized according to 
the Institute of Medicine recommendation.20  
Gestational hypertensive disorders were defined by the presence of gestational hypertension 
or preeclampsia/eclampsia, always considered only when explicitly recorded on obstetrical 
records as a diagnosis during the index pregnancy. Gestational hypertension was only 
considered in the absence of a previous diagnosis of chronic hypertension.  
 Newborn’s birth weight was registered to the nearest 1g and gestational age to the 
nearest 0.1 weeks. Classes of the sex specific adequate birth weight for gestational age 
were defined according to the Canadian fetal growth standard.21 
Missing data on the questionnaires at baseline were recovered through the review of 
obstetrical records. The agreement between data collected by questionnaire and abstracted 
from medical records was good for personal history of hypertension, weight and height, and 
there was very low inter-rater variability between two independent abstractors.22  
 
 
Follow-up evaluation 
 At the cohort’s follow-up, after a median [interquartile range (IQR)] follow-up time of 
50 (48-54) months, data were collected by trained interviewers using structured 
questionnaires, regarding the health of the mother and her child. For the sake of simplicity, 4 
years of age will be assumed hereafter. Socioeconomic characteristics, personal and family 
history of disease, lifestyles and obstetric history of the mother were self-reported. Family 
history of hypertension was considered present when the women reported to have at least 
one parent or sibling affected by this condition. Current smokers included both daily and 
occasional smokers. Ex-smokers did not smoke for at least 6 months.  
 Anthropometrics of mothers and children were measured with the participants 
wearing light clothing and no footwear. Weight was measured using a digital scale to the 
nearest 0.1 kg and height measured to the nearest 0.1 cm. The mothers’ BMI was 
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categorized according to the standard World Health Organization definition.19 Regarding the 
children, height and BMI was classified according to the age specific percentiles estimated 
by the United States Center for Disease Control and Prevention.23 
 Blood pressure was measured on a single occasion by non-physician trained 
interviewers. For the mother, two measurements of blood pressure separated by at least 5 
minutes were taken with an automatic upper arm blood pressure monitor (OMRON M6 
comfort (HEM-7000-E)) after 10-minute rest, on the dominant upper arm resting at the heart 
level. The mean was calculated and when the difference was larger than 5 mmHg for systolic 
or diastolic blood pressure a third measurement was taken and the mean of the 2 closest 
values was considered. Arterial hypertension was defined as systolic and/or diastolic blood 
pressure ≥140/90 mmHg and/or self-reported antihypertensive drug therapy prescribed 
specifically for hypertension. Blood pressure of the child was measured with an aneroid 
sphygmomanometer (Erka Vario DeskModel), with a proper size cuff. Korotkoff phases I and 
V were used to indicate systolic and diastolic blood pressure. Blood pressure was measured 
twice, in a seated position with the antecubital fossa supported at heart level, after 5 minutes 
of rest. The two measurements of blood pressure were separated by at least 5 minutes and 
when the difference was larger than 5 mmHg for systolic or diastolic blood pressure a third 
measurement was taken and the mean of the 2 closest values was considered. Systolic and 
diastolic blood pressure were classified according to the criteria of the American Academy of 
Pediatrics24 and hypertension was considered as systolic and/or diastolic blood pressure 
≥95th percentile for sex, age and height.21 
 
Statistical analysis 
 Statistical analysis was performed using the software Stata 9.0 (College Station, TX, 
2005). To estimate adjusted mean differences in systolic and diastolic blood pressure, for 
mothers and offspring, according to gestational hypertensive disorders, multiple linear 
regression was used. Women under anti-hypertensive drug therapy were excluded from this 
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analysis (n=49). No child was under anti-hypertensive drug therapy. The association 
between gestational hypertensive disorders and the mother’s incidence of hypertension 4 
years after giving birth was estimated by crude and adjusted incidence rate ratios (IRR) and 
respective 95% confidence intervals (95% CI), using Poisson regression. Both for children 
and mothers, separate analyses were performed for girls and boys, since an interaction term 
between fetal sex and gestational hypertensive disorders was statistically significant at the 
5% level.  
 
 
Ethics 
 The study protocol was approved by the Ethics Committee of Hospital de São João 
and by the Portuguese Authority of Data Protection. Written informed consent was obtained 
from all the mothers and children, who gave it through their legal representative.  
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RESULTS 
 
Characteristics of the study sample 
 There were no significant differences in socio-demographic characteristics, the 
number of subsequent births and the smoking status 4 years after delivery between 
participants with and without gestational hypertensive disorders (Table 1). Mothers who 
developed those conditions during pregnancy were more likely to report a family history of 
hypertension, more often gained more weight during pregnancy than recommended and 
remained more likely to be overweight and obese 4 years after giving birth. The proportion of 
women who delivered a small for gestational age newborn was higher among those who 
developed gestational hypertension or preeclampsia/eclampsia during the index pregnancy.  
 
Outcomes of the mother 
 In this sample of Portuguese primiparae, approximately 4 years after delivery, the 
mean (SD) systolic and diastolic blood pressure were significantly higher in mothers with 
gestational hypertensive disorders who delivered a girl (120.7 (15.7) vs. 106.4 (11.1) mmHg; 
p<0.001, and 84.7 (12.5) vs. 73.1 (10.8) mmHg; p<0.001, respectively), and among those 
who delivered a boy (113.5 (12.5) vs. 105.6 (10.8) mmHg; p<0.001, and 79.5 (9.6) vs. 72.9 
(9.0) mmHg; p<0.001, respectively). The 4-year crude incidence rate of hypertension per 
1000 person-years was much higher in women with gestational hypertension or 
preeclampsia/eclampsia during pregnancy who gave birth to a female (114.6 vs. 12.2, 
p<0.001) or to a male newborn (52.7 vs. 11.6, p<0.001) than normotensive women (Figure 
2). After adjustment for age, family history of hypertension, BMI at follow-up and smoking 
status, gestational hypertensive disorders were significantly associated with an increase of 
systolic blood pressure of 11 and 6 mmHg for women who delivered a female and a male 
newborn, respectively (p for interaction=0.018). Similarly, gestational hypertension or 
preeclampsia/eclampsia were significantly associated with an approximately 8 and 5 mmHg 
115 
 
higher diastolic blood pressure in mothers of girls and in mothers of boys, respectively (p for 
interaction=0.033). Four years after delivery, gestational hypertensive disorders were 
significantly associated with an almost 6-fold increase in the incidence of hypertension 
among mothers who delivered a girl, and with a 3-fold increase in those who delivered a boy 
(p for interaction=0.265) (Table 2). 
 
Outcomes of the offspring 
 An average of 4 years after birth, the incidence rate of hypertension per 1000 person-
years was higher for both girls (50.0; vs. 32.0, p=0.218) and boys (39.1 vs. 28.0, p=0.334) 
born of women with gestational hypertension or preeclampsia/eclampsia, when compared 
with those born of normotensive women (Figure 2). After adjustment for classes of birth 
weight for  gestational age, current age and height, gestational hypertensive disorders were 
associated with a non-significant increase of approximately 2 mmHg on systolic and 0.5 
mmHg on diastolic blood pressure, at age 4 among girls. Among boys, gestational 
hypertensive disorders remained significantly associated with a 2 and 3 mmHg higher 
systolic and diastolic blood pressure after adjustment (Table 3).  
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DISCUSSION  
 
 In this sample of Portuguese primiparous women, the development of gestational 
hypertensive disorders was significantly associated with higher systolic and diastolic blood 
pressure, an average of 4 years after giving birth. Overall, the 4-year risk of hypertension in 
women who developed those conditions during pregnancy was almost 6 times higher among 
mothers who delivered a girl, and 3 times higher among those who delivered a boy. Systolic 
and diastolic blood pressure at 4 years were higher in boys born of mothers with 
hypertensive disorders of pregnancy, while no effect was detected among girls. 
 The increase of more than 5 mmHg in both systolic and diastolic blood pressure, 
among mothers with gestational hypertensive disorders during the index pregnancy, 
represents a substantial shift to the right in blood pressure distribution. Similar estimates 
were found in a case-control study, with a mean increase of 7.3mmHg and 4.7mmHg in 
systolic and diastolic blood pressure, after a average period of 7.8 years from the index 
pregnancy.25 In the long term, at least preeclampsia is associated with a 4-fold increased risk 
of a later diagnosis of hypertension, with over 50% of women with preeclampsia developing 
chronic hypertension after 14 years.4 Recently, a prospective study in which women were 
interviewed by telephone 6 to 13 months after delivery reported a strong and positive 
association between preeclampsia and self-reported chronic hypertension.26 Our study adds 
the prospective follow-up with objective measurement of blood pressure of mothers of a 
population-based birth cohort, showing that as soon as 4 years after delivery, the risk of 
chronic hypertension was already significantly higher in women with gestational hypertensive 
disorders. Taken together and considering the overlap of determinants of chronic and 
gestational hypertensive disorders, these findings question the transient nature of this 
hypertension. Evidence of sub-clinical maternal endothelial dysfunction after a pregnancy 
affected by preeclampsia but before the onset of clinical cardiovascular disease supports that 
a continuous uninterrupted pathological process develops.13, 27 Heterogenous causes of 
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gestational hypertensive disorders have been proposed, comprising both a background 
increased vascular risk possibly with a yet unidentified higher blood pressure beforehand and 
hypertension induced by disturbed perfusion of the placenta.12 In light of this causal model, 
the role of an immune response to paternal antigens in a de novo and transient hypertensive 
state could be expected to occur more often with male babies, resulting in a smaller effect of 
hypertension in pregnancy on later blood pressure of the mother when the fetus is male, 
while hypertension in pregnancy with a female fetus might more often only represent the 
revelation of a previous higher vascular risk. 
 Despite controversial,28 aggregation of gestational hypertension and 
preeclampsia/eclampsia into a composite endpoint is an advantage, assuming the two 
entities could represent different stages of one pathological process and reducing the 
possibility of misclassification between more specific outcomes. Moreover, studies that 
analyzed gestational hypertension and preeclampsia described similar associations with 
chronic hypertension later in life.29   
 It has been argued that women with uncomplicated pregnancies have a lower rate of 
later cardiovascular disease than the general population and are therefore not an appropriate 
reference category.12 Thus, we compared the 4-year incidence of hypertension of our 
unexposed study participants with that from a general population to assess a putative 
differential selection in exposed and unexposed. In a representative sample of the adult 
population of Porto, assembled from 1999 to 2003,30 the 4-year crude incidence rate of 
hypertension in women aged below 40 years (median age similar to the one of our cohort) 
was 22.3 per 1000 person-years (data not shown). This rate is considerably higher than that 
of women with uncomplicated pregnancies in our current sample, confirming the expected 
healthier average profile of women who achieved successful uncomplicated pregnancies, but 
it is still much lower than the one estimated for those with gestational hypertensive disorders. 
We restricted our analysis to primiparae in order to remove the possible effect of a 
gestational hypertensive disorder occurring in a previous pregnancy. Additionally, achieving 
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an additional successful pregnancy is expected to be associated with a lower likelihood of 
hypertension, which would introduce selection bias.  
 In a meta-analysis considering 10 studies6 of offspring between 6 and 19 years old, 
those born from women with preeclampsia had an increase of 2.3 mmHg  and 1.7mmHg in 
systolic and diastolic blood pressure when compared with offspring from normotensive 
pregnancies.6 Our study shows that this increase in systolic and diastolic blood pressure is 
already observed in preschool children. Regarding systolic blood pressure, a higher mean 
was described among 3 to 6-year-old children of mothers with elevated blood pressure 
during pregnancy than that of children whose mothers did not have hypertension in 
pregnancy.31 Despite the lack of significance, the point estimates of systolic and diastolic 
blood pressure remained higher in the offspring female of mothers with gestational 
hypertensive disorders. We found a statistical significant increase of 2.3 and 3.1 mmHg in 
systolic and diastolic blood pressure of boys born from mothers who developed gestational 
hypertension or preeclampsia/eclampsia. This association was not explained after 
adjustment for systolic and diastolic blood pressure of the mother (data not shown). A 
stronger association between gestational hypertensive disorders and diastolic blood pressure 
in boys had already been described at 6 years of age, suggesting a possible sex-specific 
effect of preeclampsia.32 In fact, male sex has been described as an independent risk factor 
for adverse pregnancy outcome.33 In the womb, boys grow more rapidly and invest less in 
placental growth, which puts them at greater risk of becoming undernourished. During fetal 
development the kidney has low priority because the placenta performs most of its functions. 
In case of impaired capacity of the placenta to transport nutrients, boys exchange more 
easily renal development than girls to protect more important organs, which will lead to a 
lifelong reduction in the number of nephrons.17 Sex differences are observed in the placenta 
at multiple levels, from epigenetic modification of DNA, through gene expression to functional 
changes in the way in which the placenta responds to hormones and transports nutrients. It 
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is clear that these changes become established in the placenta via mechanisms such as 
DNA methylation, and are not simply due to direct effects of fetal sex hormones.34 
 A major strength of this study is the prospective assessment, relying on objective and 
standardized measurements, of hypertension risk in a short period of time after birth, at a 
point when women and children may be in a time window for more effective prevention. 
However, some limitations should be acknowledged. Despite the large size of the cohort, the 
number of women with gestational hypertensive disorders was relatively small. However, it 
was enough to demonstrate a differential effect by sex of the child. The absence of objective 
measurements of the mother’s blood pressure before and during pregnancy, together with 
the low awareness of chronic hypertension in young women35 can lead to an erroneous 
diagnosis of gestational hypertension or preeclampsia/eclampsia and, consequently, an 
overestimation of the prevalence of these pathologies. In this case, this would lead to an 
overestimation of the incidence of chronic hypertension, 4 years after delivery. However, 
since 75% of the pregnancies were planned and 85% of women had the first prenatal visit 
before 12 weeks of pregnancy (data not shown), it is unlikely that a diagnosis of chronic 
hypertension before pregnancy was underreported or undetected.  Also, it is possible that the 
refusals of participation at baseline occurred mainly in cases with higher maternal and/or 
perinatal complications in the post-partum period, namely when the newborn was admitted to 
a neonatal intensive care unit. Since hypertensive disorders in pregnancy are associated 
with increased risks of adverse maternal and fetal outcomes,1-3 the cases with worst 
outcomes may have been lost. Despite the high proportion of participation at follow-up, 
mothers who attended the follow-up re-evaluation were older, more educated and more likely 
to live with a partner. However, we found similar proportions of preeclampsia and gestational 
hypertension between women who participated and those lost to follow-up, suggesting that 
the associations examined should not be markedly different in those lost to follow-up.  
 In the present study, hypertension in children was defined as systolic and/or diastolic 
blood pressure above the 95th percentile measured in only one moment, while the American 
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Academy of Pediatrics’24 recommends the measurement of blood pressure in 3 or more 
occasions. It was previously described that the proportion of children with elevated blood 
pressure based on one visit was 4 to 5 times higher than based on three measurements 
taken at few-week intervals.36, 37 Therefore, we may be overestimating children’s usual blood 
pressure as well as the incidence rate of hypertension in both exposed and unexposed 
groups. However, we do not expect that this overestimation occurred differentially by 
gestational hypertensive disorders during pregnancy and, in the worst scenario, this would 
result in underestimating the reported associations.  
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PERSPECTIVES  
 
 Four years after a single pregnancy complicated by gestational hypertensive 
disorders in primiparae, mothers already have higher blood pressure and more frequently 
have chronic hypertension, and this effect is stronger when the fetus was female. The effects 
on offspring’s blood pressure are evident only among male sex children, supporting the 
thesis that boys live dangerously in the womb. Such short-term outcomes reinforce the 
importance of effective preventive strategies to control cardiovascular risk beginning 
immediately after birth, possibly by extending post-partum care and integrating it with 
children’s health care plan.  
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Table1. Characteristics of primiparae with single pregnancies and no previous chronic hypertension, and their children, according to sex 
of the offspring and the occurrence of gestational hypertensive disorders. 
 
 Girls  Boys 
 GHDa  Normotensive  p  GHDa  Normotensive  p 
Mothers n=39  n=1359    n=60  n=1419   
Age at baseline (years), mean (SD) 29.2 (5.9)  28.4 (5.1)  0.391  28.9 (4.9)  28.4 (5.0)  0.405 
Education (years), median (IQR) 10 (7-12)  12 (9-16)  0.082  12 (9-16)  12 (9-16)  0.061 
Family history of hypertension, n (%) 27 (69.2)  674 (49.6)  0.016  38 (63.3)  687 (48.4)  0.024 
Smoking at 4 years, n (%)     0.231      0.195 
   Never smoker 24 (61.5)  819 (60.3)    42 (70.0)  835 (59.0)   
   Current smoker 6 (15.4)  335 (24.6)    10 (16.7)  371 (26.2)   
   Ex-smoker 9 (23.1)  205 (15.1)    8 (13.3)  211 (14.9)   
Weight gain during pregnancyb, n (%)     0.151      0.152 
   Below recommended 7 (21.2)  327 (26.9)    10 (19.6)  338 (26.5)   
   As recommended 9 (27.3)  461 (37.9)    17 (33.3)  503 (39.5)   
   Above recommended 17 (51.5)  427 (35.1)    24 (47.1)  434 (34.0)   
BMI at 4 years (kg/m2), n (%)     <0.001      0.002 
   <24.9 5 (12.8)  721 (53.1)    19 (31.7)  747 (52.6)   
   25.0-29.9 15 (38.5)  393 (28.9)    22 (36.7)  428 (30.2)   
   ≥30.0 19 (48.7)  245 (18.0)    19 (31.7)  244 (17.2)   
At least one birth after the index birth, n (%) 9 (23.1)  272 (20.0)  0.638  9 (15.0)  309 (21.8)  0.210 
Children n=35  n=1151    n=51  n=1223   
Birth weight for gestational agec, n (%)     0.010      0.369 
   Small  (<10th percentile) 10 (28.6)  180 (15.6)    12 (23.5)  197 (16.1)   
   Adequate (10th - 90 percentile) 22 (62.9)  940 (81.7)    38 (74.5)  1004 (82.1)   
   Large (≥90th percentile) 3 (8.6)  31 (2.7)    1 (2.0)  22 (1.8)   
Age at follow-up (months), median (IQR) 51 (50-55)  53 (50-59)  0.190  53 (50-58)  51 (50-55)  0.377 
 BMI, body mass index; GHD, gestational hypertensive disorders; IQR, interquartile range; SD, standard deviation 
 a Gestational hypertension and/or preeclampsia/eclampsia 
 b According to the Institute of Medicine classification (2009) 
 c According to Canadian fetal growth standard 
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Table 2. Mean difference (β) of systolic and diastolic blood pressure (mmHg), and incidence rate ratio (IRR) of hypertension, an average 
of 4 years after delivery, for mothers who delivered girls (n=1398) and boys (n=1479), according to gestational hypertensive disorders. 
Women under antihypertensive drug therapy were excluded from the analysis of mean blood pressure. 
 
 Systolic blood pressure  Diastolic blood pressure  Hypertension 
 β (95% CI)  β (95% CI)  IRR (95% CI) 
 Crude Adjusteda  Crude Adjusteda  Crude Adjusteda 
Mothers who delivered girls         
Gestational hypertensive disorders (yes vs. no) 14.89 (10.93 to 18.85) 12.34 (8.57 to 16.11)  11.55 (8.61 to 14.49) 8.52 (5.73 to 11.30)  12.07 (8.82 to 15.32) 9.89 (6.78 to 12.89) 
Mothers who delivered boys         
Gestational hypertensive disorders (yes vs. no) 7.71 (4.85 to 10.57) 6.16 (3.37 to 8.94)  6.54 (4.22 to 8.86) 4.80 (2.58 to 7.02)  6.20 (3.82 to 8.58) 4.62 (2.35 to 6.89) 
95%CI, 95% confidence interval; β, linear regression coefficient; IRR, incidence rate ratio 
a Adjusted for mothers’ age at birth, family history of hypertension, body mass index (BMI) at follow-up and smoking status at follow-up 
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Table 3. Mean difference (β) of systolic and diastolic blood pressure (mmHg) for girls (n=1186) and boys (n=1274), at 4 years, according 
to gestational hypertensive disorders. 
 
 Systolic blood pressure  Diastolic blood pressure 
 β (95% CI)  β (95% CI) 
 Crude Adjusteda  Crude Adjusteda 
Girls      
Gestational hypertensive disorders (yes vs. no) 2.36 (-0.45 to 5.17) 1.93 (-0.71 to 4.56)  0.56 (-2.19 to 3.32) 0.48 (-2.20 to 3.17) 
Boys      
Gestational hypertensive disorders (yes vs. no) 2.60 (0.28 to 4.92) 2.29 (0.10 to 4.48)  3.10 (0.83 to 5.38) 3.11 (0.87 to 5.34) 
       95%CI, 95% confidence interval; β, linear regression coefficient. 
       a Adjusted for childs’ percentile of birth weight for gestational age classes (according to the Canadian fetal growth standard), age (continuous) and  height percentile 
classes at follow-up (according to the CDC criteria) 
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Figure 1. Flowchart for study sample definition. 
8495 mothers
4506 mothers and children at baseline
8647 children
313 (3.7%) recruited and evaluated during pregnancy 
3461 (40.7%) multiparae
91 (1.1%) multiple gestations
85 (1.0%) with chronic hypertension before pregnancy
39 (0.5%) with missing data on gestational hypertensive disorders
3070 face-to-face 
follow-up interview 
759 telephone
follow-up interview 
1398 gave birth to 
a girl
1479 gave birth to 
a boy
39 with GHD
1359 without GHD
60 with GHD
1419 without GHD
2460 face-to-face 
follow-up interview 
(with BP 
measurement)
713 face-to-face 
follow-up interview 
(without BP 
measurement)
1186
girls
1274
boys
35 with GHD
1151 without GHD
51 with GHD
1223 without GHD
Mothers
Children
751 telephone
follow-up interview 
4721 primiparae
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Figure 2. Incidence rates of hypertension among mothers and children, according to the 
occurrence of gestational hypertensive disorders (GHD) in the index pregnancy and child’s 
sex. The symbols represent the incidence rate point estimates and vertical lines the 95% 
confidence intervals. Hypertension was defined as blood pressure ≥140/90 mmHg and/or or 
reported antihypertensive drug therapy prescribed specifically for hypertension in women 
and as systolic and/or diastolic blood pressure ≥95th percentile for sex, age and height in 
children. 
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ABSTRACT 
 
INTRODUCTION: Pregnancy is a privileged opportunity in women’s life to promote 
tobacco cessation but information is lacking regarding the long term effect of 
pregnancy related behavioural changes. We assessed the smoking cessation during 
pregnancy and its sustainability 4 years after delivery. 
METHODS: A birth cohort was assembled at public maternities of Porto, Portugal in 
2005-2006 and reevaluated an average of 4 years after delivery. In the current 
analysis, 5420 mothers were included. Smoking status at baseline and at follow-up was 
ascertained by interview. Adjusted prevalence ratios (PR) and 95% confidence 
intervals (95%CI) were computed using robust Poisson regression. 
RESULTS: During pregnancy, almost half of smokers stopped and approximately 40% 
reduced consumption. Cigarette smoking cessation during pregnancy was more likely 
among primigestae, those living with a partner, with higher educational levels, 
overweight or obese, with adequate prenatal care, who began smoking later and who 
smoked less. Four years after delivery, only a third of the women who ceased smoking 
during pregnancy remained non-smokers. They were more likely older, primigestae, 
living with a partner at 4 years, with lower tobacco consumption before pregnancy, who 
breastfed ≥52 weeks, got pregnant again after the index pregnancy and whose child 
had a medical diagnosis of asthma and/or rhinitis. 
CONCLUSIONS: Most smokers stopped or decreased consumption during pregnancy, 
but this behavioural change showed little long-term impact on their smoking trajectory. 
 
Keywords: Cohort studies; Pregnancy; Recurrence; Smoking Cessation. 
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INTRODUCTION 
 
Worldwide, smoking is the single most frequent preventable cause of death 
(WHO, 2011) and smoking cessation reduces the long-term risk of cancer and 
cardiovascular diseases (Kenfield, Stampfer, Rosner, & Colditz, 2008; Teo et al., 
2006).   
Cigarette smoking during pregnancy is associated with increased risks of 
adverse maternal and fetal outcomes such as ectopic pregnancy, placental abruption, 
placenta previa (Castles, Adams, Melvin, Kelsch, & Boulton, 1999), small for 
gestational age babies (Rodrigues & Barros, 2007), low birth weight and preterm birth 
(Jaddoe et al., 2008). Mothers tend to be strongly motivated to protect the health of the 
unborn baby and there is important social pressure to quit smoking during pregnancy 
(Edwards & Sims-Jones, 1998; Ripley-Moffitt et al., 2008). However, it is not clear 
whether, or to what extent, smoking cessation during pregnancy persists long after 
pregnancy, since studies have focused on the sustainability of smoking cessation only 
in the initial postpartum period, shortly after birth (Carmichael & Ahluwalia, 2000; 
Colman & Joyce, 2003; Polanska, Hanke, Sobala, Lowe, & Jaakkola, 2011). 
In Portugal, smoking remains more frequent among men but its prevalence is 
increasing in women (Fraga et al., 2005). The prevalence is higher among younger and 
more educated women placing Portugal at a relatively early stage of the epidemic 
compared to other Western European countries (Precioso et al., 2009; Santos & 
Barros, 2004). Therefore, it is expected that, in the near future, the burden of tobacco-
related illness will increase substantially (Lopez, Collishaw, & Piha, 1994). In order to 
guide the development of preventive strategies to reduce the future burden of smoking 
and promote the health of children and families, it is important not only to describe 
exposure to smoking in pregnancy and postpartum but also to identify modifiable 
determinants of such behaviours.  
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In this study, our objective was to assess the frequency and determinants of 
maternal smoking cessation during pregnancy and of the sustainability of smoking 
cessation 4 years after delivery. 
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METHODS 
 
Study design and sample characteristics 
This study is based on the birth cohort Geração XXI, which has been described 
previously (Alves, Correia, Barros, & Azevedo, 2012). Briefly, the cohort was 
assembled between 2005 and 2006 at 5 public maternity units covering the 
metropolitan area of Porto, Portugal. A total of 8495 mothers (91.4% of those invited), 
who gave birth to 8647 infants, were enrolled in the cohort. An average of 4 years after 
delivery, the cohort was re-evaluated and the mothers were invited to participate in a 
parallel study on women’s cardiovascular health. 
We excluded 313 mothers who had been recruited and evaluated from the first 
trimester of pregnancy to address specific objectives (Pinto et al., 2010), since smoking 
habits before and during pregnancy report is expected to change over time during 
pregnancy. From the remaining 8182 participants, 6881 participated in the follow-up 
evaluation. After exclusion of women with missing or inconsistent data in any variable 
used in the current analyses, 5420 women were available (Figure 1). 
Mothers who attended the follow-up re-evaluation were older [mean (standard 
deviation (SD)): 29.3 (5.4) vs. 27.1 (5.9) years, p<0.001], more educated (education >9 
years: 53.4% vs. 37.2%, p<0.001), with higher income (income >1000€/month: 61.6% 
vs. 37.2%, p<0.001), less frequently smokers before pregnancy (24.8% vs. 34.7%, 
p<0.001) and more likely to stop smoking during pregnancy (45.8% vs. 35.8%, 
p<0.001) ) than those who did not participate in the re-evaluation. 
 
Baseline evaluation 
At baseline, data on demographic and socioeconomic characteristics, lifestyles, 
obstetric history and anthropometrics were collected within 72 hours after delivery, 
during the hospital stay, in a face-to-face interview conducted by trained interviewers 
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using structured questionnaires. Clinical records were also reviewed at birth to retrieve 
data on complications of pregnancy, birth weight and gestational age of the newborn.  
Pregnant current smokers included both daily (at least one cigarette per day) 
and occasional smokers (less than a cigarette per day) in the 3 months prior to 
pregnancy. Women were considered former smokers if they ever smoked but not 
during the 3 months before pregnancy. Smoking cessation during pregnancy was 
defined as quitting during the first or second trimester of pregnancy. Reduction of 
consumption was considered when women reported to smoke a lower daily number of 
cigarettes in the third trimester than in the three months before pregnancy.  
Prepregnancy weight was recorded to the nearest 0.1 Kg as recalled. At 
baseline, height was measured to the nearest 0.1 cm. When measurement was not 
possible, height was reported by the mother as registered in the identity card (30.8% of 
women with data on height). The body mass index (BMI) was categorized according to 
the standard World Health Organization definition as underweight (<18.5 kg/m2), 
normal (18.5-24.9 kg/m2), overweight (25.0–29.9 kg/m2) and obese (≥30 kg/m2) 
(Expert Panel, 1998). Pregnancy complications included the diagnosis of any 
infectious, placental, hemorrhagic and cardiovascular events during pregnancy. 
Adequacy of prenatal care was determined by the Adequacy of Prenatal Care 
Utilization (APNCU) Index (Kotelchuck, 1994), based on the combination of the month 
of initiation of prenatal care, the observed and expected number of prenatal visits and 
the gestational age at birth. According to the APNCU index, having less than 50% of 
the recommended number of prenatal visits for a given gestational age or initiation of 
prenatal care after the first trimester was defined as inadequate care. 
Part of the data missing on the questionnaires at baseline was recovered 
through the review of delivery medical records. The agreement between data collected 
by questionnaire and abstracted from medical records was good for weight and height, 
and there was very low inter-rater variability between 2 independent abstractors (Alves 
et al., 2010).  
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Follow-up 
At the fourth anniversary of the children from the cohort a follow-up was 
performed and data were collected using structured questionnaires, regarding the 
health of the mother and her child. All mothers and children were invited to participate 
in a face-to-face interview but, if they refused, a telephone interview was performed. 
From the 5420 mothers included in our sample, 4343 (80.1%) attended a face-to-face 
interview and physical examination at the study site and 1077 (19.9%) provided self-
reported data by telephone interview. There were no significant differences between 
participants evaluated by face-to-face and telephone interview regarding smoking 
characteristics at baseline (smokers before pregnancy: 22.5% vs. 24.3%, p=0.416; 
respectively), changes in consumption during pregnancy (reduced consumption: 42.0% 
vs. 40.5% and smoking cessation: 47.8% vs. 45.8%, p=0.564) and smoking habits at 
follow-up (smokers: 24.5% vs. 26.3%, p=0.191, respectively). 
Smoking habits were self-reported and included information on the daily number 
of smoked cigarettes, 4 years after giving birth. An ex-smoker was a woman who 
formerly smoked but not for at least 6 months. Current smokers included both daily (at 
least one cigarette per day) and occasional smokers (less than a cigarette per day) at 
the time of the survey. Women who sustained their smoking cessation were defined as 
those who reported not to smoke 4 years after delivery, among those who had stopped 
smoking during pregnancy. Thirty women were excluded due to contradictory data 
regarding baseline and follow-up smoking habits.  
Socioeconomic characteristics, personal and family history of disease, lifestyles 
and obstetric history of the mother were self-reported. The duration of breastfeeding 
was recorded in weeks, as the period of time that a child received maternal milk 
exclusively or together with complementary foods. Offspring’s history of asthma or 
rhinitis was considered present when mothers recalled a medical diagnosis of these 
conditions. 
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Statistical analysis 
Statistical analysis was performed using the statistical software Stata 9.0 
(College Station, TX, 2005). Sample characteristics are presented as counts and 
proportions and were compared using the chi-square test. Crude and adjusted 
prevalence ratios (PR) and 95% confidence intervals (95%CI) were estimated by 
robust Poisson regression in order to assess the maternal determinants of smoking 
cessation during pregnancy and of sustainability of cessation 4 years after delivery. 
Determinants were selected taking into account those previously described in the 
literature, such as socioeconomic characteristics, lifestyles, gynaecologic and obstetric 
history, prenatal care, complications of the index pregnancy and delivery. In the final 
model all the determinants which were statistically significant were included as well as 
those who based on previous knowledge could possibly confound the associations. 
 
Ethics 
The study protocol was approved by the Ethics Committee of Hospital de São 
João and by the Portuguese Authority of Data Protection. Written informed consent 
was obtained from all the mothers and children, the latter through their legal 
representative, in case of face-to-face interview. Verbal consent was explicitly solicited 
at the beginning of telephone interviews.  
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RESULTS 
 
Characteristics of study sample according to smoking before pregnancy  
 In this sample of Portuguese women who delivered a live born, 22.9% (95%CI: 
21.8-24.0) reported smoking in the three months prior to pregnancy and 11.4% 
(95%CI: 10.6-12.3) to be former smokers (Figure 1). 
Mothers who smoked during the three months prior to pregnancy, were 
younger, less educated, with a lower household income and were more frequently 
unemployed or housewives (Table 1). These women were less likely to be overweight 
or obese before pregnancy but more likely to have inadequate prenatal care during the 
index pregnancy. Prepregnancy smokers less often lived with a partner at follow-up, or 
returned to work, within 1 year after delivery and never breastfed or breastfed their 
child for a short period of time. Overall, 29.8% of the smoking mothers initiate their 
tobacco consumption before 15 years and 29.6% after 18 years old. Among the 
mothers who smoked before pregnancy, 45.5% smoked more than 10 cigarettes per 
day. 
   
 
Cigarette smoking cessation during pregnancy 
Overall, 47.4% of the women ceased smoking and 41.7% reduced their tobacco 
consumption during pregnancy, on average by 8.9 cigarettes per day, from 15.4 to 6.5 
cigarettes.  
In this sample of women who achieved a successful pregnancy, those who did 
not live with a partner at delivery and those with at least 1 additional previous 
pregnancy, are 20% less likely to cease smoking during pregnancy. Educational level 
and prepregnancy BMI were progressively and significantly associated with smoking 
cessation during pregnancy.  Those with an educational level above 12 years had a 
40% higher probability of quitting smoking, in comparison with mothers with 
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educational level below 10 years, while obese women had a 30% increased probability 
of quitting smoking, in comparison with normal weight. Inadequacy of prenatal care 
was associated with a lower probability of quitting smoking in a graded mode, up to 
45% reduction. The later the women initiated smoking the higher the likelihood of 
stopping, with up to 30% increase in probability for women who started smoking after 
18 years of age. Heavier smokers (more than 10 cigarettes per day in the three months 
prior to pregnancy) had an almost 50% lower probability of smoking cessation. 
 
 
Sustainability of smoking cessation 4 years after delivery 
Four years after delivery, 32.1% of former smokers remained smoke-free and 
19.0% sustained a reduction in the amount smoked. On average, smokers at both time 
points smoked 2.5 cigarettes per day less at 4 years than during the 3 months before 
pregnancy.  
The sustainability of smoking cessation 4 years after pregnancy increased with 
age (≥35 vs. <25 years: PR=2.21; 95%CI: 1.43-3.41) and duration of breastfeeding 
(≥53 weeks vs. never or ≤4 weeks: PR=1.53; 95%CI: 1.07-2.19). Women who got 
divorced during the follow-up period were over two-fold less likely to maintain the 
smoking cessation. Multiparous women at the index pregnancy were 30% less likely to 
sustain smoking cessation at 4 years whereas those who achieved subsequent 
pregnancies were 50% more likely to maintain abstinence within this period. Mothers 
who smoked more than 10 cigarettes per day in the three months prior to pregnancy 
had a 30% lower probability of sustain the smoking cessation. A diagnosis of asthma or 
rhinitis in the offspring was positively associated with the sustainability 4 years after 
delivery (PR=1.56; 95%CI: 1.08-2.25).  
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DISCUSSION  
 
In this study of Portuguese women who delivered of a live born, the prevalence 
of smoking was 23% before pregnancy but almost half stopped during the index 
pregnancy. Factors associated with smoking cessation during pregnancy were parity, 
marital status, education, BMI, prenatal care, smoking initiation age and the amount of 
cigarettes smoked per day. Four years after delivery two thirds resumed smoking. 
Older women, primigestae, with lower tobacco consumption, married or living with a 
partner at follow-up, who got pregnant again after the index pregnancy and breastfed 
more than 52 weeks and whose child had a medical diagnosis of asthma and/or rhinitis 
were more likely to maintain the cigarette smoking cessation. 
The EURO-PERISTAT study, that monitored and evaluated perinatal health in 
Europe, reported prepregnancy smoking prevalence levels in 2004 ranging from 7.9% 
in Lithuania to 35.9% in France (EURO-PERISTAT, 2008). According to a study 
performed in 25 public maternity units, 30% of women smoked before pregnancy in 
Portugal (Rodrigues & Barros, 2008). The lower prevalence described in our study may 
be explained by the higher educational level of the mothers included in the Geração 
XXI cohort. Since more educated women more frequently planned their pregnancy, it is 
possible that these women had stopped smoking before pregnancy, because they 
intended to get pregnant. In Portugal, the prevalence of smoking is higher among more 
educated women (Fraga et al., 2005), and the higher prevalence described in this 
study may be due to the specific characteristics of the women included. In the latest 
National Health Survey, in 2005-2006, the prevalence of smoking among women from 
the general population aged between 15 to 44 years was 18.4% (INS, 2009), possibly 
underestimated since the questionnaire could be answered by a proxy in case the 
index subject was absent and proxies might not be aware of the smoking status of 
these women, especially in younger ones. 
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In many countries in Europe, more than 10% of women smoke during 
pregnancy (EURO-PERISTAT, 2008). In our study, 12.0% reported to smoke during 
pregnancy, which means that almost half of the women stopped smoking during 
pregnancy. This estimate is in accordance with previous literature reporting smoking 
cessation rates ranging from 30% to 50% (Colman & Joyce, 2003; Correia et al., 2007; 
DiSantis, Collins, & McCoy, 2010; Fingerhut, Kleinman, & Kendrick, 1990).  
Overall, maternal socio-demographic characteristics, as well as the mother's 
reproductive history and prenatal care, are associated with smoking during pregnancy 
(Al-Sahab, Saqib, Hauser, & Tamim, 2010; Colman & Joyce, 2003; Lu, Tong, & 
Oldenburg, 2001; Mohsin & Bauman, 2005; Severson, Andrews, Lichtenstein, Wall, & 
Zoref, 1995). Predictors of smoking cessation among pregnant women have been well 
investigated, internationally. Women who quit smoking during pregnancy are more 
likely to report being married or in a stable relationship and having higher educational 
qualifications (Al-Sahab et al., 2010; Colman & Joyce, 2003; Fingerhut et al., 1990). 
However, a study that assessed the reporting of prenatal smoking in birth certificates 
and in confidential questionnaires found that more educated women are less willing to 
admit smoking to prenatal care providers, which may lead to overestimation of the 
association between education and smoking cessation during pregnancy (Dietz, 
Adams, Kendrick, & Mathis, 1998). Quitting in pregnancy appears to be more 
successful in first pregnancies regardless of social background, with the probability 
decreasing with the number of pregnancies (Graham, Hawkins, & Law, 2010). It has 
been suggested that past pregnancies resulting in the birth of a healthy child despite 
tobacco consumption might weaken the women’s motivation to change their smoking 
habits in subsequent pregnancies (Chaaya, Awwad, Campbell, Sibai, & Kaddour, 
2003).  
Women receiving adequate prenatal care show a higher rate of smoking 
cessation (Bachir & Chaaya, 2008; Mohsin & Bauman, 2005). In fact, those smokers 
who quitted while pregnant were more likely to have initiated prenatal care in the first 
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trimester and to have an adequate number of prenatal visits. Despite the impact of 
adequate prenatal care on smoking cessation, this may also be due to personal 
characteristics of women since those more prone to quit smoking are also probably 
more prone to attend prenatal care (Barros, Tavares, & Rodrigues, 1996). According to 
a study that assessed women’s knowledge and sources of information about adverse 
effects of smoking during pregnancy in Portugal, in 2003-2004, 45% of the mothers 
were misinformed or had no information about the adverse effects of smoking during 
pregnancy. Additionally, the doctors’ role as a source of information was surpassed by 
the media, which was the main source of information (Correia et al., 2007). 
Women who initiate smoking earlier or were heavier smokers were more likely 
to smoke during pregnancy, emphasizing the physiological and psychological role of 
nicotine dependence in smoking cessation (Ebbert, Montori, Erwin, & Stead, 2009). 
Concern about weight gain during and after pregnancy may be a factor that interferes 
with smokers’ efforts to quit during pregnancy (Berg, Park, Chang, & Rigotti, 2008), 
with pregnant smokers reporting the use of smoking as a weight management strategy 
(Pomerleau, Brouwer, & Jones, 2000). In our study there was no association with 
weight gain during pregnancy (data not shown) but we found a positive association 
between prepregnancy overweight and obesity and smoking cessation during 
pregnancy. Therefore, it is possible that women with a normal prepregnancy BMI had a 
higher concern with postpartum weight gain and therefore, were less likely to try to quit 
smoking during pregnancy than those with a BMI above 25Kg/m2.  
Besides the high proportion of women who stopped smoking during pregnancy, 
most of the remaining smokers reported to have reduced their tobacco consumption. 
The reduction in consumption during pregnancy to an average of 6.5 cigarettes per day 
found in our study is in accordance to previous findings that reported an average daily 
consumption of 7 cigarettes during the third trimester (Al-Sahab et al., 2010) among 
Canadian women. Despite the undeniable benefit of reducing the number of cigarettes 
on health, the main aim of prevention is smoking cessation and for this reason, this 
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article focuses, essentially, on smoking cessation during pregnancy and its 
determinants and long-term sustainability. Also, the potential for misclassification 
regarding dose is higher than for smoking versus not. Still, we considered important to 
also present data about reduction in a descriptive perspective, since it highlights 
women’s concern with their unborn baby protection and can promote a long term 
reduction in the consumption of cigarettes, which will have a positive impact on the 
future health of the mother (Edwards & Sims-Jones, 1998; Ripley-Moffitt et al., 2008). 
Unfortunately, the tendency observed among those women who reduce their 
consumption is the same as for cessation, since 80% of mothers who reduced the 
number of cigarettes during pregnancy returns to its regular consumption, 4 years after 
delivery. 
Despite a high proportion of women quitting or reducing their tobacco 
consumption during pregnancy the rate of relapse or return to previous rates following 
childbirth is high. In fact, approximately 25% of women who quit smoking during 
pregnancy will relapse within one month of delivery (Fingerhut et al., 1990). By three 
months postpartum, 40% to 50% of women will have returned to smoke and, 70% will 
have experienced a relapse within one year postpartum (Colman & Joyce, 2003; 
Fingerhut et al., 1990; Polanska et al., 2011). In our study, 4 years after giving birth, 
68% of women returned to smoke among those who had quitted during pregnancy.  
As described previously, younger women, divorced or without a partner and 
with a lower education were more likely to resume smoking (Colman & Joyce, 2003; 
Fingerhut et al., 1990). These results are consistent with a large body of evidence on 
inequalities in smoking. Women with lower levels of education may have limited access 
to smoking cessation programs, and the programs available may not be adequate for 
them (Cluss, Levine, & Landsittel, 2011; Gilman, Breslau, Subramanian, Hitsman, & 
Koenen, 2008). Despite the positive association between the number of previous 
pregnancies and resumption of tobacco consumption, having a subsequent pregnancy 
revealed to be associated with the sustainability of smoking cessation. Breastfeeding 
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may help prevent or delay postpartum smoking relapse (DiSantis et al., 2010). 
Therefore, educating women about the benefits of breastfeeding and  facilitating its 
continuity throughout the first postpartum year may be an effective strategy to reduce 
smoking resuming (Kendzor et al., 2010). Accordingly, in our sample, the longer the 
women breastfed, the longer they sustained their smoking cessation.  
A substantial body of evidence supports that involuntary tobacco smoke 
exposure adversely affects children’s respiratory health by increasing the risk of 
respiratory infections (Gilliland, Li, & Peters, 2001; Johansson, Ludvigsson, & 
Hermansson, 2008). In uterus exposure to maternal smoking was associated with an 
almost two-fold increased prevalence of physician-diagnosed asthma (Gilliland et al., 
2001). Additionally, children exposed after birth had more often rhinitis than children of 
non-smoking parents (Johansson et al., 2008). The higher smoking cessation 
sustainability among mothers of children with a diagnosis of asthma or rhinitis may 
reflect a concern of the mother with the health of the child, beyond the period of 
pregnancy. 
This is the first study that approaches the prevalence of smoking before, during 
and after pregnancy in a large population-based cohort study of Portuguese women 
who achieved a successful pregnancy. However, some limitations should be pointed. 
Firstly, we did not validate the self-reported information on tobacco smoking. Though 
self-reported data are most often used for this purpose and in general are reliable 
(Patrick et al., 1994) and yield a favourable cost-effectiveness balance for collection of 
such data in large samples (Gorber, Schofield-Hurwitz, Hardt, Levasseur, & Tremblay, 
2009), reliance on self-reported smoking status, especially during pregnancy, may 
result in exposure misclassification due to social desirability and an increased concern 
of the negative effects of smoking in the foetus (Bottorff, Johnson, Irwin, & Ratner, 
2000; Shipton et al., 2009). Also, the definition of ex-smokers as those who did not 
smoke in the 3 months before pregnancy may have underestimated the prevalence of 
regular smoking before pregnancy and, consequently, the pregnancy smoking 
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cessation, since it is possible that women had stopped smoking more than 3 months 
before pregnancy already because they intended to get pregnant. However, since the 
estimated prevalence of smoking in our sample is not lower than reported for the 
Portuguese general population (INS, 2009), large underestimation is unlikely. 
Additional limitations were the lack of information regarding other potentially important 
risk factors (Severson et al., 1995). In particular, despite collected at baseline, data 
regarding partner’s smoking status before, during and after pregnancy were available 
only for a subsample and adjustment for this factor would differentially condition the 
sample, thereby reducing generalizability and introducing bias. 
There was a high proportion of participation at follow-up but losses may have 
introduced bias once they occurred differentially by smoking characteristics before and 
during pregnancy. This differential effect could have contributed to an underestimation 
of prepregnancy smoking and an overestimation of the prevalence of smoking 
cessation during pregnancy and sustainability of cessation 4 years after delivery. 
Besides, the lower proportion of participation at follow-up among younger and less 
educated women also raises the possibility of a selection bias. In this case, we may be 
overestimating the smoking cessation during pregnancy and the sustainability of that 
cessation among these women and, consequently, the association described.  
The present study revealed that although many women stopped smoking during 
pregnancy, this change does not appear to have a lasting impact on their smoking 
trajectory. To remain abstinent, it is necessary that the motivation not to smoke remain 
higher than the motivation to smoke on all occasions when smoking could occur. In this 
context, long-term abstinence is achieved through a process of identity change, from 
‘smoker’ towards ‘non-smoker’ (Vangeli & West, 2012). The high proportion of women 
who ceased tobacco consumption during pregnancy demonstrated that women are 
aware of the harmful impact of smoking on reproductive and infant health during 
pregnancy (Ingall & Cropley, 2009). Nevertheless, the also high relapse rate suggests 
that mothers are less aware of the adverse effects of second hand smoke exposure on 
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their offspring. Therefore, successful educational interventions should be focused on 
the detrimental effects of passive exposure to smoking on the child’s health after birth 
and not just during pregnancy. This may promote the long-term sustainability of 
smoking cessation after delivery, which would benefit the health of the whole family. 
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Table 1. Characteristics of the participants at baseline and at follow-up, according to 
smoking status before pregnancy (n=5420). 
 Smoking status 
 Never smoker Ex-smoker Current smoker  
 n (%) n (%) n (%) p 
Age (years)     
   <25 589 (16.6) 83 (13.4) 351 (28.3)  
   25-29 1140 (32.0) 189 (30.5) 338 (27.2)  
   30-34 1234 (34.7) 217 (35.0) 358 (28.9)  
   ≥35 596 (16.7) 131 (21.1) 194 (15.6) <0.001 
Marital status (baseline - follow-up)     
   Married/cohabiting - married/cohabiting 3175 (89.2) 550 (88.7) 944 (76.1)  
   Married/cohabiting - divorced/widow 241 (6.8) 50 (8.1) 170 (13.7)  
   Single/divorced - single/divorced 81 (2.3) 11 (1.8) 74 (6.0)  
   Single/divorced - married/cohabiting 62 (1.7) 9 (1.4) 53 (4.3) <0.001 
Education (years)     
   ≤9 1630 (45.8) 222 (35.8) 659 (53.1)  
   10-12 921 (25.9) 192 (31.0) 360 (29.0)  
   ≥13 1008 (28.3) 206 (33.2) 222 (17.9) <0.001 
Employment status     
   Employed 2728 (76.8) 481 (77.6) 813 (65.7)  
   Unemployed 560 (15.8) 103 (16.6) 314 (25.4)  
   Housewife 203 (5.7) 16 (2.6) 62 (5.0)  
   Other (student/retired) 62 (1.8) 20 (3.2) 49 (4.0) <0.001 
Household income (€/month)     
   <500 158 (4.6) 21 (3.5) 99 (8.1)  
   500-1000 1016 (29.3) 153 (25.4) 375 (30.5)  
   1001-1500 918 (26.5) 161 (26.7) 329 (26.7)  
   ≥1501 1096 (31.6) 212 (35.2) 296 (24.1)  
   Does not know/ Prefers not to answer 277 (8.0) 55 (9.1) 131 (10.6) <0.001 
Return to work     
   Did not have a paid job  before pregnancy 204 (7.1) 36 (7.2) 91 (9.3)  
   Did not return to work within 1 year 353 (12.3) 50 (10.1) 140 (14.3)  
   Returned to work within 1 year 2314 (80.6) 411 (82.7) 749 (76.4) 0.019 
Primigestae 1789 (50.3) 308 (49.7) 606 (48.8) 0.681 
At least 1 subsequent pregnancy 758 (21.3) 148 (23.9) 291 (23.5) 0.152 
Prepregnancy BMI (kg/m
2
)     
   <25.0 2415 (67.9) 432 (69.7) 918 (74.0)  
   25.0-29.9 796 (22.4) 137 (22.1) 237 (19.1)  
   ≥30.0 348 (9.8) 51 (8.2) 86 (6.9) 0.001 
Pregnancy complications
b
 1047 (31.6) 167 (29.5) 370 (32.3) 0.496 
Adequacy of prenatal care
c
     
   Adequate Plus 280 (7.9) 63 (10.2) 125 (10.1)  
   Adequate 1610 (45.2) 317 (13.0) 521(42.0)  
   Intermediate 1538 (43.2) 223 (36.0) 533 (42.9)  
   Inadequate 131 (3.7) 17 (2.7) 62 (5.0) <0.001 
Breastfeeding (weeks)     
   Never or ≤4 791 (22.2) 135 (21.8) 355 (28.6)  
   5-16 865 (24.3) 168 (27.1) 332 (26.7)  
   17-52 1198 (33.7) 209 (33.7) 326 (26.3)  
   ≥53 705 (19.8) 108 (17.4) 228 (18.4) <0.001 
Offspring’s asthma or rhinitis 260 (7.3) 54 (8.7) 96 (7.7) 0.459 
BMI, body mass index 
a According to the Institute of Medicine classification (2009) 
b Including infectious, placental, hemorrhagic and cardiovascular complications during pregnancy 
c According to the Adequacy of Prenatal Care Utilization Index (APNCU) 
Note: In each variable, the total may not add to 5420 due to missing data 
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Table 2. Crude and adjusted prevalence ratios to assess the determinants of smoking 
cessation during pregnancy (588 women) among 1241 prepregnancy smokers 
 
95%CI, 95% confidence interval; BMI, body mass index; PR, prevalence ratio 
* Adjusted for all the variables in the table 
a According to the Adequacy of Prenatal Care Utilization Index (APNCU) 
 
 n (%) Crude PR (95%CI) 
Adjusted PR* 
(95%CI) 
Age (years)    
   <25 168 (47.0) 1 1 
   25-29 163 (48.2) 1.03 (0.88-1.20) 0.91 (0.77-1.06) 
   30-34 168 (46.9) 1.00 (0.85-1.17) 0.82 (0.70-0.97) 
   ≥35 92 (47.4) 1.01 (0.84-1.21) 0.88 (0.72-1.06) 
Marital status at baseline    
   Married/cohabiting 542 (48.7) 1 1 
   Single/divorced/widow 46 (36.2) 0.74 (0.59-0.94) 0.81 (0.64-1.01) 
Education (years)    
   ≤9 268 (40.7) 1 1 
   10-12 185 (51.4) 1.26 (1.10-1.45) 1.19 (1.05-1.36) 
   ≥13 135 (60.8) 1.50 (1.30-1.72) 1.41 (1.21-1.64) 
Gravidity    
   1 328 (54.1) 1 1 
   ≥2 260 (40.9) 0.76 (0.67-0.85) 0.81 (0.72-0.92) 
Prepregnancy BMI (Kg/m
2
)    
   <25.0 414 (45.1) 1 1 
   25.0-29.9 126 (53.2) 1.18 (1.03-1.35) 1.23 (1.08-1.41) 
   ≥30 48 (55.8) 1.24 (1.01-1.51) 1.29 (1.08-1.54) 
Adequacy of prenatal care
a
    
   Adequate Plus 63 (50.4) 1 1 
   Adequate 273 (52.4) 1.04 (0.86-1.26) 1.01 (0.85-1.21) 
   Intermediate 236 (44.3) 0.88 (0.72-1.07) 0.90 (0.75-1.09) 
   Inadequate 16 (25.8) 0.51 (0.32-0.81) 0.55 (0.34-0.87) 
Smoking initiation age (years)     
   ≤14 143 (37.0) 1 1 
   15-18 249 (49.7) 1.35 (1.15-1.57) 1.26 (1.09-1.47) 
   ≥19 196 (55.5) 1.50 (1.28-1.76) 1.29 (1.10-1.52) 
Number of cigarettes smoked 
before pregnancy per day 
   
   ≤10 407 (60.2) 1 1 
   >10 181 (32.0) 0.53 (0.46-0.61) 0.55 (0.48-0.62) 
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Table 3. Crude and adjusted prevalence ratios to assess the determinants of smoking 
cessation sustainability 4 years after delivery (189 women) among 588 who stopped 
smoking during pregnancy 
 
 
 
 
           95%CI, 95% confidence interval; PR, prevalence ratio 
           * Adjusted for all the variables in the table 
                   a According to the Adequacy of Prenatal Care Utilization Index (APNCU) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 n (%) 
Crude PR 
(95%CI) 
Adjusted PR* 
(95%CI) 
Age (years)    
   <25 42 (25.5) 1 1 
   25-29 47 (28.8) 1.13 (0.79-1.62) 1.27 (0.86-1.87) 
   30-34 66 (39.3) 1.54 (1.12-2.13) 1.76 (1.21-2.55) 
   ≥35 34 (37.0) 1.45 (1.00-2.11) 2.11 (1.37-3.25) 
Marital status (baseline - follow-up)    
   Married/cohabiting - married/cohabiting 166 (35.0) 1 1 
   Married/cohabiting - divorced/widow 10 (14.9) 0.43 (0.24-0.77) 0.45 (0.25-0.81) 
   Single/divorced - single/divorced 6 (24.0) 0.69 (0.34-1.40) 0.74 (0.35-1.55) 
   Single/divorced - married/cohabiting 7 (33.3) 0.95 (0.51-1.77) 1.28 (0.67-2.43) 
Education (years)    
   ≤9 79 (29.5) 1 1 
   10-12 61 (33.0) 1.12 (0.85-1.48) 0.98 (0.74-1.30) 
  ≥13 49 (36.3) 1.23 (0.92-1.65) 0.92 (0.67-1.27) 
Gravidity at baseline    
   1 114 (34.8) 1 1 
   ≥2 75 (28.9) 0.83 (0.65-1.06) 0.70 (0.54-0.91) 
Subsequent pregnancies    
   0 128 (29.0) 1 1 
   ≥1 61 (41.8) 1.44 (1.13-1.84) 1.51 (1.17-1.93) 
Number of cigarettes smoked before 
pregnancy per day 
   
   ≤10 146 (35.9) 1 1 
   >10 43 (23.8) 0.66 (0.49-0.89) 0.69 (0.52-0.92) 
Breastfeeding (weeks)    
   Never or ≤4 35 (25.0) 1 1 
   5-16 46 (30.5) 1.21 (0.84-1.77) 1.13 (0.78-1.62) 
   17-52 64 (35.2) 1.41 (0.99-1.99) 1.28 (0.92-1.80) 
   ≥53 44 (38.3) 1.53 (1.06-2.21) 1.49 (1.04-2.12) 
Offspring’s asthma or rhinitis    
   No 172 (31.3) 1 1 
   Yes 17 (43.6) 1.39 (0.95-2.03) 1.56 (1.08-2.25) 
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Figure 1. Definition of the study sample, prevalence of smoking status before 
pregnancy and changes in tobacco consumption during pregnancy and 4 years after 
delivery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
6881 mothers 
8647 children 
8495 mothers 
1461 (20.7%) with missing data in any variable use for analyses 
313 (3.7%) recruited and evaluated during pregnancy  
1301 (15.3%) lost to follow-up 
5420 mothers 
3559 (65.7%) never 
136 (11.0%) did not change the consumption 
98 (7.9%) reduced consumption and sustained 
419 (33.8%) reduced consumption but resumed 
189 (15.2%) stopped smoking and sustained 
399 (32.1%) stopped smoking but resumed 
620 (11.4%) ex-smokers 1241 (22.9%) smokers 
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ABSTRACT 
Background: Cardiovascular risk at young ages is increasing, even in societies that 
shown important decreases in cardiovascular mortality for decades. Pregnancy may 
unmask or induce cardiovascular disorders, and should be a good opportunity to 
promote healthier lifestyles.  
Purpose: To estimate the prevalence of smoking, low fruits and vegetables 
consumption, sedentariness, overweight/obesity, abdominal obesity, hypertension, 
dyslipidemia and diabetes mellitus, in mothers of a Portuguese birth cohort, 4 years 
after child’s birth.  
Methods: A birth cohort was assembled at public maternities of Porto, in 2005-2006, 
and reevaluated at 4 years. In the current analysis, 5435 women were included. 
Socioeconomic characteristics, smoking, diet and exercise were self-reported. 
Anthropometrics and blood pressure were measured. A subgroup of 2483 randomly 
selected women provided blood for lipids and glucose.  
Results: Overall, 25.3% of the participants smoked, 50.7% consumed less than 3 
portions of fruits or vegetables per day, 81.3% did not practice physical exercise, 
31.4% were overweight, 21.3% obese and 31.8% had abdominal obesity. The 
prevalence of hypertension, dyslipidemia and diabetes mellitus was 8.7%, 18.5% and 
0.9%, respectively. The presence of at least one risk factor from each of the 3 groups 
(adverse lifestyles, adiposity and cardiometabolic comorbidities) was observed in 
17.0% of women. All risk factors were associated with unemployment, lower education 
and lower income.  
Conclusions: The prevalence of unfavorable lifestyles and adiposity was very high, 
and the clustering of risk factors emphasizes the adverse cardiovascular risk profile at 
a young age. The potential for prevention is vast.  
 
Keywords: Cohort studies; Prevalence; Risk factors; Women's Health 
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INTRODUCTION 
 
 Cardiovascular diseases (CVD) are the leading cause of death and morbidity 
worldwide (1). Although women have traditionally been thought of as a low-risk 
population for CVD, this is the main cause of death in women in Europe, responsible 
for almost half of the deaths (2). In Portugal, diseases of the circulatory system 
accounted for 37.3% of all deaths among women in 2006 (3). 
 CVD reflect a complex interplay of genetic, developmental, environmental and 
behavioural factors (4, 5). In European populations, CVD is mainly attributable to 
classical risk factors, namely cigarette smoking, high blood pressure, high serum 
cholesterol, diabetes, overweight/obesity and adverse diet (6). The relation between 
these risk factors and CVD is independent, strong, continuous and graded, and the 
modification of these risk factors can result in substantial reduction in mortality (7). In 
the last decades, several studies have reported that CVD mortality rates increase with 
the number of risk factors present in an individual, suggesting that the lower the risk 
factor profile, the lower the risk for CVD and all-cause mortality (8, 9, 10, 11). Despite 
the difficulty in assessing the impact of cardiovascular risk factors measured in young 
adulthood on mortality, due to low short-term death rates, results from a prospective 
cohort study of women aged below 40 years (9) showed that favourable levels of major 
risk factors were associated with lower long-term CVD and all-cause mortality.  
 According to the World Health Organization (12), health risks are in transition: 
populations are ageing and, at the same time, patterns of physical activity and diet, 
alcohol and tobacco consumption are changing. The modifiable pattern, as well as the 
considerable impact of lifestyles on the development of CVD (13), emphasize the 
importance of primary prevention.  
 Pregnancy puts a physiological stress on the body that can unmask an 
underlying propensity for chronic disease (14). Additionally, pregnancy is often 
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regarded as a good opportunity for health promotion and disease prevention (15), due 
to the strong motivation of the mothers to protect the health of the unborn baby.  
In this study, our objective was to estimate the prevalence of eight established 
cardiovascular risk factors (hypertension, dyslipidemia, diabetes mellitus, general 
overweight/obesity, abdominal obesity, smoking, low fruits and vegetables 
consumption and sedentariness), in mothers of a Portuguese birth cohort, 4 years after 
delivery, and to describe their distribution by age, gravidity and indicators of 
socioeconomic position (SEP).  
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METHODS 
 
This study is based on the birth cohort Geração XXI, which has been described 
previously (16). Briefly, the cohort was assembled between 2005 and 2006 at 5 public 
maternity units covering the metropolitan area of Porto, Portugal. Of the invited 
mothers, 91.4% accepted to participate. A total of 8495 mothers, who gave birth to 
8647 infants, were enrolled in the cohort. At 4 years of the child’s age, between 2009 
and 2011, the cohort was re-evaluated. Mothers were invited to participate in a parallel 
study on women’s cardiovascular health, and 67.4% attended a face-to-face interview 
and physical examination at the study site. Among those, 47.7% provided a fasting 
blood sample. An additional 16.8% provided self-reported data by telephone interview, 
but were not included in the current analysis due to the lack of physical examination 
data. 
Among the 5729 mothers who attended the face-to-face interview, we excluded 
174 women who were pregnant at the follow-up visit and 120 participants who 
presented at least one missing value on variables used in this study. The remaining 
5435 women were included in the current analysis, among whom 2483 (45.7%) had 
biochemical laboratorial data. 
At the cohort’s reevaluation, an average of 4 years after delivery, data were 
collected in a face-to-face interview conducted by trained interviewers using structured 
questionnaires, regarding the health of the mother and her child. Socioeconomic 
characteristics, personal and family history of disease, lifestyles and obstetric history of 
the mother were self-reported. Current smokers included both daily (at least one 
cigarette per day at the time of the survey) and occasional smokers (less than a 
cigarette per day), and ex-smokers did not smoke for at least 6 months. A food 
frequency questionnaire was used to assess the frequency of consumption of fruits, 
soup and “vegetables on the dish”, without considering the specific items in each of 
these 3 groups or portion sizes. Low fruits and vegetables consumption was defined as 
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the combination of items from any of these groups summing less than 3 per day. 
Leisure physical exercise was considered as the practice of any leisure-time physical 
activity, of mild, moderate or vigorous intensity, not taking into account the time spent 
on exercise. 
All the mothers undertook a physical examination at the study site. Participants 
were measured wearing light clothing and no footwear. Weight was measured using a 
digital scale to the nearest 0.1 kg and height measured to the nearest 0.1 cm. The 
mothers’ body mass index (BMI) was categorized according to the standard World 
Health Organization definition as underweight (<18.5 kg/m2), normal (18.5-24.9 
kg/m2), overweight (25.0–29.9 kg/m2) and obese (≥30 kg/m2) (17). Waist 
circumference was measured midway between the lowest rib and the superior border 
of the iliac crest. Abdominal obesity was defined as waist circumference >88 cm 
according to American Heart Association (18). Blood pressure was measured on a 
single occasion by non-physician trained interviewers. Two measurements of blood 
pressure separated by at least 5 minutes were taken with an automatic upper arm 
blood pressure monitor (OMRON M6 comfort (HEM-7000-E)) after 10-minute rest, on 
the dominant upper arm resting at the heart level. The mean was calculated and when 
the difference was larger than 5 mmHg for systolic or diastolic blood pressure a third 
measurement was taken and the mean of the 2 closest values was considered. Arterial 
hypertension was defined as systolic blood pressure ≥140 mmHg and/or diastolic blood 
pressure ≥90 mmHg and/or or self-reported antihypertensive drug therapy prescribed 
specifically for hypertension (19). 
For the subgroup of women who collected a blood sample, dyslipidemia was 
considered when one of these conditions were verified: total cholesterol ≥ 240 mg/dL, 
high-density lipoprotein (HDL) ≤ 40 mg/dL, low-density lipoprotein (LDL) ≥ 160 mg/dL,  
triglycerides ≥ 200 mg/dL (20) or self-reported antidyslipidemic drug therapy . Diabetes 
mellitus was defined, according to the World Health Organization criteria, as fasting 
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plasma glucose concentration ≥ 126 mg/dL (21), or self-reported antidiabetic drug 
therapy prescribed specifically for diabetes. 
Overall, the socio-demographic characteristics of the participants were similar 
between all the women included for the current analysis and those with a fasting blood 
sample collection (Table 1). Almost half of the mothers were 35 or more years old and 
the index pregnancy was the only pregnancy of approximately 37%. Most of the 
mothers were married or lived with a partner, approximately 27% had 13 or more years 
of education and more than 75% were employed. Less than 5% of women had a 
household monthly income below 500€ and more than 40% above 1500€ (Table 1).  
Statistical analysis was performed using the statistical software Stata 9.0 
(College Station, TX, 2005). Sample characteristics are  presented  as  counts  and  
proportions  and the  prevalence  of  the  outcomes  is  presented  with  95% 
confidence  intervals  (95%  CI). To assess the clustering of cardiovascular risk factors, 
these were grouped into unfavourable lifestyles (smoking, low fruits and vegetables 
consumption, and sendentariness), adiposity (overweight/obesity and abdominal 
obesity) and cardiometabolic risk factors (hypertension, dyslipidemia and diabetes 
mellitus), and possible combinations of at least one factor from each group were 
analyzed, only for the subsample with information available for all risk factors. 
Unconditional  binary  logistic  regression  models  were fitted  to  compute  age-
adjusted  odds  ratios  (OR)  and  95%  confidence  intervals  for hypertension, 
dyslipidemia, diabetes  mellitus, abdominal obesity, fruits and vegetables consumption 
and physical activity,  and  multinomial  logistic  regression models for BMI  and  
smoking  status,  taking  BMI  <25  Kg/m2   and  never  smokers  as reference classes, 
respectively.  
The study protocol was approved by the Ethics Committee of Hospital de São 
João and by the Portuguese Authority of Data Protection. Written informed consent 
was obtained from all the participants. 
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RESULTS 
 
An average of 4 years after delivery, a quarter (25.3%; 95%CI: 24.1-26.5) of the 
participants were smokers, while approximately half (50.7%; 95%CI: 49.4-52.0) 
consumed less than 3 portions of fruits and vegetables per day and 81.3% (95%CI: 
80.2-82.3) did not practice any leisure-time physical exercise. At that time, 31.4% 
(95%CI: 30.2-32.7) were overweight, 21.3% (95%CI: 20.2-22.4) were obese and 31.8% 
(95%CI: 30.6-33.1) had abdominal obesity. Regarding the cardiometabolic 
comorbidities, 8.7% (95%CI: 7.9-9.5) of the women had hypertension and, among the 
subsample with available data from the fasting blood sample collection, the prevalence 
of dyslipidemia and diabetes mellitus was 18.5% (95%CI: 17.0-20.1) and 0.9% (95%CI: 
0.6-1.3), respectively (Figure 1). Overall, the presence of at least one risk factor from 
each of 3 groups (unfavorable lifestyles, adiposity and cardiometabolic comorbidities) 
was observed in 17.0% of women. Moreover, more than 30% presented both adverse 
lifestyles and adiposity, almost 6% unfavorable lifestyles and cardiometabolic risk 
factors, and only 1.4% had excessive weight and/or abdominal obesity and at least one 
cardiometabolic risk factor (Figure 2). 
Above 30 years of age, the prevalence of smoking, low intake of fruits and 
vegetables and sedentariness was approximately half that of younger women. Women 
with 3 or more pregnancies were 31% and 38% more likely to smoke and to be 
sedentary, whereas those not living with a partner were almost 3-fold more frequently 
smokers. In general, adverse lifestyles were inversely associated with education and 
income, independently of age. When compared with employed women, the 
unemployed were 40% more likely to smoke and 53% more likely to consume less than 
3 portions of fruits and vegetables per day, while housewives were 37% less likely to 
smoke. Four years after delivery, smokers were 28% less likely to be obese, while 
those who did not practice any physical exercise were 27% more likely to be obese. 
171 
 
The prevalence of former smoking increased with age and educational level, and was 
lower among housewives (Table 2). 
In this study, women aged above 40 years were 62% more frequently 
overweight and just above 30% more likely to have overall and abdominal obesity, 
compared to women aged less than 30 years. Gravidity was also associated with both 
outcomes, independently of age. A significant inverse association was observed for 
education and household monthly income with a clear dose-response effect for both 
variables. Married women or those living with a partner were more likely to have 
excessive weight or abdominal obesity, as well as housewives and unemployed, when 
compared with employed women (Table 3). 
The prevalence of the three cardiometabolic comorbidities – hypertension, 
dyslipidemia and diabetes mellitus – increased significantly with age and BMI. Women 
aged over 40 years were more likely to have hypertension (6.82-fold), dyslipidemia 
(1.55-fold) and diabetes (4.57-fold), while obesity was associated with a 4-fold increase 
in the prevalence of hypertension and a 3-fold increase in the prevalence of 
dyslipidemia or diabetes, independently of age. Overall, an inverse association was 
observed with income for the three cardiometabolic comorbidities, and a similar 
association was observed with education, with a more relevant effect for hypertension 
(>12 years vs. ≤4 years: age-adjusted OR=0.51; 95%CI: 0.35-0.73). Unemployed 
women were more frequently hypertensive, dyslipidemic or diabetic, when compared 
with employed women. Marital status was only associated with diabetes mellitus, with a 
3-fold increase in the prevalence of diabetes among women who lived without a partner 
(Table 4).  
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DISCUSSION  
 
In this study of Portuguese women who delivered a live born, almost 90% of the 
participants presented at least one unfavorable lifestyle, more than half had a marker of 
adiposity and a quarter presented one or more cardiometabolic comorbidities. Overall, 
17% of the women presented the aggregation of factors from all three groups. 
Smoking, low fruit and vegetables intake and sedentary lifestyle were more common in 
younger women, while adiposity and cardiometabolic risk factors were more frequent in 
older women. The prevalence of all hypertension, dyslipidemia, diabetes mellitus and 
sedentariness increased with BMI. Unemployment, education and income were 
inversely associated with all risk factors, except smoking.  
 This is the first study that presents the prevalence of several cardiovascular risk 
factors in a large sample of young Portuguese women, embedded in the context of 
their reproductive life. The objective measurements of weight, height, blood pressure, 
fasting blood lipids and glucose are obvious advantages when considering prevalence.  
In 2006, the global prevalence of smoking in female adults in Europe was 27%, while in 
Portugal, the prevalence in the female population over 15 years of age was only 11.8% 
(22). According to data from the 2005/2006 Portuguese National Health Survey, the 
prevalence of current smoking for women aged between 15 to 54 years old, was 17.0% 
(23). The higher prevalence of smoking in our sample could reflect its urban nature. 
Moreover, in the National Health Survey (23), the prevalence may have been 
underestimated since the questionnaire could be answered by a proxy in case the 
index subject was absent and proxies might not be aware of the smoking status of 
these women. In our sample, more than half of the women consumed fruits and 
vegetables less than 3 times per day, which was previously associated with higher 
cardiovascular incidence and mortality, after adjustment for established cardiovascular 
disease risk factors (24). In 1997, among fifteen countries of the European Union, 
Portugal presented the highest rate of sedentary lifestyles, with 90.0% of women aged 
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above 15 years having low energy expenditure (25). Additionally, in a study performed 
in 2000, among European university female, aged between 18 and 30 years old, 36.7% 
of women were considered physically active, which was defined as the practice of any 
exercise in the 2 weeks before the survey (26). In the present study, less than 20% of 
women reported to practice any kind of physical exercise. The high prevalences of 
adverse lifestyles in this cohort of mothers highlight the need for prevention early in life. 
The implications for the health of the family and particularly of their children, both 
through the shared environment and their responsibility as role models, are a major 
indirect consequence of these unfavorable behaviors.  
In Portugal, the prevalence of overweight and obesity in women aged between 
18 and 49 years in a national survey conducted in 2003-2005, was 34.0% and 10.6%, 
respectively. This same study reported a prevalence of abdominal obesity among 
women aged between 20 to 29 years and between 30 to 39 years of 11.2% and 19.9%, 
respectively (27). We observed a considerably higher prevalence of both overall and 
abdominal obesity. There is evidence that adiposity is increasing in Portugal, with a 
systematic review reporting an increase in overweight prevalence of 3.2% and obesity 
prevalence of 7.4% among women, between 1995 and 2005 (28). Moreover, these 
women had been pregnant 4 years before, and approximately 20% had a subsequent 
pregnancy meanwhile (data not shown). Thus, the observed body size may reflect 
changes induced by this experience with incomplete recovery (29). 
In 2003, the prevalence of hypertension in Portuguese women aged below 35 
years was 12.4%, which is higher than the one described in the present study, where 
the mean age was 35 years (30). In a systematic review that assessed trends in 
hypertension prevalence in Portugal, between 1990 and 2005, the authors estimated a 
prevalence of 23.2% for women at average age 35 years, in 2005 (31). Regarding 
dyslipidemia, the heterogeneity of definitions among different studies is a universally 
recognized difficulty for their comparison. No Portuguese study could be identified 
using similar enough methodology and criteria. In the United States, the prevalence of 
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high blood cholesterol or low HDL was 25.9% in women aged between 20 and 39 
years (32), which is higher than the one described in the present study. Data from a 
recent study that aimed to determine the prevalence of type 2 diabetes, in the 
Portuguese population described a prevalence of 0.6% among women aged between 
20 and 39 years (33). Although slightly lower than the prevalence described in the 
current study, taking into account that the authors did not include type 1 diabetes and 
that approximately 15% of the mothers included in the cohort are above 40 years of 
age, we believe that the 0.9% prevalence described is probably lower than the true 
prevalence of diabetes mellitus in general Portuguese women within this age range. 
This assumption is supported by data from the Portuguese National Health Survey, that 
described a self-reported prevalence of 2.7% for diabetes mellitus in women aged 
between 15 and 44 years old (23). Overall, the prevalence of the cardiometabolic 
comorbidities seems to be lower than previously described in the general population. 
This may be explained by the specific characteristics of our sample, since we studied a 
sample of women who successfully led at least one pregnancy to a live born, which 
may imply that these women were on average healthier than the general population of 
the same age group. In contrast, this is not true for the metabolic and lifestyle risk 
factors.  
The high prevalence of young women with at least one cardiovascular risk 
factor, as well as their clustering, highlights the adverse cardiovascular profile of these 
women. Results from a prospective cohort study (9) showed that only about 20% of 
American women younger than 40 years of age presented favourable levels of five 
major risk factors (smoking, hypertension, diabetes, serum cholesterol and body mass 
index). Another study found that, in women aged between 18 and 75 years, 19% 
presented a clustering of three or more metabolic risk factors for coronary heart 
disease (11). In this study of Portuguese women who delivered a live born the 
proportion of women without any of the 8 cardiovascular risk factors considered is less 
than 5%, shortly after delivery. Additionally, the clustering of cardiovascular risk factors 
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is already evident, with 17% of women presenting at least one risk factor from each 
group of risk considered: unfavorable lifestyles, adiposity and cardiometabolic 
comorbidities. Our intention in approaching several risk factors in the same population 
is related with the need to appreciate global cardiovascular risk, more than the 
fragmented view of individual risk factors. Tools for absolute risk estimation have been 
recommended for this purpose, even to support therapeutic decisions (34). In Europe, 
the SCORE system is recommended to evaluate CVD risk (35). These guidelines have 
several limitations and tend to underestimate CVD risk in the younger age-groups (36). 
Therefore, we believe that the aggregation of risk factors is more informative of risk at 
younger ages than a risk score. 
A previous work from our research group presented the self-reported 
prevalence of 5 risk factors, in this sample of Portuguese women, before pregnancy 
(16). Overall, 21.3% were overweight, 8.8% were obese and 26.6% smoked. The 
prevalence of hypertension, dyslipidemia and diabetes mellitus was 1.7%, 1.7% and 
0.6%, respectively, with an evident tendency to cluster. Only 4 years after delivery, the 
prevalence of these risk factors, except smoking, increased drastically. Although part of 
this increase may be due to underreport of weight by women (37) and to the lack of 
awareness of clinical diagnoses in young ages (30, 38), it is unlikely that this would 
totally explain such a huge increase in prevalence. 
In the present study, indicators of socio-economic position were inversely 
associated with all risk factors. This reveals the existence of inequalities in health with 
those from lower social classes having an unfavorable cardiovascular risk profile. In the 
last 30 years, Portugal experienced a significant development regarding economic 
modernization and social structure (39), which resulted in lifestyle changes that may 
have an impact on cardiovascular risk. The economic improvements may contribute to 
a higher frequency of adverse lifestyles, such as sedentary behaviours and unhealthy 
eating habits, especially among the lower social classes (40, 41). Therefore, women 
from the lowest educational and income strata should be the main target group for 
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educational intervention regarding cardiovascular risk factors. In this context and since 
low health literacy is associated with a range of adverse health outcomes (42), health 
education should be literacy sensitive in order to enhance health knowledge and self-
efficacy to promote the adoption of healthier lifestyles (43). 
In conclusion, the prevalence of unfavorable lifestyles and adiposity was very 
high among women who achieved a successful pregnancy, as early as 4 years after 
delivery, and the clustering of risk factors emphasizes the unfavourable cardiovascular 
risk profile at a young age. However, the potential for prevention is vast especially 
when considering the modifiable nature of the most important risk factors. Thus, these 
data emphasize the need for prevention early in life, by lifestyle approaches, which 
should be considered a national public policy priority. 
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Table 1. Participant’s characteristics in the overall study sample and those with 
fasting blood sample. 
 
 All women With fasting blood sample  
 n=5435 n=2483 
Age (years), n (%)   
   < 25 240 (4.4) 115 (4.6) 
   25-29 829 (15.2) 407 (16.4) 
   30-34 1780 (32.8) 819 (33.0) 
   35-39 1784 (32.8) 795 (32.0) 
   ≥ 40 802 (14.8) 347 (14.0) 
Gravidity, n (%)   
   1 2007 (36.9) 926 (37.3) 
   2 2172 (40.0) 1014 (40.9) 
   ≥ 3 1256 (23.1) 543 (21.9) 
Marital status, n (%)   
   Married/living with a partner 4843 (89.1) 2177 (87.7) 
   Single/divorced/widow   592 (10.9) 306 (12.3) 
Education (years), n (%)   
   ≤ 4 345 (6.4) 177 (7.1) 
   5-9 2088 (38.4) 968 (39.0) 
   10-12 1516 (27.9) 671 (27.0) 
   > 12 1486 (27.3) 667 (26.9) 
Working condition, n (%)   
   Employed 4117 (75.8) 1869 (75.3) 
   Unemployed 928 (17.1) 446 (18.0) 
   Housewife 254 (4.7) 106 (4.3) 
   Others  136 (2.5) 62 (2.5) 
Household monthly income (€), n (%)   
   < 500 224 (4.1) 125 (5.0) 
   500-1000 1296 (23.9) 641 (25.8) 
   1001-1500 1523 (28.0) 648 (26.1) 
   > 1500 2304 (42.4) 1030 (41.5) 
   Does not know/ Prefers not to answer 88 (1.6) 39 (1.6) 
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Table 2. Prevalence of smoking, low fruits and vegetables consumption and sedentariness, 4 years after delivery, and age-adjusted odds 
ratios for the association with gravidity, socio-economic characteristics and BMI, in mothers of a Portuguese birth cohort (n=5435). 
95%CI, 95% confidence interval; BMI, body mass index, OR, odds ratio 
a Reference class of outome: never smokers 
b Except for age 
c Reference class 
 
Smoking Status
a  Fruits and vegetables 
consumption 
 
Leisure physical exercise
 
 Current  Former  <3 portions/day  Sedentariness 
 n (%) 
Age-adjusted 
OR (95%CI)
b 
 
n (%) 
Age-adjusted 
OR (95%CI)
b
 
 
n (%) 
Age-adjusted OR 
(95%CI)
b
 
 
n (%) 
Age-adjusted 
OR (95%CI)
b
 
Age (years)            
   < 30 409 (38.3) 1c  136 (12.7) 1c  687 (64.3) 1c  939 (87.8) 1c 
   30-34 424 (23.8) 0.49 (0.41-0.58)  238 (13.4) 0.82 (0.65-1.04)  910 (51.1) 0.58 (0.50-0.68)  1414 (79.4) 0.53 (0.43-0.66) 
   35-39 371 (20.8) 0.43 (0.36-0.51)  303 (17.0) 1.05 (0.84-1.32)  827 (46.4) 0.48 (0.41-0.56)  1397 (78.3) 0.50 (0.40-0.62) 
   ≥ 40 172 (21.5) 0.47 (0.38-0.58)  164 (20.5) 1.36 (1.05-1.76)  331 (41.3) 0.39 (0.32-0.47)  666 (83.0) 0.68 (0.52-0.88) 
Gravidity            
   1 507 (25.3) 1c  295 (14.7) 1c  1076 (53.6) 1c  1605 (80.0) 1c 
   2 531 (24.5) 1.10 (0.95-1.27)  347 (16.0) 1.04 (0.87-1.24)  1061 (48.9) 0.93 (0.81-1.05)  1759 (81.0) 1.14 (0.97-1.33) 
   ≥ 3 338 (26.9) 1.31 (1.10-1.56)  199 (15.9) 1.01 (0.82-1.25)  618 (49.2) 1.01 (0.87-1.17)  1052 (83.8) 1.38 (1.14-1.68) 
Marital status            
   Married/living with a partner 1100 (22.7) 1c  772 (15.9) 1c  2420 (50.0) 1c  3940 (81.4) 1c 
   Single/ divorced/widow   276 (46.6) 2.71 (2.24-3.27)  69 (11.7) 1.08 (0.82-1.43)  335 (56.6) 1.16 (0.97-1.38)  476 (80.4) 0.84 (0.68-1.05)  
Education (years)            
   ≤ 4 75 (21.7) 1c  43 (12.5) 1e  205 (59.4) 1e  319 (92.5) 1e 
   5-9 650 (31.1) 1.51 (1.13-2.00)  269 (12.9) 1.33 (0.93-1.91)  1213 (58.1) 0.80 (0.63-1.02)  1833 (87.8) 0.57 (0.37-0.87) 
   10-12 377 (24.9) 1.23 (0.92-1.65)  260 (17.2) 1.76 (1.23-2.52)  789 (52.0) 0.65 (0.51-0.82)  1201 (79.2) 0.31 (0.21-0.48) 
   > 12 274 (18.4) 0.96 (0.71-1.29)  269 (18.1) 1.63 (1.14-2.33)  548 (36.9) 0.39 (0.31-0.50)  1063 (71.5) 0.22 (0.14-0.33) 
Working condition            
   Employed 985 (23.9) 1c  653 (15.9) 1c  2003 (48.7) 1c  3308 (80.4) 1c 
   Unemployed 299 (32.2) 1.40 (1.19-1.66)  139 (15.0) 1.07 (0.87-1.31)  563 (60.7) 1.53 (1.32-1.78)  773 (83.3) 1.13 (0.94-1.38) 
   Housewife 48 (18.9) 0.63 (0.45-0.88)  28 (11.0) 0.57 (0.38-0.85)  122 (48.0) 0.96 (0.74-1.24)  217 (85.4) 1.35 (0.94-1.93) 
   Others  44 (32.4) 1.35 (0.91-1.99)  21 (15.4) 1.14 (0.69-1.87)  67 (49.3) 0.90 (0.63-1.27)  118 (86.8) 1.45 (0.87-2.40) 
Household monthly income (€)            
   < 500 94 (42.0) 1c  26 (11.6) 1c  136 (60.7) 1c  201 (89.7) 1c 
   500-1000 390 (30.1) 0.61 (0.45-0.83)  160 (12.4) 0.88 (0.55-1.40)  738 (56.9) 0.89 (0.66-1.19)  1129 (87.1) 0.81 (0.51-1.29) 
   1001-1500 368 (24.2) 0.50 (0.37-0.68)  239 (15.7) 1.09 (0.69-1.72)  859 (56.4) 0.90 (0.67-1.21)  1303 (85.6) 0.74 (0.47-1.17) 
   > 1500 495 (21.5) 0.48 (0.36-0.66)  403 (17.5) 1.19 (0.76-1.86)  974 (42.3) 0.55 (0.41-0.73)  1711 (74.3) 0.38 (0.24-0.59) 
   Does not know/ Prefers not to answer 29 (33.0) 0.77 (0.44-1.33)  13 (14.8) 1.09 (0.51-2.32)  48 (54.6) 0.86 (0.52-1.42)  72 (81.8) 0.53 (0.27-1.07) 
Body mass index (kg/m
2
)            
<24.9 735 (28.6) 1c  384 (15.0) 1c  1329 (51.7) 1c  2071 (80.6) 1c 
25.0-29.9 378 (22.1) 0.72 (0.62-0.84)  276 (16.2) 0.97 (0.81-1.15)  844 (49.4) 0.94 (0.83-1.07)  1370 (80.2) 0.98 (0.84-1.14) 
≥30 263 (22.7) 0.72 (0.61-0.85)  181 (15.6) 0.95 (0.78-1.15)  582 (50.3) 0.95 (0.83-1.09)  975 (84.3) 1.27 (1.06-1.54) 
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Table 3. Prevalence of overweight, obesity and abdominal obesity, 4 years after delivery, and age-adjusted odds ratios for the 
association with gravidity and socio-economic characteristics, in mothers of a Portuguese birth cohort (n=5435).  
 
           95%CI, 95% confidence interval; BMI, body mass index, OR, odds ratio 
               a Reference class of outcome: BMI <25 Kg/m2 
               b Except for age 
               c Reference class 
 BMIa  
Abdominal obesity
 
 Overweight  Obesity  
 n (%) 
Age-adjusted 
OR (95%CI)
b
 
 
n (%) 
Age-adjusted OR 
(95%CI)
b
 
 
n (%) 
Age-adjusted OR 
(95%CI)
b
 
Age (years)         
   < 30 299 (28.0) 1c  240 (22.5) 1c  329 (30.9) 1c 
   30-34 542 (30.5) 1.12 (0.94-1.34)  380 (21.4) 0.98 (0.81-1.19)  546 (30.7) 1.00 (0.84-1.17) 
   35-39 576 (32.3) 1.18 (0.99-1.41)  346 (19.4) 0.89 (0.73-1.08)  555 (31.1) 1.02 (0.86-1.20) 
   ≥ 40 292 (36.4) 1.62 (1.31-2.01)  191 (23.8) 1.32 (1.04-1.67)  298 (37.2) 1.33 (1.10-1.62) 
Gravidity         
   1 598 (29.8)  1c  382 (19.0) 1c  565 (28.2) 1c 
   2 697 (32.1) 1.12 (0.97-1.29)  447 (20.6) 1.18 (1.00-1.39)  694 (32.0) 1.19 (1.04-1.36) 
   ≥ 3 414 (33.0) 1.28 (1.07-1.51)  328 (26.1) 1.71 (1.41-2.06)  469 (37.3) 1.47 (1.26-1.72) 
Marital status         
   Married/living with a partner 1539 (31.8) 1c  1052 (21.7) 1c  1588 (32.8) 1c 
   Single/ divorced/widow   170 (28.7) 0.81 (0.66-0.99)  105 (17.7) 0.70 (0.55-0.88)  140 (23.7) 0.63 (0.52-0.78) 
Education (years)         
   ≤ 4 132 (38.3) 1c  123 (35.7) 1c  169(49.0) 1c 
   5-9 684 (32.8) 0.63 (0.47-0.84)  565 (27.1) 0.54 (0.40-0.73)  817 (39.1) 0.73 (0.58-0.93) 
   10-12 483 (31.9) 0.48 (0.36-0.65)  284 (18.8) 0.30 (0.22-0.40)  437 (28.8) 0.45 (0.36-0.58) 
   > 12 410 (27.6) 0.32 (0.23-0.42)  185 (12.5) 0.15 (0.11-0.21)  305 (20.5) 0.27 (0.21-0.35) 
Working condition         
   Employed 1282 (31.2) 1c  778 (18.9) 1c  1185 (28.8) 1c 
   Unemployed 296 (31.9) 1.33 (1.12-1.58)  267 (28.8) 1.94 (1.62-2.33)  376 (40.5) 1.70 (1.47-1.98) 
   Housewife 90 (35.4) 1.60 (1.18-2.17)  75 (29.5) 2.19 (1.59-3.02)  115 (45.3) 2.02 (1.56-2.61) 
   Others  41 (30.2) 1.19 (0.79-1.79)  37 (27.2) 1.70 (1.12-2.60)  52 (38.2) 1.57 (1.10-2.34) 
Household monthly income (€)         
   < 500 75 (33.5) 1c  62 (27.7) 1c  91 (40.6) 1c 
   500-1000 422 (32.6) 0.96 (0.68-1.34)  370 (28.6) 1.02 (0.72-1.46)  523 (40.4) 0.98 (0.73-1.31) 
   1001-1500 494 (32.4) 0.83 (0.60-1.16)  366 (24.0) 0.75 (0.53-1.07)  537 (35.3) 0.77 (0.58-1.03) 
   > 1500 693 (30.1) 0.58 (0.42-0.80)  340 (14.8) 0.35 (0.24-0.50)  546 (23.7) 0.42 (0.32-0.56) 
   Does not know/ Prefers not to answer 25 (28.4) 0.61 (0.34-1.10)  19 (22.5) 0.57 (0.31-1.08)  31 (35.2) 0.75 (0.45-1.26) 
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Table 4. Prevalence of hypertension, dyslipidemia and diabetes mellitus, 4 years after delivery, and age-adjusted odds ratios for the 
association with gravidity, socio-economic characteristics and BMI, in mothers of a Portuguese birth cohort. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
  
  95%CI, 95% confidence interval; BMI, body mass index; OR, odds ratio 
  a Except for age 
  b Reference class
 Hypertension 
n=5435 
 Dyslipidemia 
n=2483 
 Diabetes mellitus 
n=2483 
 n (%) 
Age-adjusted 
OR (95%CI)
a
 
 
n (%) 
Age-adjusted 
OR (95%CI)
a
 
 
n (%) 
Age-adjusted OR 
(95%CI)
a
 
Age (years)         
   < 30 33 (3.1) 1b  81 (15.5) 1b  2 (0.4) 1b 
   30-34 117 (6.6) 2.21 (1.49-3.28)  146 (17.8) 1.18 (0.88-1.59)  2 (0.2) 0.64 (0.09-4.53) 
   35-39 179 (10.0) 3.50 (2.40-5.12)  156 (19.6) 1.33 (0.99-1.78)  12 (1.5) 3.98 (0.89-17.88) 
   ≥ 40 143 (17.8) 6.82 (4.62-10.09)  77 (22.2) 1.55 (1.10-2.20)  6 (1.7) 4.57 (0.92-22.80) 
Gravidity         
   1 152 (7.6) 1b  157 (17.0) 1b  6 (0.7) 1b 
   2 187 (8.6) 0.90 (0.72-1.14)  187 (18.4) 1.06 (0.83-1.34)  10 (1.0) 1.14 (0.41-3.21) 
   ≥ 3 133 (10.6) 0.95 (0.73-1.23)  116 (21.4) 1.24 (0.94-1.63)  6 (1.1) 1.12 (0.35-3.63) 
Marital status         
   Married/living with a partner 432 (8.9) 1b  409 (18.8) 1b  16 (0.7) 1b 
   Single/ divorced/widow   40 (6.8) 0.88 (0.62-1.23)  51 (16.7) 0.90 (0.65-1.25)  6 (2.0) 3.39 (1.29-8.91) 
Education (years)         
   ≤ 4 51 (14.8) 1b  32 (18.1) 1b  2 (1.1) 1b 
   5-9 180 (8.6) 0.78 (0.56-1.11)  195 (20.1) 1.26 (0.83-1.92)  13 (1.3) 1.66 (0.36-7.59) 
   10-12 129(8.5) 0.75 (0.52-1.07)  126 (18.8) 1.14 (0.74-1.76)  3 (0.5) 0.57 (0.09-3.47) 
   > 12 112 (7.5) 0.51 (0.35-0.73)  107 (16.0) 0.86 (0.55-1.33)  4 (0.6) 0.54 (0.10-2.99) 
Working condition         
   Employed 337 (8.2) 1b  329 (17.6) 1b  14 (0.8) 1b 
   Unemployed 93 (10.0) 1.37(1.07-1.75)  102 (22.9) 1.42 (1.10-1.83)  6 (1.4) 1.79 (0.68-4.72) 
   Housewife 30 (11.8) 1.43 (0.95-2.14)  21 (19.8) 1.17 (0.71-1.92)  1 (0.9) 1.16 (0.15-9.00) 
   Others  12 (8.8) 1.34 (0.72-2.47)  8 (12.9) 0.72 (0.34-1.53)  1 (1.6) 2.63 (0.33-20.63) 
Household monthly income (€)         
   < 500 24 (10.7) 1b  24 (19.2) 1b  2 (1.6) 1b 
   500-1000 130(10.0) 0.89 (0.56-1.44)  126 (19.7) 1.03 (0.63-1.68)  10 (1.6) 0.94 (0.20-4.41) 
   1001-1500 127 (8.3) 0.68 (0.43-1.10)  127 (19.6) 1.00 (0.61-1.63)  6 (0.9) 0.54 (0.11-2.78) 
   > 1500 186 (8.1) 0.57 (0.36-0.91)  175 (17.0) 0.80 (0.49-1.29)  3 (0.3) 0.14 (0.02-0.88) 
   Does not know/ Prefers not to answer 5 (5.7) 0.39 (0.14-1.06)  8 (20.5) 1.02 (0.41-2.50)  1 (2.6) 1.21 (0.11-14.00) 
Body mass index (kg/m
2
)         
<24.9 116 (4.5) 1c  135 (11.6) 1b  6 (0.5) 1b 
25.0-29.9 158 (9.3) 2.02 (1.57-2.59)  165 (21.1) 2.00 (1.56-2.56)  6 (0.8) 1.40 (0.45-4.38) 
≥30 198 (17.1) 4.38 (3.43-5.59)  160 (29.9) 3.24 (2.50-4.20)  10 (1.9) 3.60 (1.30-9.99) 
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Figure 1. Prevalence and 95% confidence intervals of individual risk factors. 
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Figure 2. Number of women with no risk factors or at least one risk factor from each 
of 3 groups considered: unfavorable lifestyles, adiposity and cardiometabolic 
comorbidities. The area of the individual rectangles and overlap areas are 
proportional to the number of women in the respective level of exposure. Only the 
subsample with information available for all risk factors was considered (n=2483). 
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GENERAL DISCUSSION 
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In this dissertation, the cardiovascular risk profile of mothers of a Portuguese birth 
cohort was assessed referring to before and 4 years after pregnancy, including both 
descriptive and analytic approaches to cover the quantification of the burden of risk factors, 
factors contributing to such exposure, consequences to mother and child, and the effect of 
pregnancy itself on the change of risk. Overall, the results suggest a high level of risk among 
this young female population with successful reproduction, and unfortunately do not support 
long-term effects of lifestyle changes during pregnancy.  
Before pregnancy, approximately a third of the women were overweight or obese and 
more than a quarter smoked. Although the prevalence of self-reported cardiometabolic 
comorbidities (hypertension, dyslipidemia and diabetes mellitus) was lower than 2%, their 
tendency to cluster was evident. As early as 4 years after delivery, almost 90% of the 
participants had at least one the three unfavourable lifestyles: smoking, low intake of fruit and 
vegetables, and sedentariness. At this time, more than half were overweight, obese or had 
abdominal obesity and a quarter presented hypertension, dyslipidemia or diabetes mellitus. 
Overall, 17% of the women presented at least one risk factor from each of the 3 groups: 
adverse lifestyles, adiposity and cardiometabolic comorbidities. 
It has been recognized that cardiovascular risk factors are associated with each other 
and their effects tend to be synergistic rather than additive (20). Thus, the assessment of 
multiple risk factors is crucial to identify a high risk population. The aggregation found 
between these risk factors, even before pregnancy, among young and apparently healthy 
women, suggests that the pathogenic process is initiated early in life. Results from a 
prospective cohort study of women aged 18 to 39 years (17) showed that favourable levels of 
major risk factors were associated with lower long-term CVD and all-cause mortality. 
Unfortunately, only about 20% of the women met the lowest criteria of having no 
unfavourable risk factors. In our cohort, the prevalence of women without any cardiovascular 
risk factors was even lower. Overall, a high prevalence of potentially modifiable 
cardiovascular risk factors was described among women who were able to successfully lead 
a pregnancy to a live born. It has been shown that major changes in the risk of CVD can be 
reduced by modifications of the lifestyle and social behaviour of individuals (180, 181), 
contributing to a marked reduction in mortality, morbidity, and maintaining quality of life (182, 
183). Therefore, early detection of individuals with modifiable and treatable cardiovascular 
risk factors may result in saving lives, and reducing the burden of disease and healthcare 
costs. 
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Pregnancy induces profound alterations in maternal haemodynamics and 
metabolism, which may reveal previous background risk and/or induce long-term metabolic 
and vascular abnormalities that increase the propensity to develop cardiovascular diseases 
(67, 68).  
In fact, the presence of risk factors before pregnancy was also associated with 
pregnancy-related complications. In the cohort Geração XXI, 5% of primiparous and 4% of 
multiparous women had a hypertensive disorder in pregnancy and a high proportion of cases 
were explained by the joint effect of previously recognized prepregnancy risk factors. This 
emphasizes the importance of preconception and prenatal health, widely recognized as 
critical components of maternal and child health promotion, during women’s reproductive life 
(184, 185). However, in Portugal, a study performed in the north of the country showed that, 
although 99% of pregnant women received prenatal surveillance, only 27% had 
preconceptional care (186). Therefore, it is important to invest in pregnancy planning, with 
the objective of optimizing women’s wellness and subsequent pregnancy outcomes. 
Additionally, the development of gestational hypertensive disorders was significantly 
associated with higher systolic and diastolic blood pressure an average of 4 years after birth, 
both in mothers and their male offspring. Despite the relatively low prevalence of 
hypertensive disorders in pregnancy, the severity of short-term consequences observed 
emphasizes the period after delivery as critical to develop and promote preventive strategies. 
In Portugal, a puerperium visit is recommended but there are no specific guidelines regarding 
further care after a pregnancy (187). Since children are regularly followed by their family 
physician, until enter in adulthood (188), this contact with the health care may constitute an 
opportunity to manage cardiovascular risk and other relevant health issues in the mothers, 
shortly after pregnancy. In this context, integration of the mother’s care during the routine 
appointments of the child might constitute an effective strategy to assess and manage 
maternal health, with a higher likelihood of attendance and adherence. Obviously, this model 
would have to be tested to confirm its feasibility and success, which is out of scope of this 
work. 
Beyond the harmful effects on the health of the developing foetus, a compelling 
reason to promote smoking cessation during pregnancy is the prospect that the short-term 
abstinence would become lifelong cessation. However, although almost half of smokers 
stopped during pregnancy, 4 years after delivery, two thirds resumed smoking. This high rate 
of relapse questions the true impact of smoking cessation during pregnancy on women’s 
smoking trajectory. Quitting smoking during pregnancy is a different behaviour than quitting 
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at any another time in a woman’s life. Because the intention to quit is often motivated by the 
health of the baby and not the woman’s own health (66), the process and motivation for 
smoking cessation is different compared to quitting smoking at other times. Postpartum 
relapse may reflect the extent to which initial cessation was extrinsically motivated by social 
pressure and concerns with the child health (189). Although there are still negative health 
consequences of secondhand smoke on children, parents may feel that they can have a 
higher control of the child exposure to smoke after delivery than during pregnancy. 
Additionally, depression, anxiety and the stress of caring for a newborn (190), as well as the 
lack of perceived social support to remain abstinent, may also precipitate relapse (191). To 
remain abstinent, it is necessary that the motivation not to smoke remain higher than the 
motivation to smoke on all occasions when smoking could occur. In this context, long-term 
abstinence is achieved through a process of identity change, from ‘smoker’ towards ‘non-
smoker’ (192). Therefore, successful educational interventions should be implemented from 
preconceptional care to postpartum, in a continuum process of promotion of smoking 
cessation.  
Following Western European countries movement, the fertility rate has been 
decreasing over the last 20 years, from 2.1 to 1.37 children per woman, between 1980 and 
2008.  Simultaneously, a drop in the fertility rate in the age groups below 30 was observed, 
opposed to an increase in higher age groups (7). These changes in the pattern of fertility 
may also play a role among the implications of pregnancy for the future health of the women, 
since older age is a risk factor for cardiovascular risk factors and for the development of 
cardiometabolic comorbidities during pregnancy. 
Overall, indicators of socio-economic position were inversely associated with a 
favourable cardiovascular profile, before, during and after pregnancy. This suggests the 
existence of inequalities in health with those from lower social classes having a higher risk of 
developing cardiovascular disease in the future. In the last 30 years, Portugal experienced a 
significant development regarding economic modernization and social structure (193), which 
resulted in lifestyle changes that may have an impact on cardiovascular risk. The economic 
improvements may contribute to a higher frequency of adverse lifestyles, especially among 
the lower social classes (29, 30). In this context and since low health literacy is associated 
with a range of adverse health outcomes (194), health education should be literacy sensitive 
in order to enhance health knowledge and self-efficacy to promote the adoption of healthier 
lifestyles at a long term (195). However, it was reported that, during pregnancy, more 
educated women are less willing to admit smoking to prenatal care providers (160), which 
can lead to misclassification of the exposure. Therefore, it is possible that, at least during 
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pregnancy, the association between socio-economic position and adverse lifestyles has been 
overestimated, due to social desirability. 
This is the first study to assess the cardiovascular risk profile of young Portuguese 
women, before, during and shortly after a successful pregnancy. However, some limitations 
should be discussed. The cohort Geração XXI is a birth cohort and maternal data was 
collected in this context. Therefore, mothers were invited to participate after delivery and data 
regarding prepregnancy characteristics were self-reported. Consequently, the prevalence of 
the risk factors before pregnancy may be underestimated due to the underreport of weight by 
women (196) and the lack of awareness of disease in young ages (197, 198). As early as 4 
years after delivery, we described a drastic increase on the prevalence all the risk factors, 
except smoking. Although part of this increase may be explained by the self-report of the risk 
factors at baseline, it is unlikely that this would explain totally the increase in prevalence. 
In the last decades, a stronger emphasis on women’s health status and risk 
behaviour patterns before pregnancy is advocated (199) in order to increase the awareness 
and the potential for prevention at younger ages. In fact, the high prevalence of several 
cardiovascular risk factors, as well as their clustering, not only after but also before 
pregnancy, reveals an unfavourable cardiovascular risk profile of these women. Therefore, 
the main results of this thesis emphasize the need to implement coherent and effective 
strategies of health promotion and disease prevention at early stages of life in order to 
optimize women’s current and future health. 
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